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Allegheny County (AC) has limited information on asthma morbidity.   In order to 
improve upon the sensitivity of asthma, a cross sectional study from January 1, 2002 through 
December 31, 2005 was conducted to determine whether the data received for emergency room 
visits from a large regional medical center might be a good predictor for quantifying asthma 
cases for surveillance.  An electronic medical record (EMR) abstract using the Council for State 
and Territorial Epidemiology (CSTE) Asthma Surveillance case definition of an ICD 9 coded 
physician diagnosis for  primary and secondary asthma (n= 18,284), and primary asthma (n = 
5,100) were used to define asthma.  The analysis used data from a subset of six hospitals from a 
large regional medical center covering approximately 60% of adult ED visits in AC that use 
electronic data for reporting.  A secondary analysis of the physician diagnosed primary asthma 
cases (n= 180) was applied against the CSTE Clinical and Laboratory case definition.   Statistical 
software was used to validate these data abstracted from the EMR.  Once these data were 
validated for accuracy, a fourth dataset of any primary asthma emergency room visits (n= 
10,183) were used to test the relationship between asthma morbidity and exposure to ozone.  
Recent studies have linked asthma hospitalizations in several cities to ozone action days.  
However, data on the effects of ozone as they relate to asthma emergency room (ER) visits have 
not been well studied.  Electronic medical records from the six hospitals representing the large 
metropolitan medical center in Allegheny County, PA were obtained on individuals with asthma 
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based on the ICD-9 discharge diagnosis of (493.0-493.9) for the respective time.  Data on ozone, 
PM2.5, and temperature were obtained for same period.  A case crossover methodology using 
conditional logistic regression as the statistical estimator was conducted to assess the relationship 
between levels of ozone and PM 2.5 and increases in asthma ER visits.  A time stratified sampling 
strategy was employed assuming a 3:1 case-control ratio. 
A total of 6,979 individuals were included in the study, with a mean age of 39.25 ±21.0.    
The mean ozone exposure for this period was 40.6 ppb (range: 0-126).  The effect estimates for 
year-round data was greatest for a 2-day lag adjusted for temperature (OR= 1.02 (95% CI= 1.01-
1.04) (p<.05).  For each 10-ppb increase in 24-hour maximum ozone, a 2% increase was noted in 
asthma ER visits.  These results reflect the public health significance of ozone on asthma 
morbidity and indicate a vital source of information that can be used for environmental public 
health tracking.  
 v 
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1.0  CHAPTER 1- INTRODUCTION AND SIGNIFICANCE 
Asthma is a chronic inflammatory disease of the airway that affects over 32 million 
individuals living in the United States (National Center Health Statistics [NCHS], 2005).  
Despite the dramatic rise in the prevalence of asthma over the last two decades, limited 
methodologies to conduct asthma, surveillance continues to challenge the public health 
professional when studying this disease (Boss, et al., 2001).  The inability to identify asthma due 
to the lack of an operational definition, failure to access data to determine surrogate markers for 
asthma and the inability to determine asthma triggers for those already ill has hindered the 
understanding of the disease (Pearce, Douwes, & Beasley, 2000; Peat, Toelle, Marks, & Mellis, 
2001; Pekkanen & Pearce, 1999: Pekkanen, Sunyer, Anto & Burney, 2005).   
In the 2000 report, “Attack Asthma: Why America Needs a Public Health Defense System 
to Battle Environmental Threats” published by the Pew Environmental Health Commission, the 
need to develop surveillance capacity to detect major public health threats including asthma was 
highlighted.  The ability to detect asthma cases first begins with a proper understanding of what 
constitutes a diagnosis of asthma.  The use of the survey questionnaires to ascertain information 
about asthma has been widely reported in the literature (Pekkanen & Pearce, 1999).  Although 
the use of a symptom questionnaire provides valuable information on asthma, limitations include 
recall and selection bias, which reduces the researcher’s full understanding of the burden of 
illness from this disease (Peat et al., 2001; Pekkanen & Pearce, 1999).  Since asthma consists of 
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a group of symptoms, careful consideration to the type of measurement used to capture 
information on these symptoms needs to be given (Marks, 2005).  Using a definition, which can 
be agreed upon by the physician removes the potential for misclassification of the diagnosis and 
provides the opportunity to have a consistent approach to validate asthma cases for observation 
(Peat et al., 2001; Pekkanen & Pearce, 1999).  
Describing the trends and burden of disease in individuals diagnosed with asthma is an 
essential component to public health surveillance.  Data collected from national surveys on 
asthma prevalence and the burden of disease is useful for descriptive epidemiology, but does not 
provide data on health care utilization, which includes emergency room visits, hospitalizations, 
doctor office visits and prescription drug usage (Lanphear & Gergen, 2003).  These data provide 
a more comprehensive picture of asthma and thus, serve as a valuable resource for conducting 
asthma surveillance.  Moreover, data collected in the emergency room can be used to evaluate 
short-term effects caused by environmental factors such as in the case of air pollution exposure 
and asthma exacerbation.  
A surveillance system using information technology to make these data readily available 
in an automated format, either during the delivery of medical care or with health plans linked to 
large medical practices that serve a well defined population, has been recommended by the U.S. 
Department of Health and Human Services [USDHHS] for conducting this type of surveillance 
(Baxter et al 2000 study cited in Lazarus, Kleinman, Dashevsky, Demaria & Platt, 2001, p. 2).  
Thus, the electronic medical record, the automated repository for these data has the 
capacity to provide immediate access to emergency room visits data for monitoring asthma 
outcomes and conducting surveillance (Lazarus, et al., 2001; Lombardo et al., 2003; Sanders, 
Gregg & Arnosky, 2007; Vollmer, et al., 2004; Donahue, et al., 1997; Lanphear & Gergen, 2003; 
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Panackal et al., 2002; Hung, Posey, Freedman & Thorton, 1998.  However, the scientific 
methods used to extract the data from the electronic medical record, decode it in a manner, which 
can be meaningfully interpreted with a high degree of statistical validation, must first be tested 
and the data interpreted for accuracy of diagnosis before these methods can be accepted as valid 
tools for conducting epidemiological research.   
1.1 STATEMENT OF RESEARCH PROBLEM AND SPECIFIC AIMS 
There is great need for identifying a consistent approach for conducting asthma 
surveillance (Peat et al., 2001).  The capacity to detect a case of asthma could be improved by 
using a standard case definition with definable criteria limits for carrying out asthma surveillance 
(Council of State and Territorial Epidemiologists Case Definition for Asthma [CSTE], 1998).  
Since no one gold standard is available to diagnosis asthma, collecting data on multiple 
symptoms along with a physician diagnosis of asthma can be tested to determine which 
symptoms may be better at predicting an asthma diagnosis (Lanphear & Gergen, 2003; Sistek et 
al., 2001; Sistek et al., 2006; Sanders et al., 2007; Yu, Wong & Li, 2004).  Data abstracted from 
the EMR and used for scientific conclusion must first be validated beyond the gold standard 
medical chart review.  The use of a natural language processing system, a tool for transforming 
data from text to code is one methodology that can be used for data interpretation (Manning & 
Schuetze, 1999; Krauthammer & Hripcsak, 2001; Friedman, Shagina, Lussier & Hripcsak, 2004; 
Hripcsak, Austin, Alderspcsak, & Friedman, 2002; Chuang, Friedman, & Hripcsak, 2002; 
Melton & Hripscak, 2005; Chen, Hripcsak, Xu, Markatou, & Friedman, 2008).  Moreover, data 
abstracted from the EMR can be used to test hypotheses about environmental factors, which may 
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precipitate an asthma event (Barnett, et al., 2005; Burnette, et al., 2001; Lin, Burnett, Villeneuve, 
Krewski, 2002; Villeneuve, Chen, Rowe & Coates, 2007; Luginaah, Fung, Gorey, Webster, & 
Wills, 2005; Pope, 1989; Wansoo & Schneider, 2005; Paulu & Smith, 2008).  The goal of this 
research is to evaluate different methodologies for asthma surveillance and demonstrate the 
sensitivity of their results.  These specific aims are:   
1. To describe asthma in a population of Allegheny County residents.  Characteristics 
include age, sex, race, hospital, patient type, insurance type, zip code, chief complaint, and 
admitting and discharge diagnosis.  
2.  To describe whether the use of electronic medical records are complete enough to use 
for asthma surveillance.  The following questions are posed.  
A. Can the use of automated software extract key discriminating clinical 
characteristics from the EMR to validate a diagnosis of asthma?  
B. What is the degree of reliability between the different methodologies, manual 
vs. automation? 
C. Can the use of the Council of State and Territorial Epidemiologists clinical and 
laboratory case classification definition be used against the robustness of an ICD-
9 coded physician diagnosis of asthma? 
3. To determine the association between short-term changes in air pollution 
concentrations and the acute effects of asthma within a specified population using a case 
crossover study. 
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1.2 DEFINITION AND CLINICAL FEATURES  
Asthma is a chronic disease of the airway that is characterized by a narrowing of the 
airway passages.  The inflammation noted in asthma is produced through a series of “immune-
mediated” events causing airway reduction (Merck Medicus Modules: Asthma-Diagnosis, 2001).  
The clinical symptoms manifested by the asthmatic include wheeze, cough, shortness of breath, 
and chest tightness.  These symptoms occur from the bronchoconstriction created by the 
inflamed airway in response to variety of asthma triggers.  These triggers provoke acute episodes 
of asthma symptoms which have been reported to be worse in the evening hours and morning 
hours or when exacerbated by such stimuli as cold air, allergens, air pollution, household dust 
mites, viruses and tobacco smoke (Merck Medicus Modules: Asthma-Definition, 2001).  The 
symptoms of asthma can be treated with medications or relieved spontaneously on their own  
Asthma is not one specific disease rather a spectrum of clinical symptoms, which appear 
through a number of unconventional pathways.  “There are no clinical criteria that are both 
necessary and sufficient for the diagnosis of asthma” (Marks, 2005, p. 3).  Particular to asthma is 
the inconsistencies associated with this disorder.  Asthma can appear as an acute episodic 
disorder, which can last, from minutes to hours.  “Although, asthma may “disappear” in 30-50% 
of children, it does tend to reappear in adulthood; and even among those who do not have clinical 
symptoms, lung function may remain altered” (Martin et al. 1982 study cited in Braman, 2006, p. 
7).  Moreover, the hallmark symptoms of asthma, which include wheezing, shortness of breath 
and cough, can suggest a diagnosis other than asthma (Marks, 2005).  Thus, the considerable 
amount of overlap in the clinical symptoms of asthma and other respiratory diseases, plus the 
variability surrounding the manifestation of these symptoms, produces a challenge for not only 
diagnosing the disease but also controlling the clinical course.  
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1.2.1 Historical aspect  
Asthma is not a new disease.  Accounts dating as far back as 2 century AD where noted 
by Aretaues Cappacdocian, “if from running, gymnastic exercises, or any other work, the 
breathing becomes difficult, it is called Asthma” (D. Skonner, personal communication, October 
27, 2007).  Almost twenty centuries later, physicians are still focusing on the same clinical 
context to diagnosis asthma through symptoms of breathlessness induced through exercise, 
nighttime stress occurrence, and occupation (O’Donnell & Frew, 2002).  Different terminology 
has been used to differentiate the different forms of asthma.  These include extrinsic asthma, 
which is allergen related and intrinsic, a non-allergen type.  These two forms are now referred to 
as atopic or non-atopic asthma (Kelley, Mannino, Homa, Savage-Brown, & Holguin, 2005).  
Atopy is the genetic marker for asthma, which has been reported in almost 66%-75% of all 
asthma cases (McFadden 1992 study as cited in May, 1996).  Despite knowing the genetic 
marker to asthma, environmental factors are necessary to the acquisition of the disease.  
The pathophysiological features of asthma produce a wide range of symptoms that 
eventually lead to structural changes or airway remodeling (Marks, 2005; Strek, 2006).  The 
many different expressions from the unique clinical phenotypes exhibited by individuals with 
asthma have given way to describing asthma as a “heterogeneous disorder” (Kelly et al., 2005, p. 
726).  
1.2.2 Diagnosing and managing asthma 
Over the past decade, researchers began to create new guidelines that focused on the 
treatment and management of asthma.  The National Asthma Education and Prevention Program 
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(NAEPP) Expert Panel 2 Report, “Guidelines for the Diagnosis and Management of Asthma” 
through the National Heart, Lung, and Blood Institute (NHLBI), National Institute of Health 
(NIH) provide a structured approach for managing and treating asthma (NHLBI, 1997).  The 
guidelines are prearranged into four areas: (a) measures of assessment and monitoring, (b) 
influencing factors, (c) medication, and (d) patient education.  A diagnosis of asthma is made 
through an assessment of the patient’s symptoms and results of their pulmonary function tests 
(PFTs).  The test includes the use of spirometry to assess the exchange of airflow going in and 
out of the lungs.  Measurements are used to assess normal breathing, forced inhalation and 
exhalation after a deep breath.  This test remains the best test to help the practitioner determine 
the degree of airway obstruction (Merck Medicus Modules: Asthma-Definition, 2001; 
Spirometry and Flow Measurements-Standards & Guidelines, 1998).  A methacholine challenge 
is another test, which can be done if there is not sufficient evidence from the patient’s symptom 
history and spirometry results to confirm a diagnosis of asthma.  Methacholine is administered 
through inhalation therapy to determine the degree of airway reactiveness.  The results of the 
lung function measurements taken before and after the challenge is then compared (American 
Association Respiratory Care Clinical Practice Guidelines, 2001).  Depending on the level of 
impaired lung function and signs and symptoms of the asthmatic determines the severity 
classification assigned to each individual.  This classification of severity includes intermittent, 
mild, moderate and severe.  The treatment goal is to control the asthma by minimizing the 
symptoms through medication therapy.  Individuals with a mild form of asthma may only require 
a rescue drugs for relief of symptoms while individuals with a more severe form of asthma may 
use daily medications to control their disease.  The more severe asthmatics represent 
approximately “5% of individuals who are resistant to therapy or difficult to control despite 
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taking the maximally recommended doses of inhaled medications-in particular, inhaled 
corticosteroids” (Strek, 2006, p. 116).  Despite the severity of classification, the asthma treatment 
and management guidelines are designed to be an adjunct tool to aid the clinician in proper 
treatment and management of this disease.  
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2.0  CHAPTER 2- EPIDEMIOLOGY 
Asthma is a public health problem reported worldwide with increasing prevalence noted 
for both adults and children (Beasley, 2002).  Worldwide estimates for asthma have been 
reported at approximately 300 million people (Braman, 2006).  The rise in prevalence appears to 
be associated with urbanization and westernization.  National reports from the United States 
reveal one of the highest prevalence rates in the world with approximately 22.2 million 
Americans (7.7%) reporting a case of asthma (NCHS, 2005).  Among those individuals 
diagnosed with asthma, an estimated 4.2% of the population (12.2 million) had at least one attack 
in the past year and 11.2% of persons (32.6 million) have even been diagnosed with asthma 
during their lifetime.  Children under 18 years of age make up over one third of the asthma cases; 
8.9% of children (6.5 million) have asthma compared to 7.2% (15.7 million) of adults.   
 The economic impact associated with asthma has been estimated at over 19 billion 
dollars (Weiss, Gergen, & Hodgson, 1992; [NHLBI, unpublished data] cited in the American 
Lung Association Report, 2007).  Asthma affects individuals of all age groups, with the highest 
prevalence increase reported in children and adolescents (Beasley, 2002).  Asthma is more 
common in school age children than preschool children or adults (NCHS, 2005).  Asthma is the 
leading cause of school absenteeism from a chronic disease, which accounts for 14.7 million lost 
school days each year and limits some form of activity for school children age 5-17 (NCHS, 
2002).  Although, the burden of disease is high in children under the age of five symptoms are 
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frequently overlooked by parents or not recognized until a severe attack occurs (U.S. News & 
World Report: Asthma & Allergy, 2007).   
The diagnosis although usually made in childhood, can occur in adulthood.  Asthma in 
adulthood can be intermittent, persist from childhood, or present as a new diagnosis (Marks, 
2005, USDHHS, 2000).  A new case of adulthood asthma is to a great extent related to atopy or 
allergen sensitivity (Merck Medicus Modules: Asthma-Epidemiology, 2001).  In working adults, 
studies have reported occupational factors (Kuschner & Stark, 2003) such as industry type and 
amount of work place exposure as the cause of 10-20% of the newly diagnosed adulthood 
asthma cases.  The National Institute for Occupational Safety and Health (NIOSH) purport 
occupational asthma to be the most common occupational lung disease (NIOSH, 2004). 
 The presentation of asthma prevalence differs significantly by gender and age.  Females 
overall report higher prevalence rates than males.  “The male-to-female ratio of asthmatics is 3:2 
among children ages 6-11 and increases to an 8:5 ratio among those ages 12-17” (Merck 
Modules: Asthma-Epidemiology, p.1).  The converse is true in adults with females having the 
highest rates, which continue through adulthood.  This gender reversal is not fully understood, 
however, hormonal differences have been shown to play a role (Strek, 2006).   
Asthma is considered to be a disparate disease.  A higher disease burden reported has 
been reported in certain racial and ethnic groups such as African Americans and Hispanics 
(MMWR, 1998; MMWR, 2002; MMWR, 2007; NCHS, 2005).  African Americans are more 
likely to have asthma than their white counterparts.  This finding has been consistent in all 
asthma categories which includes, lifetime, current and attack prevalence (NCHS, 2005).  Ethnic 
subgroups, which include Hispanics, report lower prevalence rates than non-Hispanic Whites and 
non-Hispanic Blacks.  Puerto Ricans have the highest asthma prevalence rate in the Hispanic 
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subgroups except for the non-Hispanic Blacks.  Certain demographic groups are also at a 
disadvantage for poorer asthma outcomes.  For example, a disproportionate number of Blacks 
are more likely to die of asthma than Whites (3.1 vs. 1.7 per 10,000) population, with Black 
females having the highest mortality rates (3.2 vs. 2.2 per 10,000) population, respectively. 
Asthma related deaths increases with age.  A total of 186 children 0-17 years of age died from 
asthma in 2004 which represents (0.3 per 10,000) population.  Individuals 18 years of age and 
over were more likely to die of asthma (2.5 per 10,000) population (National Vital Statistics 
System, 1980-2004; MMWR, 2007).  Disparities were also reported for hospital admissions with 
rates being higher in Blacks vs. Whites (33.3 vs. 10.0 per 10,000) population, females vs. males 
(19.0 vs. 14.5 per 10,000 population) and in the northeast region of the country (23.7 per 10,000) 
population vs. (13.8 per 10,000) population in the West (MMWR, 2007). 
The association between the increase in asthma prevalence and low socioeconomic has 
been reported for individuals living below the poverty level (MMWR, 2007).  Asthma 
prevalence rates are higher for those individuals who live below the poverty level and live in the 
inner cities (Wissow, Gittelsohn, Szklo, Starfield & Mussman, 1998; USDHHS, 2000).  The 
National Cooperative Inner-City Asthma project found that poor children living in the inner 
cities have difficulties gaining access to asthma care, and medications (Kattan 1997 study cited 
in USDHHS, 2000).  Inner city children are exposed to a high level of household allergens 
(Crain et al., 2002).  These allergens produce sensitivities, which precipitate asthma attacks 
(Rosenstreich, Eggleston, Kattan & Baker, 1997).  Lower socioeconomic status places 
individuals at risk for (a) more frequent emergency room visits (b) higher number of asthma 
hospitalizations, and (c) non compliance with follow up care (Camargo, Ramachandran, 
Ryskina, Lewis, & Legorreta, 2007). 
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A cohort study examining enrollees in a State Medicaid program found recidivism rates 
to be higher for emergency room visits and hospital admissions in children who failed to take 
their asthma medications.  Controlling asthma through medication compliance was the key to 
reducing risk (OR =0.55), (p = < .001) (Camargo et al., 2007).  The outcome of not controlling 
asthma results in a more severe form of disease.  Volmer (2001) reports that individual of lower 
socioeconomic status are more likely to have a severe form of asthma and die prematurely from 
the consequences.  The reduction of income further complicates the risk by increasing 
hospitalization risk by 20% [OR= 1.20 (95% CI 1.02-1.4) for a reduction in income by $10,000 
decrements (Eisner, Katz, Yellin, Shiboski & Blanc, 2001).  
In order to understand the disparities noted for asthma, better data are needed to describe 
the differences in the demographic subgroups of age, race and sex.  Currently, the best estimate 
of asthma prevalence comes from survey data.  The primary survey most commonly used to 
report trends and track progress toward meeting national objectives on asthma is the National 
Health Interview Survey (NHIS).  Three estimates are currently used to describe asthma 
prevalence (a) lifetime asthma, (b) current asthma, and (c) asthma attack.  Until 1997, prevalence 
estimates were based a 12-month self-reporting measure which at the time did not require a 
physician diagnosis of asthma.  Data reported after this time period (1997) reflects the use of two 
new measures, which are based on a physician diagnosis of asthma; lifetime prevalence or 
cumulative prevalence, and attack prevalence, which is based on someone reporting they had an 
asthma attack within the past 12 months.  A third measure, current asthma prevalence was added 
in 2000 to establish whether someone still had asthma, given they reported a previous asthma 
history (Centers for Disease Control and Prevention, NHIS Asthma Prevalence; MMWR, 2007). 
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 TRENDS  
 
The increase in asthma prevalence over the past 40 years has become a global public 
health problem.  The unanswered questions about what is causing this increase continue to 
challenge the public health practitioner (Beasley, 2002).  Although this increase is not fully 
understood, multiple factors have been suggested to be responsible for this global issue (Buist, & 
Vollmer 1990 study cited in Balmes, 1993; Beasley, 2002).  A review of the current trends in 
asthma prevalence for the United States is presented below.  
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Figure 1: Asthma Prevalence for the United States, 1980-2004 
 
1 Reproduced from “Asthma Prevalence” by the Centers Disease Control and Prevention: 
Asthma Data and Surveillance. Source: NHIS, NCHS 1980-2004. 
 
  13
An overall assessment of asthma rates between 1980 and 1996 demonstrates a rise in 
asthma prevalence (Figure 1).  This rise was based on the 12-month self-report asthma 
prevalence estimate.  The lifetime and attack prevalence estimates following this time period 
fluctuated through 2004 (NCHS, 1980-2004; MMWR, 2007).  Attack prevalence in 1997 to 2004  
were 4.2%, 4.0%, 3.9%, 4.0%, 4.3%, 4.3%, 3.9% and 4.1%, respectively.  Following this time 
period, attack prevalence has been at 4.2%, 2005-2007 (NHIS: [January-June 2007]), NCHS, 
1997-2007).  Lifetime asthma prevalence from 1997-2004 has also fluctuated (Figure 1), with 
estimates at 10.4% in 2000, increasing up to 13% in 2006.  Current prevalence estimates in 2001 
were 7.6%, decreased to 7.1% in 2003, increased to 7.3 % in 2004, 7.8% in 2005 and 8.0% in 
2006. 
Available data for US asthma deaths were also increasing from 1980-1995 (MMWR, 
2002).  This increase was highest for Blacks, females and older adults.  There was a gradual 
decline in US death rates, which was noted after 1996 and continues up to present time (MMWR, 
2007).  The 1999 ICD-9 coding classification change from ICD-9 to ICD-10 may have likely 
influenced this trend.  However, a “comparability ratio” was used to adjust rates to make data 
comparable from previous years.  Following the adjustment to the classification code, disparities 
continued to persist with mortality rates reflecting similar patterns in the demographic 
subgroups. 
Average annual numbers of deaths from 2001-2003 with asthma as the underlying cause 
were (2.1 per 10,000) population.  The female death rate was higher (2.3 per 10, 000) than the 
males (1.8 per 10,000) population.  Racial differences were noted with mortality rates being 
highest for Blacks (3.4 per 10,000) than Whites (1.9 per 10,000), Others (1.3 per 10,000), and 
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Hispanics (1.5 per 10,000) population.  Black females had the highest mortality rate overall (3.5 
per 10,000) population ((NCHS, 1980-2004; MMWR, 2007).  
An admission to the hospital for asthma serves as a marker to assess trends in asthma 
morbidity.  The asthma admission rates in the United States have increased and, similarly in 
other westernized countries over the past 40 years (Beasley, 2002).  “Between the mid 1960s and 
the mid 1980s, hospitalization rates for asthma increased by more than 200% in children and 
50% in adults” (Evans et al. 1989 study cited in Beasley, 2002, p. 483).  Hospital admissions 
rates in 1980 were (18.5 per 10,000) and (17.9 per 10,000) population in 2004.  Rates increased 
in 2003 to (19.9 per 10,000) population and decreased in 2004 (17.0 per 10,000) population 
(MMWR, 2007).  Asthma hospitalization rates were consistently higher for females from 1985-
2004 (18.7- 23.2 per 10,000 population) than males (16.8-17.4 per 10,000) population, 
respectively.  Hospital admission rates have consistently been higher for Blacks (33.3 per 
10,000) than Whites (10.0 per 10,000) and Others (19.0 per 10,000) population (US 1980-2004: 
MMWR, 2007).  Contrasting to emergency room visit rates which were (66.2 per 10,000) 
population in 2000, (59.8 per 10,000) population in 2001, (68 per 10,000) population in 2002, 
and (63.4 per 10,000) population in 2004.  Emergency room visits for asthma are at least 270% 
times greater than hospital admissions for asthma.  This difference demonstrates that emergency 
room visits represent the largest at risk population versus hospital admissions, which reflect rates 
of the sickest population who are only at the highest level of risk due to a more severe form of 
illness.   
The variations noted for the trends in asthma mortality and morbidity over the last half of 
the decade have been suggested to result from several factors.  These factors include “ (a) the 
1979 change in the International Classification of Diseases (ICD) coding of asthmatics bronchitis 
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as asthma rather than bronchitis, (b) a shift in physician diagnosis away from bronchitis to 
asthma, (c) an improved ability of physicians to diagnose asthma through greater availability and 
use of pulmonary function tests, (d) increased toxicity due to asthma medications, and (e) true 
increase in the prevalence and /or severity of asthma” (Buist & Vollmer 1990 study cited in 
Balmes, 1993, p. 221).  Additionally, the change in the 1999 ICD classification code from ICD-9 
to ICD-10 and environmental pollutants have likely played a role (MMWR, 2007, Balmes, 
1993).  
2.1 ASTHMA PREVALENCE AND BURDEN OF DISEASE 
2.1.1 Asthma prevalence 
The following information describes asthma prevalence and burden of disease in the 
United States for 2005.  Data from the 2005 NHIS, National Center for Health Statistics were 
used to create the following graphs and report on these data. 
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Prevalence of Lifetime Asthma 
Diagnosis: United States, 2005
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Figure 2: Lifetime Prevalence of Asthma, 2005 
 
1. An estimated 32.6 million Americans or (112 per 1,000) persons report a lifetime 
diagnosis of asthma. 
2. More females report a lifetime prevalence of asthma than males (121 vs. 102.7 per 1,000) 
persons, respectively.   
3. Children less than 18 years of age had higher prevalence rates (126.6 per 1,000) persons 
than individuals 18 years of age and older (107.1 per 1,000) persons. 
4. Children 5-17 were diagnosed with lifetime prevalence at a rate of (142.2 per 1,000) 
persons. 
5. The rate in Blacks (136.1 per 1,000) persons was higher in both Whites (112.5 per 1,000) 
and Hispanics (91.9 per 1,000) persons.  
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Current Asthma Prevalence by Age: 
United States, 2005
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Figure 3: Current Prevalence by Age, 2005 (age specific rates) 
 
1. A total of 22.2 million Americans report they currently have asthma (76.3 per 1,000) 
persons. 
2. Children under 5 years of age report the lowest current asthma prevalence rate (67.5 per 
1,000) persons compared to all other age groups.  
3. Children and adolescents under 18 years of age (89.0 per 1,000) persons reported the 
highest current asthma prevalence than those 18 years of age and older (72.1 per 1,000) 
persons.  
4. Current asthma prevalence rates increased from childhood to adulthood (67.5 per 1,000 
persons to 76.2 per 1,000) persons, respectively.   
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Current Asthma Prevalence by Sex and 
Race: United States, 2005
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Figure 4: Current Asthma Prevalence by Sex and Race, 2005 (sex and race specific rates) 
 
1. The current asthma prevalence rate in females vs. males was (88.3 per 1,000) to (63.8 per 
1,000) persons, respectively.  
2. The rate for adult females 18 years of age and older was (97.5 per 1,000) persons and 
greater than males in this same age category (54.7 per 1,000) persons.  Contrasting the 
younger males under 18 years of age who have higher current asthma prevalence rate 
(100.8 per 1,000) persons than females (78.3 per 1,000) persons. 
3. Black had higher current prevalence rates (99.3 per 1,000) persons compared to Whites 
(76.3 per 1,000) and Hispanics (62.2 per 1,000) persons.
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Asthma Attack Prevalence: United 
States, 2005
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Figure 5: Attack Prevalence, 2005 
 
1. 12.2 million Americans reported having an asthma attack within the past 12 months (42.0 
per 1,000) persons.  
2. Children 5-17 years of age had the highest attack prevalence (55 per 1,000) persons vs. 
the lowest rate which was found in the oldest age group (65+) (30.4 per 1,000) persons. 
3. Asthma attack prevalence rates are higher in the 0-17 year old age group (52.0 per 1,000) 
persons than in individuals 18 years of age and over (38.7 per 1,000) persons. 
4. More females than males had an asthma attack within the past 12 months (49.8 per 1,000 
vs. 33.9 per 1,000) persons. 
5. Blacks have higher asthma attack prevalence rates (47.6 per 1,000) persons than Whites 
(42.3 per 1,000) and Hispanics (36.9 per 1,000) persons. 
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2.1.2 Burden of disease 
The burden of disease and mortality from asthma can be characterized by a review of 
data on health care use, which includes emergency room visits, asthma hospitalizations, 
physician office visits, and mortality data.  Asthma emergency room visits are far greater in 
number than asthma hospitalizations.  For example, in 2004 the numbers of emergency room 
visits for asthma were 1.8 million compared to the number of asthma hospitalizations, which 
were 504,000.  This represents (63.4 per 10,000) vs. (17.0 per 10,000) population, respectively or 
a 270% greater difference (US 1980-2004: MMWR, 2007). A rise in emergency service 
utilization and hospitalizations are a direct result of poorly controlled asthma (Camargo, 2007; 
Strek, 2006). Although asthma hospitalization can be used to characterize the burden of disease, 
they only capture the highest at risk population or those with the most severe form of the disease.  
Furthermore, individuals with a more severe form of asthma are at risk for premature death 
(Volmer, 2001).  
The National Ambulatory Medical Care Survey, National Hospital Ambulatory Care 
Survey, National Hospital Discharge Survey, and National Vital Statistic System were all data 
sources used to report on these findings.  The National Surveillance for Asthma: United States 
1980-2004 Surveillance Summary Report (MMWR, 2007) was the main document referenced 
for this section of the review. 
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Figure 6: Asthma related emergency room visits, 2004 
 
1. Asthma accounted for 1.8 million emergency room visits in 2004.  This represents 63.4 
per 10,000 populations.   
2. Females have a higher usage of emergency room services than males (65.3 per 10,000 vs. 
62 per 10,000) population, respectively.   
3. Rates for Blacks (195 per 10,000) are much greater than Whites (43.6 per 10,000) 
population.   
4. Children aged 0-17 were the highest users of emergency room care, a rate of (103.5 per 
10,000) population.    
5.  The highest rate was among children 0-4 years of age at (168.3 per 10,000) population.   
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6. In 2004, adults 18 years of age and older used the emergency room less frequently (49.9 
per 10,000) populations than individuals less than 17 years of age (103.5 per 10,000) 
population.   
7. Use of the emergency room by the individuals 5-14 years of age were (155.1 per 10,000) 
population and the elderly at (138.4 per 10,000) population.  
Rate of asthma hospitalizations with 
asthma as the first listed diagnosis per 
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Figure 7: Asthma Hospitalizations, 2004 
 
1. There were 504, 000 asthma hospitalizations in 2004 due to asthma, which represents (17 
per 10,000) population.  
2. A total of 204,700 hospitalizations were in children under the age of 17 or (27.4 per 
10,000) population.  
3. The hospitalization rate (59.9 per 10,000) population was highest in children 0-4 years of 
age followed by individuals 65+ (28.7 per 10,000) population. 
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4. Blacks were over 3 times more likely to be admitted (33.3 per 10,000) vs. that of their 
white counterparts (10 per 10,000) population. 
5. Females had a higher admission rate than males (19 vs. 14.5 per 10,000) population.    
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Figure 8: Asthma Physician office visits, 2004 
 
1. There were 13.6 million outpatient visits related to asthma care in 2004.  This represents 
(468.1 per 10,000) population.  
2. Children 17 years of age and younger utilized services at a higher rate (897 per 10,000) 
population than adults 18 years of age and older (325.3 per 10,000) population.   
3. Blacks’ rates were slightly higher than Whites (477.1 vs. 476.6 per 10,000) population, 
respectively.  
4. Females had a higher rate of utilization of outpatient services than males (514.8 vs. 418.8 
per 10,000), respectively.  
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 Number of asthma deaths per 10,000 
population: United States, 2004
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Figure 9: Asthma Deaths, 2004 
 
1. A total of 3,816 people died of asthma in 2004. This represents (1.9 per 10,000) 
population. 
2. A total of 186 children 0-17 years of age died from asthma in 2004 which represents (0.3 
per 10,000) population. Individuals 18 years of age and over are more likely to die of 
asthma (2.5 per 10,000) population.     
3. Death rates were 31% higher in females than males (2.1 v. 1.6 per 10,000) population, 
respectively. 
4. Blacks were more likely to die of asthma (3.1 per 10,000) than Whites (1.7 per 10,000), 
Hispanics (1.3 per 10,000) and Non-Hispanics (1.9 per 10,000) population.  
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2.1.3 Economic burden  
Asthma is a major public health problem with significant economic consequences.  The 
estimated cost of one case of asthma results in a price tag of approximately “$300 to $1300 
dollars per-person per-year” with the largest burden coming from those individuals whose 
asthma can not be controlled (Sullivan et al 1996 study cited in Beasley, 2006, p. 487); Barnes, 
Johnson & Kilm, 1996).  A rise in emergency service utilization and asthma hospitalizations has 
been reported as a direct result of poorly controlled asthma (Camargo, 2007; Strek, 2006).  
Although, the number of individuals with poorly controlled asthma represents the smallest 
proportion of asthmatics (10-20%), they are considered to be “high cost-patients,” who are 
responsible for using over 50% of the direct medical care expenditures (Beasley, 2006, p. 488; 
Sullivan et al 1996 study cited in Beasley, 2006, p. 487; Braman, 2006).  The data reported in 
Table 1 provides an overview by category for asthma cost.  Direct expenditures account for 14.7 
billion or 77% of the total economic burden for asthma.  It appears that if asthma could be 
controlled through medication management, the financial burden would be drastically reduced.  
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Table 1: Economic cost of asthma, United States 2007 
 
Category Costs (Billions) 
Direct medical   expenditures  
Hospital Care 4.7 
Physicians Services 3.8 
Prescription Drugs 6.2 
All Direct Expenditures 14.7 
Indirect Costs  
Morbidity 3.1 
Mortality 1.9 
All Indirect Costs 5.0 
All Costs 19.7 
 
Source: Weiss, et al., New England Journal of Medicine. (March 26, 1992): Vol.  326;13.   
NHLBI chart book on cardiovascular, lung and blood disease, 2007 [unpublished data] cited in NCHS, 2007 
 Reproduced from the 2007 American Lung Association Report, “Trends in Asthma Morbidity 
  and Mortality”, p. 32.  
 
In summary, several factors have been reported that describe the burden of disease for 
asthma.  Although each factor is important for understanding the disease, the emergency room 
visit estimates appear to be a better marker for conducting asthma surveillance.  First, emergency 
room visits for asthma are greater in number than hospital admissions (1.8 million ED visits vs. 
504,000 asthma hospitalizations), respectively.  This represents (63.4 per 10,000) vs. (17.0 per 
10,000) population, respectively or a 270% greater difference (US 1980-2004: MMWR, 2007).  
A rise in emergency service utilization is directly related to poorly controlled asthma (Camargo, 
2007; Strek, 2006).  A comparison of ED visits to asthma hospitalizations in our preliminary 
analysis (Section 3.2, Figure 10) has demonstrated that for 1 asthma hospital admission per 
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person, there are 4 ED visits (1116 to 4907).  These visits result in a huge economic burden to 
the health care system (Beasley, 2006, Weiss, et al; 1992).  Furthermore, by using asthma 
hospitalizations as a marker for asthma only touches upon patients who are severely ill.  Asthma 
hospital admissions do not represent the total at risk population, but rather those who are at the 
highest risk with a more severe form of the disease.    
Second, the short-term evaluations for asthma require more detailed data to include 
physician diagnosis and the hallmark signs and symptoms, which characterize this disease.  
These data can be found in the medical record with multiple supporting documents that provide a 
more comprehensive picture of asthma.  The application of an automated feature to the medical 
record provides a stream of clinical data for conducting asthma surveillance.  Moreover, the 
facilitation of  these data through an electronic system would support national tracking efforts for 
testing hypotheses related to this chronic condition (L. Brink, personal communication, April 15, 
2008).   
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2.2 RISK FACTORS 
One of the difficulties in differentiating risk factors for asthma is the fact that we are 
unable to identify the cause (Anto, 2004; Pearce et al., 2000; von Mutius, 2000).  To better 
address what may be causing asthma, research suggest an interaction between the environment 
and genetic factors (Etzel, 2003; Johnston & Sears, 2006; May, 1996; von Mutius, 2000). 
Migration studies support the role of the environment in the etiology of asthma.  Individuals, 
who move from developing countries where prevalence rates are low to western countries where 
prevalence rates are high, see a sharp rise in asthma (Braman, 2006).  A purely genetic 
component would take years to influence this change.  However, changing influences in the 
environment are believed to play a role on disease development and exacerbation in susceptible 
individuals.    
The risk of asthma exacerbation has been shown to differ significantly by age and sex 
with asthma being more dominant in young males up through puberty with a trend reversal in 
females continuing up through adulthood (Mandhane, Greene, Cowan, Taylor & Sears 2005; 
Merck Medicus Modules: Asthma-Epidemiology, 2001; Johnston & Sears, 2006; Schatz, Clark 
& Camargo, 2006).  Hormonal differences may have likely contributed to this outcome 
(Johnston & Sears, 2006).  Several studies account for the gender and age differences in asthma.  
One study reported that wheezing differed significantly in male children and female adolescents 
(p = < 0.002) (Mandhane et al., 2005).  In Schatz et al (2006) male children under the age of 15 
were reported to be two times more likely to be admitted for asthma than their female 
counterparts: A three-fold increase was reported in females over the age of fifteen.  This 
noticeable age and gender differential in asthma was apparent for asthma severity, females were 
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found to be at greater risk (1.89) of having an asthma attack than their male counter parts 
between the ages of 18-70.  For each yearly increase in age a 1% increase was noted for an 
asthma attack (OR 1.01[95% CI 1.001-1.023]) (Manfreda 2001 study cited in Johnston & Sears, 
2006 p. 724).   
Another environmental factor influencing asthma outcomes is respiratory infections, 
particularly, the rhinovirus, which has been associated with the majority of asthma exacerbations 
in children during the fall months (Dales, et al., 1996; Johnston & Sears, 2006; Wansoo & 
Schneider, 2005).  One study reported seasonal variations in hospital admissions for a group of 
preschool children who were at a four times greater risk for being admitted for asthma vs. a non-
respiratory admission, July-October.  Fourteen percent of the variation was attributed to 
respiratory infections.  Wansoo & Schneider (2005) observed a statistically significant rise in 
asthma hospitalizations in the autumn months which was linked to weed pollen (p = < 0.001).  
An epidemiological review on asthma exacerbation by Johnston & Sears (2006) provided 
documentation of this seasonal phenomenon and its presence in countries across the Northern 
Hemisphere.  Evidence suggests that this seasonal pattern is coupled with a rise in respiratory 
infections.  Thus, suggesting the role of respiratory infections on seasonal patterns of asthma and 
in asthma exacerbation.  
Asthma is significantly impacted by indoor air quality.  The Environmental Protection 
Agency (2002) reports that indoor air quality poses a health risk due to the emission of gases and 
particles from indoor pollutants such as oil, gas, coal, paints, carpets, furniture, and sanitizing 
and personal products.  If these gases and or particles are not controlled or minimized through 
proper ventilation, they can invoke an allergic response triggering an asthma attack.   
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Indoor air exposures to house dust mites; cockroach and cat allergen concentrations also 
play a role in asthma morbidity (Etzel, 2003).  Sensitivity to cockroach allergens demonstrated 
by a positive skin test correlated to a three-fold increase in asthma hospitalizations amongst 
inner- city children (Rosenstreich et al., 1997).  Individuals exposed to indoor molds can also 
develop allergen sensitivities capable of triggering an asthma attack (Etzel, 2003) 
Exposure to environmental tobacco smoke is another significant risk factor for asthma 
(Etzel, 2003; Chilmonczyk, 1993; Stick et al., 1996).  According to a report, “Clearing the Air” 
published by the Institute of Medicine (IOM, 2000), there is sufficient causal evidence to link 
tobacco smoke to the development and exacerbation of asthma (IOM 2000 study cited in Etzel, 
2003, p. 235).  Children of parents who smoke are reported to have decreased pulmonary 
functions and more frequent asthma symptoms (Chilmonczyk et al., 1993).  Maternal smoking 
has also been reported to increase the risk of wheezing and asthma development in children 
(Stick, Burton, Gurrin, Sly, & LeSouef, 1996). 
Atopy or allergic asthma is a risk factor for asthma (Pearce et al., 2000; Johnston & 
Sears, 2006; Mandhane, et al., 2005; May, 1996; von Mutius, 2000).  Allergen exposure is 
hypothesized to be a causal link to asthma though not enough population studies have been done 
to support this assumption (Pearce et al., 2000).  Evidence does support a secondary cause in that 
sensitization from allergen exposure or prolonged exposure leads to the development of asthma 
symptoms (von Mutius, 2000; Wansoo & Schneider, 2005; Rosentreich et al., 1997; Pearce et al., 
2000; May, 1996; Kelley et al., 2005; Etzel, 2003; Braman 2006; Anto, 2004; Johnston & Sears, 
2006).  In sensitized individuals, exposures to allergens such as pollens and molds can 
exacerbate asthma (Wansoo & Schneider, 2005; Etzel, 2003).  Factors thought to impact allergen 
exposure include temperature, rainfall, relative humidity and thunderstorm activity.  Anderson et. 
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al. (2001) found an increase in asthma admissions related to thunderstorms (p = < .001).  The 
effect was greater in months with warm weather and not associated with rainfall.  Similar results 
were reported by Marks et al. (2001) for thunderstorm activity.  Asthma admissions were greater 
on days when (a) thunderstorms were present (OR= 15.0), (p = < .001), (b) during the warmer 
months, and (c) paralleled a 4-12 fold rise in grass pollens.  
Socioeconomic status has been purported to be a risk factor for asthma (Camargo, et al., 
2007; Volmer, 2001; Eisner et al., 2001; Wissow et al, 1988; DHHS, 2000; MMWR, 2007; Crain 
et al., 2002; Rosenstreich, et al., 1997).  Higher prevalence rates have been observed in western 
cultures (Braman, 2006).  Asthma prevalence rates have been shown to increase in individuals 
moving from rural to urban areas.  However, when looking at inner city regions of the United 
States individuals of lower socioeconomic status have demonstrated an increase in asthma 
morbidity (Wissow et al, 1988; DHHS, 2000).  Inner city children are exposed to a high level of 
household allergens (Crain et al., 2002).  These allergens produce sensitivities, which precipitate 
asthma attacks (Rosenstreich, et al., 1997).  Lower socioeconomic status correlates to (a) more 
frequent asthma emergency room visits (b) higher numbers of asthma hospitalizations, and (c) 
non compliance with asthma follow up care (Camargo, et al., 2007).  Individual of a lower 
socioeconomic status are more likely to have a severe form of asthma and die prematurely from 
the consequences (Volmer, 2001).  Lower socioeconomic status has been demonstrated to be a 
risk factor for asthma hospitalization based on a reduction in income by $10,000 decrements, 
hospitalization risk increased by 10% [OR= 1.10( 95% CI,  0.9-1.3)].  After adjusting for  
demographic and asthma clinical factors the OR was significant 1.2 (95% CI  1.02-1.4) (Eisner, 
et al., 2001).  
  32
Air pollution is another factor considered to impact asthma.  Criteria pollutants such as 
ozone, particulates, nitrogen oxide, carbon monoxide and sulfur dioxide mainly come from 
vehicle exhaust, power and industrial plants and factories (Clean Air Act, 1970).  There has been 
a considerable amount of research done, which links the short term exposure to these pollutants 
with a rise in cardiovascular and pulmonary mortality and morbidity.  Several of these studies (*) 
report directly on the relationship between air pollution and asthma (Barnett, et al., 2005*;  Bell, 
McDermott, Zeger, Samet, & Dominici, 2004; Bell, Kim & Dominici, 2007; Bell, Dominici & 
Samet, 2005; Borja-Aburto et al., 2004; Burnett et al., 2001;  Ito, De Leon, Lippmann, 2005; Lin, 
Burnett, Villeneuve & Krewski, 2002; Pope, 1989*; Luginaah, Fung, Gorey, Webster & Wills 
2005; Villeneuve, Chen, Rowe & Coates, 2007*; Aburto-Borja, Castillejos, Gold, Bierzwinski, 
& Loomis, 1998; Paulu & Smith, 2008*).  
2.3 RELEVANT RESEARCH ON AIR POLLUTION 
There is a great deal of evidence that supports the biological plausibility of the induced 
adverse health effects from exposure to ambient air pollutants.  Epidemiological studies suggest 
that inflammation or oxidative stress is produced when oxidants, metals, or reactive organic 
compounds found in these pollutants generate reactive oxygen species or free radicals, which 
damage DNA, thus promoting disease (Barry, 1991; Li et al., 2003, Risom, Moller & Loft, 2005; 
Bhattacharya, Alink, & Dopp, 2007; Rahman, Morrison, Donaldson, & MacNee, 1996).  The 
development of  free radicals and their effect on the body at the cellular level are associated with 
increased oxidative stress, which contributes to lung inflammation as seen in asthmatics 
(Rahman et al., 1996).  The small fraction size particulates penetrate the lung tissue, damage the 
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mitochondria and create airway damage (Li et al., 2003).  These particulates also have the ability 
to leave the pulmonary system and enter into the blood stream causing systemic inflammation 
responsible for sudden cardiac death, and interference in platelet activation that is capable of 
producing clots or ischemic heart disease (Nemar, Maskari, Ali & Al-Amri, 2007; Donaldson, 
Mills, MacNee, Robinson & Newby, 2005).  These mechanisms provide evidence to support the 
conclusions drawn from epidemiological studies, which link air pollution exposure to 
cardiovascular and respiratory mortality and morbidity. 
 Dockery (1993) points out that the type of epidemiological study used to investigate air 
pollution exposure and its human health effects is particularly challenging due to the 
complexities surrounding air pollutant mixtures.  First, individual exposure is universal and 
varies considerably from person and place.  Although, National Ambient Air Quality Standards 
are in place to protect individuals from risk, including sensitive populations such as children, the 
elderly and asthmatics, the 2008, ‘State of the Air Report” published by the American Lung 
Association (ALA) indicates that nearly half of the US population (46.0%) live in areas where 
either ozone or particulate levels are at unhealthy levels.   
The biological response resulting from these exposures is impacted by a time scale based 
on a pollutant threshold.  In a chronic disease such as lung cancer, the exposure threshold is 
cumulative from the effects of smoking, while in acute disease the exposure threshold can be 
based on a less frequent or more severe form of an exposure.  This is evident in the individual 
who is exposed to carbon monoxide and presents to the emergency room with carbon monoxide 
poisoning (Jaakkola, 2003; Committee on Advances in Assessing Human Exposure to Airborne 
Pollutants, 1991).  In a disease such as asthma whose exposure pathway is not fully understood, 
a dose-response relationship is difficult to quantify.  Furthermore, several environmental factors 
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are strongly linked to asthma development and exacerbation, thereby, making it difficult to 
measure the exposure relationships (Etzel, 2003; Rosenstreich et al., 1997; EPA, 2002: 
Chilmonczyk, 1993; Stick et al., 1996; Barnett, et al., 2005; Pope, 1989; Villeneuve et al., 2007; 
Wansoo & Schneider, 2005; Paulu & Smith, 2008).  Therefore, finding the appropriate 
methodology that provides the structure to measure the short term effects of air pollution 
exposure on asthma requires careful consideration.  
2.4 CASE CROSSOVER DESIGN 
Epidemiologist have begun grappling with the inability to capture the onset “trigger” of 
an acute event such as asthma from the short term changes in air pollution using known 
retrospective review methods (Maclure, & Mittleman, 2008; Jaakkola, 2003).  A new study 
design, the case crossover methodology was proposed “using cases only, and, for each 
individual, compares exposure just prior to the event with exposure at other control, or referent 
times” (Janes, Jones, Sheppard, & Lumley, 2005, p. 717).  The same day of the week is usually 
chosen as the control or referent time to eliminate any confounding from weekly or and personal 
activity patterns (Janes et al., 2005; Maclure, & Mitttleman, 2008; Haley et al., 2006).  
Furthermore, the ability to make an intra-subject comparison between the cases and controls 
eliminates confounding in personal and exposure characteristics. 
The exposure in the case crossover design is based on the exposure measure for the 
hazard period- the time period immediately prior to the event.  A comparison is made to assess 
the exposure in the matched control for the same time period the exposure was taken for the case.  
Exposure can be measured in terms of the level of pollutant on the event day (Lag 0), cumulative 
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effect represented by (Lag 0+1+2), or an average over several days (Average 0,1, 2) (Haley et 
al., 2006).  The strategies used to measure the effect should be modeled using a comparison of 
the different lag distributions in order to explore the relationship between different exposure 
levels and the event (Bell, et al., 2004).  Solely using a single lag model would reduce the ability 
to explore these relationships.  
The goal for using a case crossover methodology is to create a “matched set” between the 
exposure and respective control while eliminating all the temporal variations in the exposure and 
outcomes data, a no trend hypothesis (Janes et al., 2005).  The proper assignment of a sampling 
strategy removes the variations in the data by having equal distance between the hazard event 
and control periods, matching for same day of the week and within the same calendar month. 
The use of several strategies has been proposed for the case crossover methodology each with 
their own particular strengths and weakness. The strategies include (a) unidirectional, (b) bi-
directional and, (c) time-stratified  The unidirectional approach is limited by a single index time. 
Therefore, exposure estimates are based solely on one measurement period.  In the bi-directional 
approach, two control periods are present, one before and one after the event.  However, the bi-
directional strata do not always assure a fixed level of exposure across the referent periods.  
Hence, the goal for controlling the variations in the exposure and outcomes data can result in an 
overlap bias (Janes, Sheppard, Lumley, 2004).  The time stratified is the preferably method of 
choice for air pollution studies (Lu, Symons, Geyh & Zeger, 2008).  A time stratified approach 
selects a hazard period within a calendar month and selects corresponding control points to the 
case within the month, using the same day of week interval to appoint the control.  The selection 
of the referent periods prior to initiating the experiment and within the same calendar month 
reduces the bias in the estimates of conditional logistic regression (Janes, et al., 2004).  
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The case crossover design is considered to be an alternative to the time series model, a 
most commonly used methodology to assess air pollution exposure and health events over time 
(Lu, et al., 2008; Maclure, & Mittleman, 2008; Haley et al., 2006).  The case crossover 
methodology can not measure effects from long-term exposure found in such diseases like 
cancer.  However, it can measure the trigger of an event or short term exposure (Jaakkola, 2003).  
This feature makes the case crossover methodology favorable for studying air pollution exposure 
and acute health outcomes.  
The analytical measurement for the case crossover design follows the assumption of the 
matched case control study (Jaakkola, 2003; Lu et al., 2008; Janes et al, 2005).  The estimator 
used to conduct the analysis in the case crossover methodology is conditional logistic regression. 
“The measure of the effect, called the odds ratio is calculated by dividing the number of subjects 
exposed only during the hazard period by those exposed during the control period.  Conditional 
logistic regression analysis allows modeling using several or a varying number of control 
periods”(Jaakkola, 2003, p. 83)  
 
Based on the statistical requirements for conditional logistic regression each event needs 
to be independent of one another (Lou & Sorock, 2007).  This would not be the case in a dataset 
with recurrent events.  One approach is to use only the single event in the analysis, however, this 
methodology results in a reduction of sample size and power estimate.  To avoid the loss in 
power from a reduction in sample size, a “within-subject pair wise resampling technique or a 
weighted estimating equation” has been proposed (p. 2890).  For the purpose of this research, 
multiple events will be included in the analysis.  However, the use of a “wash out” period will be 
applied to assume an independence status.  The wash out will be set to remove anyone who had a 
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repeat visit within a 28-day time period, thus, accounting for independence within the 28 day 
time strata (Haley et al., 2006).   
2.5 SUMMARY OF LITERATURE REVIEW   
A number of studies report on the relationship between the short term effects from ozone 
and cardiovascular and respiratory mortality.  The effect of ozone is reported to be cumulative 
and associated with the accumulation of ozone concentrations over a few days prior to death 
(Bell et al., 2004).  Although, the effects of ozone has also been observed on day-0 and days 
prior to an event, the relationship between the collective effect of ozone and death is lost when a 
single lag model is used.  The distribution lag model, which takes into account the cumulative 
effect from multiple days of ozone exposure, “thus allows more flexibility for exploring the lag 
between exposure and death than single lag models” (p. 2373).  In one study representing 95 US 
cities [approximately 120 million persons], Bell et al (2004) reported that for every 10-ppb 
increase in the previous week’s ozone levels, total mortality was increased by 0.52%(95% CI 
0.27%-0.77%).  This effect was associated with an increase in cardiovascular and respiratory 
related deaths 0.64%(95% CI 0.31%-0.98%).  While the effect of ozone on total mortality is 
evident, a comparison of these data may be limited due to the co-existence of other air pollutants 
with ozone (Bell et al., 2007).  This relationship could potentially confound the short term effects 
of ozone mortality.  In Bell’s (2004) study the use of  PM10 was selected to explore this 
relationship.  A 1-day lag for PM10  was chosen as the effect estimate as Hoek (2007 study cited 
in Bell et al, 2004) reported this lag to have the largest point estimate.  Concluding results were 
not sufficient to demonstrate that ozone mortality was impacted by the adjustment of the 
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particulate.  However, a conclusion drawn from this research study suggests that the 
consequences from ozone on total mortality and cardiovascular and respiratory mortality are 
great.  If these findings were applied to the US population, a significant number of premature 
deaths could be eliminated through proper interventions, including more stringent ozone 
regulations.  
The ozone mortality relationship was further explored as it relates to cardiovascular and 
respiratory deaths using meta-analysis data from 39 time-series studies.  The potential 
confounding relationships of particulates were not addressed in this investigation.  Pooled lag 
estimates were compared to respective estimates from the National Morbidity, Mortality, and Air 
Pollution Study (NMMAPS).  Two comparisons were made (a) the pooled effect estimates from 
the meta analysis, which includes all 9 cities, was compared to the pooled effect estimates from 
all 95 cities from the NMMAPS, and (b) the effect estimates from 8 cities, which were 
represented in both studies, were weighed against on another.  For the first comparison, single 
lag and 2-day average lag effect estimates for a 10-ppb increase of ozone on total mortality was 
higher for the meta-analysis 0.87%(95% CI 0.55%-1.18%) than the baseline comparison using 
the NMMAPS study’s day-0 lag  [0.25%(95% CI, 0.12%-0.39%)].  The second comparison also 
resulted in a higher effect estimate for the meta analysis [0.83%(95% CI, 0.38%-1.29%)] than 
the NMMAPS estimate [0.48%(95% CI, 0.03% - 0.92%)].  Results from this study provide 
evidence that a relationship does exist between ozone and mortality.  However, the authors call 
attention to the reader about a possible publication bias.  Since effect estimates were different for 
0 and 1-day lag vs. multiple lag days, Ito et al (2005, p. 447) reports that “when an association is 
found at multiple days, choosing only a single-day’s result would underestimate the multi-day 
effects. Thus, using a risk estimate for a single day lag can result in bias in either direction”.   
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Furthermore, the results in the meta-analyses were always greater than the baseline study results: 
perhaps the author wanted to publish positive findings from this study (Bell et al., 2005). 
A second meta-analysis of 43 single pollutant model studies reported a pooled risk 
estimates for every 10-ppb increase in 1-hour daily maximum ozone concentrations for all-age 
non-accidental mortality 0.39%(95% CI 0.26-0.51%).  The greatest effect was observed when 
PM was added to the model  0.40%(95% CI 0.27% -0.53%) vs. ozone alone 0.37%(95% CI 0.20-
0.54%).  The effects of PM with ozone require adjustment for temperature  since the relationship 
with temperature is greatest for ozone.  Including ozone in a model with PM without adjusting 
for the warmer to cooler temperatures may lead to particulates confounding the ozone mortality 
relationship.  To explore this seasonal phenomenon, ozone and particulates, and (cooler and 
warmer) weather were examined.  The all-age non-accidental mortality risk estimates for a 20-
ppb increase in 24-hour average ozone was 2.2%(95% CI 0.8%-3.6%) for all-year data, and 
3.5%(95% CI 2.1%-4.9%) for the summer months.  This model demonstrated the effect 
temperature has on ozone, particularly during months where temperatures were higher.  A 
second subset study included ozone with and without PM.  Non-accidental mortality did not 
change with the all cities combined in the ozone model with PM vs. without PM, 1.5% vs. 1.6%, 
respectively.  Further analysis was conducting by looking at the summer and winter months, with 
“ozone averaged for quintiles of PM ” (p. 451) to determine if any correlation could be observed 
with PM and ozone.  The results show a positive relationship between ozone in the summer 
months and a negative relationship in the winter.  Thus, suggesting that PM does not affect ozone 
during the cooler temperatures (Ito et al., 2005).  
Bell et al. (2007) continued to explore the relationship between particulates on ozone and 
mortality.  Data from the 95 urban communities NMMAPS were tested using three different 
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methods.  The first method attempted to determine whether any correlations existed between 
ozone and PM variables using different ozone concentrations accounting for geographical and 
seasonal differences.  The Pearson correlation coefficient measurement for ozone by year, 
accounting for seasons were low for the US, PM10 (r = 0.25) and PM2.5 (r =  0.22).  Regional 
differences were observed with the highest correlations reported for the Industrial Midwest and 
Northeast for PM10,  Southwest and Industrial Midwest for PM2.5.  Winter months had the lowest 
levels of both particulates, with higher seasonal correlations observed in spring, fall and summer, 
respectively.  The second method included the PM variables as covariates in a time series model,  
including the 1-day lag representation of the effect estimate.  Corresponding PM10 and PM2.5 risk 
estimates were 0.29(95% CI 0.03-0.55) and 0.22(95% CI  0.22 -0.65), respectively.  Adjusting 
the model for PM resulted in an ozone mortality risk reduction per 10-ppb increase in the day-1 
lag but the confidence intervals were wide and included negative numbers, PM10 [0.21( 95% CI, 
-0.06 - 0.47)] and PM2.5 [0.21(95% CI, -0.22- 0.65)].  Restricting the data in this model by 
adjusting for particulates limited the sample estimates, which reduced the power for finding a 
statistical association.  In the third method, sample estimates were further restricted by using 
only a subset of the ozone data.  An observation was made that the percent change in mortality 
was affected by PM at different ozone levels.  However, one can not conclude that a significant 
relationship exists due to the reduced power in using a model with a limited sample.  
Research studies have inferred an association between PM2.5 and total mortality in a study 
conducted in Mexico City.  A percent increase in total mortality was observed for every 10 
ug/m3 increase in PM25 ,  day -0 lag (1.34%) and (1.36%) on day-4 lag.  The greatest association 
for total mortality (1.48%) was observed for the 5-day mean lag exposure for every 10 ug/m3 
increase in PM25.  The elderly were the most sensitive population affected, with an increase of 
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1.6% total mortality noted in the individuals over 65 years of age (95% CI 0.04-3.12).   The day-
4 lag from PM2.5 was also associated with an increase in respiratory and cardiovascular deaths, 
2.50% and 2.19%, respectively.  The percent increase in total mortality for ozone (mean day 1-2 
lag) was 1.76% for cardiovascular causes.  This same effect was not observed for ozone and 
respiratory causes -0.74%(95% CI -3.58-2.10) (Borja-Aburto et al., 1998).   
In summary, these findings reflect the public health significance of the effects from short 
term exposure to ozone and particulates on total, cardiovascular, respiratory and total non-
accidental mortality.  The risk estimates are greatest  for ozone at lag days 0-1 and 2, and a 2-day 
average lag for total mortality and cardiovascular and respiratory mortality, and 0-1 and 2 day 
single lag  for non-accidental mortality.  Effect estimates for particulates (PM10 and PM2.5) have 
been observed with the greatest risk reported at 1-day lag and day-0 and day-4 for total mortality, 
5-day average lag for PM2.5 for total mortality, and day-4 lag for PM2.5 and cardiovascular and 
respiratory mortality.  Lag estimates represent the risk associated with short term exposure to 
these pollutants and risk of death.  If these numbers were applied to a larger population, a great 
number of premature deaths could be prevented.  Furthermore, these findings underscore the 
need to have more stringent regulations placed on ozone and particulates to protect the public’s 
health.  
There has also been a considerable amount of research done which links short term 
exposure to these pollutants with a rise in cardiovascular and pulmonary morbidity.  Several of 
these studies report directly on the relationship between air pollution and asthma, and respiratory 
disease (Barnett, et al., 2005; Burnett et al., 2001; Lin et al., 2002; Pope, 1989; Luginaah et al., 
2005; Villeneuve et al., 2007).  
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A correlation between elevated PM10 levels and increased hospital admissions for 
bronchitis, pneumonia, pleurisy and asthma were reported by Pope (1989).  During time periods 
when the steel mill was open, hospital admission rates for children 0-17 years of age were 3 
times greater during exceedance periods of the 24-hour standard (> 150 ug/m3), and nearly 
doubled when the average PM10 level (50 ug/m3 ) were equal to or greater than the standard.   
Hospital admissions during the same time period for adults had risen 44% and 47%, respectively 
for the same standards.  The closing of the steel mill resulted in a reduction in levels of PM10, 
which corresponded to a reduction in admissions for respiratory admissions.  The reduction was 
more notable for asthma and bronchitis admissions and greater for children.  
Lin and associates (2002) assessed the relationship between short term exposure to PM 
2.5, PM10, and coarse particulates 10-2.5 averaged over 1-7 days for childhood asthma 
hospitalizations using bidirectional case-crossover, and time series analysis.  No statistically 
significant relationship was observed for either PM2.5 or PM10.     However, a statistically 
significant relationship was observed for PM 10-2.5  with a consistent rise observed in asthma 
hospitalizations in both boys and girls 6-12 years of age.  The rise continued up to day-6 average 
for girls and continued up to day-7 average for boys.  The effect estimate for day- 6 average was 
(RR= 1.18) using both case crossover and time series analysis for girls, and (RR = 1.16) and (RR 
= 1.12) respectively, for boys.  The resultant rise in asthma hospital admissions 16% and 12%, 
respectively, was based on the corresponding risk estimate for an increase of 8.4 ug/m3 of PM10-
2.5.  Both methodologies yielded similar results for coarse particulates 10-2.5. 
  In another study, respiratory admissions differentiated by age and sex were reported as 
they relate to the exposure from multiple air pollutants.  The study used a case-crossover 
methodology and time series analysis to conduct the experiment.  For both methods, a higher 
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number of respiratory admissions were observed in female’s ages 0-14 and 15-64, than in males. 
In the case-crossover analysis for NO2,hospitalizations for females 0-14 years of age increased 
by 19%, (p =  < 0.05) per 16-ppb increase in the 24-hour NO2 levels.  No significant association 
was observed within any other female age group for NO2, but was present for CO in females in 
the same age group.  Effects estimates from CO were statistically significant on lag day 0-1 and 
2 using the case crossover analysis  (RR = 1.15), (RR = 1.19), (RR = 1.22), respectively, and 
time series analysis day-1 lag (RR = 1.06), (p = < 0.05).  The time series analysis was the only 
methodology which reported statistically significant findings for SO2 on  day-0 lag in the 0-14 
year old age group (RR = 1.11) (p = < 0 .05).  For all females, COH effects were present on day-
0 lag (RR= 1.09) using case crossover, and day-2 lag (RR=1.06) using time series analysis (p = < 
0.05).  An effect for CO day-2 lag was also reported in the 15-64 year old age group (RR = 1.15), 
(p = < 0.05).   The only effect observed for males was in the 15-64 year old age group for PM10  
at day -1 lag (RR=1.17), (p = < 0.05).  Females appear to be at a disadvantage for respiratory 
admissions from air pollution.  However, further investigation into factors such as biological 
differences with age and sex, and air pollution exposure needs to be conducted before any 
conclusions can be drawn from these research findings (Luginaah et al., 2005). 
 A case-crossover study conducted by Barnett and associates (2005) examined the effects 
of short-term exposure to pollutants (PM2.5, PM10, O3, SO2, and NO2) on daily counts of 
childhood respiratory hospital admissions in children <1, 1-4, and 15-14 years of age.  Hospital 
admissions significantly differed across cities, for diagnosis and age group.  A percent increase  
in respiratory hospitalizations was observed in the 0 age group 2.5%(95% CI 1.1-4.0), and 2.2% 
(95% CI 1.2-3.2) in the 1-4 age group for particulates 0.1-2 um in diameter.  For individuals in 
the 5-14 year old age group, a 6% increase was observed for asthma admissions, which 
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correlated to a 5.1 ppb increase in the 24-hour NO2  level.  When the data was split to explore the 
seasonal (cool and warm) effects on asthma hospital admissions, warmer months generally had 
higher admission rates than cooler months.  A 10.2% increase was observed in asthma 
admissions for the 5-14 year old age in the warmer months compared to seasons with cooler 
temperatures (7.2%).  
Villeneuve and associates (2007) conducted a case crossover study to examine the effects 
of ambient air pollution on ED visits for asthma.  The analysis was conducted for all months and 
by season for each different pollutant (SO2, NO2, CO, PM2.5, PM10, and O3).  This analysis 
differentiated results based on age.  The analysis that included all months demonstrated that no 
significant effect was observed during the winter months for these pollutants. Data representing 
the summer months resulted in statistically significant findings for NO2, CO, PM2.5, PM10 and O3.   
The greatest risk was found using the 5-day average lag for each pollutant.  Children 2-4 years of 
age and the elderly were the most sensitive to CO [day-5 average], (OR= 1.48 and 1.54), 
respectively, and for NO2 [day-5 average] in these same children, (OR= 1.50), (p = < 0.05).  A 
significant relationship was observed for both particulates at 3 and 5-day average lags (p= < 
0.05) for all individuals in the all seasons and warm temperature model.  A significant 
relationship was also observed with ozone during the all seasons and summer month’s model 
using the 3 and 5-day average lags.  The risk was more evident in the summer months with 
asthma admissions increasing by 11% for all individuals (p = < 0.05).  Surprisingly, the effect 
estimate for the youngest (2-4 years of age) and oldest age group (75±) did not result in any 
significant findings.  Statistically significant differences were only observed for individuals  5-14 
years of age for the all months and summer month model using the 3 and 5-day average and the 
1-day lag for the summer month model (p = < 0.05).  All ozone models were statistically 
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significant in individuals 15-44 years of age.  Only the all seasons model for individuals 45-64 
years of age at the 5-day average was significant (p = < 0.05).  
The strong seasonal effect of ozone was also observed by Burnett et al (2001) in a group 
of children less than two years of age.  A risk for being admitted to the hospital for a respiratory 
condition was increased by 35% from May through August.  The increase in the number of 
admissions corresponded to an association of 45.2 ppb increase in the 1- hour daily maximum 
ozone concentrations.  The 5-day moving average for May- August was 34.8, April-September -
4.9, and January- December 16.1.  These effect estimates demonstrate that the correlation 
between temperature and ozone is great.  No relationship was observed between April- 
September when summer months were not included in the model.  The January through 
December model that included the summer months was high but was the effect was reduced by 
including the winter months in the analysis.  The very young are vulnerable to ozone and this 
conclusion is reflected by the reported increase noted for hospital admissions (35%) during the 
summer months-May through August when children < 2 years of age are at greatest risk.  
These studies provide evidence of the relationship between exposure to ambient 
pollutants, including ozone and fine particulates and respiratory morbidity, including asthma.  A 
temporal relationship exists between exposure and outcome.  The biological response resulting 
from these exposures is impacted by a time scale based on a pollutant threshold.  The point 
estimates for lag days that are associated with a statistically significant risk (p = < 0.05) are 
highlighted in Table 2. 
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Table 2: Point estimates for lag days associated with respiratory and asthma morbidity 
 Reference  Pollutant Lag estimates Morbidity 
Luginaah et al., 2005 PM2.5-10 Day-6 average 
Day-7 average 
Asthma admissions 
Luginaah et al., 2005 Respiratory 
admissions 
Villeneuve et al., 
2007 
PM10 Day-1 
 
Day-3 average, Day-5 
average 
Asthma ED visits 
Villeneuve et al., 
2007 
PM2.5 Day-3 average, Day-5 
average 
Asthma ED visits 
Luginaah et al., 2005 Respiratory 
admissions 
Villeneuve et al., 
2007 
CO Day-0-1-2,  
 
Day-5 average  Asthma admissions 
Luginaah et al., 2005 COH Day-0-1-2 Respiratory 
admissions 
Luginaah et al., 2005 SO2 Day-0 Respiratory 
admissions 
Villeneuve et al., 
2007 
NO2 Day-1 
Day-5 average 
Asthma admissions 
Villeneuve et al., 
2007 
Day-1 
Day-3 average, Day-5 
average 
Asthma ED visits 
Burnett et al., 2001 Day-5 
(moving) average 
Respiratory 
admissions  
Paulu & Smith, 2008 
Ozone 
Day-4 average Asthma ED visits 
 
 
Since Allegheny County exceeds the standard for the annual and daily PM2.5 standard and 
8-hour ozone standard, it would be important to examine the role of these pollutants either alone 
or in conjunction with each other as they relate to asthma events.  This type of study would 
augment the knowledge of practitioners in the area by providing information about a potential 
link between exposure to air pollutants and asthma.  Information as such can be used by the 
public health official in a health alert to reduce behavior in sensitive populations when risk may 
be elevated.   
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3.0  CHAPTER 3- CRITICAL REVIEW OF LITERATURE 
3.1 SURVEILLANCE 
Disease surveillance is an essential component of public health.  Historically, several 
different methodologies have been used to detect and stop the spread of disease (Lombardo & Ross, 
2007).  Crude forms of surveillance lead to the development of vital statistic records that were used 
to collect information systematically for births and deaths (Gostin & Hodge, 1998).  The registration 
of morbidity data and reliance on these data by public health officials, eventually lead to the 
mandatory collecting of data for infectious diseases, and the classification of reportable conditions, 
which were considered to be a threat to the public’s health (Lombardo & Ross, 2007; Gostin & 
Hodge, 1998).  Currently, public health surveillance has moved beyond collecting data solely for 
infectious diseases to include information on chronic diseases, which accounts for the majority of the 
mortality and morbidity in the United States (Pew Environmental Health Commission, 2000).  
Surveillance is the first essential service of public health (CDC: National Public Health 
Performance Standards [NPHPS]: Ten Essential Services).  In order to carry out this service, key 
data fundamental to public practice needs to be collected and analyzed on a routine basis.  Without 
such data to perform these analyses, the core functions of public health, assessment, policy 
development and assurance can not be carried out (Glad, Kotchian, Barron, 2004).   
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Gaps in surveillance capacity highlight the need to have standardized information 
routinely collected on “human exposures, environmental hazards, chronic disease and other 
health related health endpoints” (IOM, 1988; Pew Environmental Health Commission Report, 
2000 as cited in Glad et al, 2004, p. 9).  An integrated public health tracking system at the 
national level would provide the infrastructure to have access to these types of data to gain a 
better understanding of the “trends, causes, and environmental factors influencing disease” Pew 
Environmental Health Commission Report, 2000, p. 6).  As the Centers for Disease Control and 
Prevention, National Environmental Public Health Tracking Program (2006) continues to build 
on this national initiative, public health practitioners continue to look for new ways to collect key 
data beyond the traditional method of using data collected from passive reporting systems such 
as data from physicians and laboratories who are fulfilling their reporting requirements imposed 
by the law (Schuchter, 2003).   
The electronic medical record is one methodology being recommended for 
comprehensive data collection.  The electronic feature provides quick access to information 
captured when the patient arrives for care.  The automated feature also creates a stream of 
clinical data, which can be integrated into existing data systems for routine analysis or monitored 
by health care professionals at off site locations.  Furthermore, the application of data mining 
tools can be applied to extract data from these records for scientific interpretation and 
visualization.  These features alone underscore the need to consider this methodology for asthma 
surveillance.  
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3.1.1 Electronic medical records 
The EMR is a rich source of health information that is slowly making its way into modern 
day health care (Coiera, 2003, Chapter 10).  Included in the medical record are the patient 
demographics, past medical history, admission and progress notes, laboratory results, pharmacy 
notes, and discharge summaries.  The arrangement of these documents into one computerized 
system eliminates the need for the conventional paper based record.  The EMR was described in 
the 1997 Institute of Medicine Report: The Computer-Based Patient Record: An Essential 
Technology for Health Care (IOM, 1997) as “a type of clinical information system, which is 
dedicated to collecting, storing, manipulating, and making available clinical information  to the 
delivery of patient care.  The central focus of such system is clinical data and not financial or 
billing information.  Such a system may be limited in their scope to a single area of clinic 
information (e.g., dedicated to laboratory data), or they may be comprehensive and cover 
virtually every facet of clinical information pertinent to patient care”.  
The EMR provides several advantages over the paper based medical record which 
includes (a) ease of access to information in a timely, automated format; (b) improved decision-
making ability for the practitioner due to the availability of comprehensive information; and (c) 
use of data to monitor and report on disease outcomes (Coiera, 2003, Chapter 10).   Furthermore, 
data mining tools can be used to extract data from the electronic medical record for quantitative 
evaluation (Krauthammer & Hripcsak, 2001; Friedman et al., 2004; Hripcsak et al., 2002; 
Chuang, Friedman, & Hripcsak, 2002; Friedman, 1997; Melton & Hripcsak, 2005; Chen et al., 
2008).   
The use of the EMR for surveillance improves efficiency of reporting since the burden to 
report a diagnosis is removed from the physician and replaced by an automated process (Lazarus, 
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et al., 2001).  A classification code can be used to extract a diagnosis from the EMR for disease 
ascertainment.  The automation features further allows data to be culled from multiple data 
sources for integration into a customized data system and used by healthcare agencies to fulfill 
reporting requirements for disease and surveillance (Pennsylvania’s National Electronic Disease 
Surveillance System [PA-NEDSS]: 33 Pa.B.2439).   
 Several epidemiological studies have demonstrated the utility of using the electronic 
medical record (EMR) as a surveillance tool for detecting outbreaks of infectious diseases 
(Lazarus, et al., 2001; Panackal et al., 2002), assessing potential bioterrorism events (Lombardo, 
et al., 2003; Barthell et al., 2002), and enumerating clinical outcomes (Donahue et al., 1997; 
Hung, et al., 1998; Vollmer, et al., 2004).   
The University of Pittsburgh Medical Center study conducted by Panackal et al. (2002) 
demonstrated the accuracy of using electronic reporting over the paper based methodology for 
confirming cases of infectious diseases.  Of the two methods tested, the electronic reporting 
system was 74%(95% CI  66%-81%) more accurate than the paper-based reporting system 65% 
(95% CI 57%-73%), ( p =  < 0 .05) for confirming disease.  The use of an automatic reporting 
system not only increased timeliness, but outperformed the paper based reporting method.  To 
improve the completeness of data for electronic reporting, the authors recommend minimizing 
the use of  free text  information. 
 Military and healthcare organizations have used automated systems to group clinical 
symptoms, which may reflect patterns indicative of a bioterrorism-associated condition (Barthell, 
et al., 2002).  A system of this type could be used to alert the medical staff if the frequency of  
signs and symptoms reached detectable levels above a normal standard (Wagner et al., 2004).  
Moreover, this system could alert emergency personnel as to a timelier response and recovery 
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plan.  Early warning syndromic systems can serve many purposes, including the benefit added to 
the public health practitioner.  For example, a syndromic system can be used to alert the 
epidemiologist about seasonal events such as influenza and allergies to communicating daily 
surveillance data to local county health departments (Lombardo et al., 2003).   
A  prototype for a syndromic surveillance system used in Allegheny County is the Real 
Time Outbreak and Disease Surveillance (RODS) system.  This system has been operational for 
approximately 9 years.  The input in the system is collected from the patient as they enter the 
hospital system.  As presented in the patient’s words, the chief complaint captured in the 
emergency department is used to detect disease clusters formulated by the syndromic 
classification of the chief complaint (Wagner, et al., 2004).  Once classified into a disease 
category, the RODS system uses a “signally out”  process to measure data in time and space to 
predict disease.  Evaluation of these data is based on the CDC recommended guidelines for 
evaluating a syndromic surveillance system (MMWR, 2004).  The assumption with RODS is 
based on the likelihood that the system can predict that a problem exists above the normal limits, 
and detects the problem in a timely manner.  The accuracy in meeting these assumptions is 
evident by the early detection of gastrointestinal outbreaks reported in both adults and children 
where RODS picked up the problem 10 and 11 days, respectively, before the event and in a most 
recent event alerted public health officials about a rise in the number of daily respiratory cases 
which correlated to an environmental exposure from carbon monoxide.   
To improve ways for positively identifying a disease, Donahue et al. (1997) recommends 
reviewing multiple databases or record types to confirm a positive diagnosis.  For example, 
individuals diagnosed with asthma are 3 times more likely to be on an asthma medication.  An 
acute visit to the emergency department for asthma with an order for a nebulizer treatment and 
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no other asthma medication criteria has been observed to be 100% predictive of a diagnosis of 
asthma vs. an urgent visit for asthma without any medication criteria (80%) (Volmer et al.,  
2004).  An order for a nebulizer treatment without any further evidence to substantiate the 
asthma diagnosis reduces the positive predictive value (27%).  Solely relying on the pharmacy 
records alone to confirm a diagnosis of asthma without further clinical information to 
substantiate the diagnosis would result in a lower sensitivity of findings.  Individuals with a less 
severe form of asthma would likely not have been identified by just reviewing the pharmacy 
record in this study since individuals who have a milder form of asthma do not use asthma 
medications on a regular basis.  This was evident in the study conducted by Volmer et al. (2004) 
where a very low positive predictive value was observed (27%) for a nebulizer treatment order 
without any further substantiating factors to back up an asthma diagnosis.  Thus, searching 
multiple data types for a longer time periods can substantially improve the validation of an 
asthma diagnosis.   
The ability to identify a patient with asthma is difficult without a physician diagnosis. 
The establishment of one standardized case definition or combination of symptoms to predict 
asthma is being considered (Sistek et al., 2006; Sistek et al., 2001; Pekkanen, et al., 2005; 
Sanders et al., 2007; Yu, Wong, & Li, 2004).   
Pekkanen and associates (2005) suggest that to obtain a high probability (OR >1.0) or 
threshold rating for asthma, grouping signs and symptoms or using them in combination with an 
objective measure such as bronchial hyperresponsiveness (BHR) may be useful for 
epidemiological research.  However, the researcher has to consider the cut-off point to use when 
combining asthma symptoms.  For example, sensitivity for asthma has been shown to decline 
when multiple symptoms are combined, wheeze alone (63%), wheeze with breathlessness (48%), 
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and wheeze, breathlessness and no cold (38%).  Specificity on the other hand is high 82%, 93% 
and 92%, respectively.  A more stringent definition has a higher specificity and a lower 
sensitivity.  Thus, including a single definition for asthma with single symptoms improves both 
sensitivity of findings and specificity.  
In Sistek et al., (2006) a combination of respiratory symptoms were analyzed to 
determine their performance at predicting a diagnosis of asthma, and whether the addition of 
BHR improved the predictive value (Table 3).  Wheezing with dyspnea overall had the highest 
discriminatory value for predicting a diagnosis of asthma with a sensitivity of 82% and 90% 
specificity.  The positive predictive value was 42.7%.  Even though the sensitivity for isolated 
wheeze was higher (93.4%) than wheeze with dyspnea (82%),  the specificity indices were lower 
76.4% vs. 90%, respectively, and the positive predictive value was lower at  26.4%.  Symptoms 
of  nocturnal and rest dyspnea and nocturnal chest tightness had rather low to moderate 
sensitivity (41-75%) and specificity greater than 85%.  The inclusion of BHR with symptoms 
resulted in a high specificity for all symptoms > 90%, (p = < 0. 0001) and lower sensitivity (< 
83%) for all symptoms except chronic phlegm, nocturnal dyspnea, and chronic bronchitis (not 
highlighted in Table 3).  Broncho hyperresponsiveness was found in both persons with asthma 
(85.2%) and without (19.5%).  The estimated risk based on the highest predictive values for the 
inclusion of BHR with symptoms was greatest for wheeze with dyspnea and (62.7%) and rest 
dyspnea (61.1)% (Table 3).  However, the inclusion of BHR with symptoms reduces predicting 
who has disease and increases the knowledge of who does not.  
 
Table 3: Diagnostic value of symptoms in the presence and absence of a physician diagnosis of asthma: Survey and chief complaint data  
Study Age Physician 
diagnosis 
of asthma 
Wheeze Cough Shortness of 
breath 
/dyspnea 
Fev
er 
Other Sensitivity 
% 
Specificity 
% 
Positive 
predictive 
value % 
 
 
X 
X    
X Phlegm  
 
63.3 
52.0 
59.2 
75.3 
69.9 
92.7 
14.1 
10.0 
34.1 
X X   X Phlegm  33.3 97.6 46.4 
1. Community Survey-self reported 
symptoms against doctor’s 
diagnosis (Yu et al., 2004, Table 1, 
p. 456). 
 
 
 
8-12 
 
 
 
Yes  
X X    45.4 96.5 44.9 
 
Yes 
 
with chief 
complaint  
X  
 
 
 
X 
 
X 
 
 
X 
 
 
X 
 
X 
 
 
 
X 
X 
 27 
4 
10 
3 
44.8 
99 
99 
99 
95 
91.6 
96 
67 
84 
33 
79.3 
2. ED visits using chief complaint 
and ICD 9 codes: characteristics for 
five chief complaints  
(Sanders et al., 2007, Table 3, 
 p. 531). 
2-18 
 
Chief 
complaint 
alone  
X 
 
 
X 
 
 
X 
 
 
 
X 
 56 
16 
21 
6 
97 
82 
91 
29 
94 
39 
64 
6.2 
    X BHR   84.6 80.5 28.2 
X  X  X BHR   72.3 96.1 62.7 
  X rest  X BHR  33.9 98.1 61.1 
X     93.9 76.4 26.4 
X  X   81.5 90.1 42.7 
X X    76.9 86.8 34.5 
 X    43.1 83.9 19.4 
    X nocturnal 
chest 
tightness 
75.4 85.1 31.4 
  X nocturnal    41.5 95.8 47.4 
3 Predictive values of respiratory 
symptoms in the clinical diagnosis 
of asthma (Sistek et al., 2006, 
Table 1, p. 2109). 
 
20-44 
 
 
 
Yes 
  X rest    43.1 92.9 35.4 
X     75 87.3 12.4 
X in 
combination 
with one 
symptom 
 X nocturnal 
X rest  
X exercise 
 
  
 
 
X nocturnal  
chest 
tightness 
37.5 
38.4 
54.2 
40.9 
98.6 
98.7 
95.7 
97.5 
39.3 
42 
23.1 
28.1 
4. Clinical diagnosis of current 
asthma: predictive value of 
respiratory symptoms 
( Sistek et al., 2001, Table 4, 
 p. 217). 
 
18-60  
 
Yes 
X alone with  
2 nocturnal 
symptoms 
  X X   X chest 
tightness 
80 85.9 11.9 
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A cross sectional survey was conducted by Yu, Wong & Li (2004) to determine how well 
child reported respiratory symptoms with and without spirometry could predict a diagnosis of 
asthma.  An observed difference was noted by gender with boys having over twice the 
prevalence estimates than girls (8.2% to 4.1%), respectively, and a higher estimate was found in 
the older children 10-12 years (6.5%) vs. the 8-9 year olds (5.5%).  Gender difference were 
reported for isolated respiratory symptoms which showed that more boys than girls had cough 
(17.0% vs. 10.7%), wheeze (36.0% vs. 31.4%), phlegm (13.2% vs. 6.5%), and in combination, 
cough and wheeze (44.4% vs. 45.7%), and cough plus wheeze and phlegm (46.8% vs. 45.5%), 
respectively.  Seventeen models were created to look at predictors of asthma based on the 
isolated respiratory symptoms with spirometry measurements.  Wheezing was highly predictive 
for asthma 59.2% (Table 3).  Less than 8% of the cohort who did not have asthma had wheezing. 
A combination of wheeze, plus cough and phlegm had a positive predictive value of 46.4%.  
Less than 2% of this combination group with phlegm had asthma.  When phlegm was removed 
from the model, sensitivity increased to 45.4% and the positive predictive value slightly 
increased but not significantly (44.9%).  Thus, phlegm is not a good predictor of asthma (Table 
3).  A cutoff for spirometry at FEV1:FVC < 75 had the highest positive predictive value for 
asthma 22.9%.  The three symptom model of wheeze with cough, and phlegm and FEV1:FVC < 
75 had the highest predictive value at 83.3%.  Removing phlegm from the model increased the 
positive predictive value from 88.3% to  88.9%.  The same indices were observed with wheeze 
alone and FEV1:FVC < 75, the positive predictive value was 88.9%.   
A review of emergency room visits for asthma in a pediatric population found that the 
chief complaint of wheezing, shortness of breath, fever, cough and dyspnea were recorded in 
greater than 95% of all asthma visits (Sanders et al., 2007).  Fifty six percent of all asthma visits 
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were due to wheezing, 21% dyspnea, 16% cough, and 6% fever (Table 3).  Each isolated chief 
complaint included in a model with a diagnosis of asthma was highly specific (99%).  For all 
chief complaints combined (wheeze, cough, shortness of breath, and fever) with a diagnosis of 
asthma, a positive predictive value of 79.3% was reported.  The most discriminating chief 
complaint for asthma was wheezing with a positive predictive value of (96%), followed by 
dyspnea (84%).  Even when no diagnosis for asthma was reported, wheeze was the most frequent 
reported chief complaint (56%), specificity (97%) and a positive predictive value of 94%.   
In Sistek et al. (2001) data was collected on 9,651 individuals 18-60 years of age.  Data 
from a community questionnaire was analyzed to determine the positive predictive value of a 
single symptom and a combination of symptoms to predict a diagnosis of asthma.  Wheezing was 
reported in 75% of the asthma cases (Sistek et al., 2001).  Less than 4% of the population who 
did not have asthma had wheeze with one of the following symptoms, rest dyspnea, nocturnal 
dyspnea, exercise dyspnea and nocturnal chest tightness.  Combining wheezing with any two of 
the nocturnal symptoms, chest tightness, shortness of breath and cough was found to have the 
highest sensitivity and specificity (80.5% and 85.9%), respectively (Table 3).   
3.1.2 Classification of clinical free text data  
The increased availability of the EMR subsequently increases the need to access the data 
using some form of knowledge model to transform the data for scientific interpretation (Manning 
& Schuetze, 1999; Krauthammer & Hripcsak, 2001; Friedman et al., 2004; Hripcsak et al., 2002; 
Chuang et al., 2002; Melton & Hripscak, 2005; Chen, Hripcsak, Xu, Markatou, & Friedman, 
2008; Visweswaran, Hanbury, Saul & Cooper, 2003; Cooper, Buchman, Kayaalp, Saul & Vries, 
1998).  One approach to aid the researcher in the automated text classification of the data is to 
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use a form of machine learning to employ algorithms and techniques that, “build classifiers by 
learning from a pre-classified set of documents, the characteristics of the categories” (Sebastiani, 
2007, p.1). 
Visweswaran and associates (2003) use this approach to build a computer model by first 
classifying words, phrases and medical language concepts to determine which algorithms 
perform better at identifying adverse drug related events found in the EMR discharge summary.   
The standard method to identify an adverse drug related event is through a medical chart review.   
However, this method is costly and time consuming.  By training a model using machine 
learning algorithms, the computer is able to pick up the relevant text data related to an adverse 
drug related incident.  These data from the original set of records are characterized and reapplied 
to a subsequent set for classification.  A continual “search and review” of the records is 
conducted to further locate words associated with an adverse drug related events (Cooper et al., 
1998, p. 182). 
A similar model was developed by Cooper and associations (1998) to identify patients in 
an intensive care unit who were diagnosed with deep vein thrombosis (DVT).  A search of the 
EMR using criteria to identify patients of interest was the first step of the study.  Once patients 
were classified during the “search and review” process it was hypothesized that new patients 
would be identified given a new search cycle was initiated.  The use of this methodology 
demonstrated the effectiveness of using a machine learning model to identify the cases of DVT 
correctly in the study, and continued to outperform the model by identifying additional cases.  
Natural Language Processing (NLP) operates through principles of machine learning to 
interpret data from clinical narratives and transforms it into a language which computers can 
understand (Manning & Schuetze, 1999).  Natural Processing Language tools are used to apply a 
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text classifier to the clinical information through a set of classifying codes that extract clinical 
data from the EMR.  The mechanism for translating the codes are established through an expert 
based classification system such as the Unified Medical Language System (UMLS).  The 
classification system allows data found in the EMR to be linked through this web-based process 
and translated for understanding of the medical terminology (Coiera, 2003, Chapter 17).  The 
UMLS is the infrastructure, which supports a network that is made up of a  metathesaurus,  
semantic network, and lexicon (Lindberg et al. 1993 study cited in Coiera, 2003).  The 
metathesaurus is a very large database made up of biomedical vocabulary and classifications that 
include the ICD-9 and ICD-10 coding systems.  The semantic network is the input classifier that 
assigns concepts from the metathesaurus into certain categories (National Library of Medicine, 
Semantic Network fact sheet).  The relationship between the categories and terminology 
concepts provide the structure of the semantic network.  The lexicon is used to assist with NLP 
to code terminology into concepts for interpretation and meaning (Coiera, 2003, Chapter 17).   
One natural language processor used by the scientific community is Medical Language 
Extraction and Encoding (MedLEE).  This processor is used to extract text data from the medical 
record and translate the data into terms identified in the UMLS (Friedman et al., 2004; Chen et 
al., 2008; Coiera, 2003, Chapter 17).  The text data is encoded and transformed into a variety of 
formats including, an XML output.  Researchers have used MedLEE to extract information on 
the frequencies and the occurrence of clinical conditions from chest radiography reports 
(Hripcsak et al., 2002), identify patterns between drug - disease relationships (Chen et al., 2008), 
parse out a broad range of clinical information from discharge summaries (Krauthammer & 
Hripcsak, 2001) and, used as a screening tool to identify adverse medical outcomes reported in 
the New York Patient Occurrence Reporting Tracking System (Melton, & Hripcsak, 2005). 
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MedLEE has been in existence for over 20-years and serves as the industry standard for the 
medical community.  Moreover, MedLee has been reported to be as accurate to that of physician 
review.  An agreement of 95% was observed for MedLee’s matching the physician review in 
accurately identifying the presence and absence of findings in the clinical narrative 
(Krauthammer & Hripcsak, 2001).  
Another type of text processor, which can be used when large amounts of data need to be 
processed, is Practical Extraction and Reporting Language (PERL), a command line driven 
processor.  This processor uses a regular search expression engine to encode pattern matching 
functions with automation (Wall, Schwartz, Christiansen, Potter, 1996).  A powerful feature of 
PERL is its ability to conduct text processing with little manipulation of the input stream.  When 
other programs require multiple lines of code to execute a simple function, PERL often times 
requires only one or two lines of code to complete the function.  The programs ability to 
specifically match on any character, types or groups of characters, in any order found in the 
document suggests that this program may have utility in analyzing free text data from the 
electronic medical record (Breeding, 2002).  Another feature of PERL is its ability to use a full 
complement of search expression for patterns for matching functionality, as well as logical and 
string manipulation capabilities of a procedural programming language.  PERL compilers are 
available for UNIX, Lenox, Windows and Mac operating systems.  However, the principal 
disadvantage of this application is that full knowledge of the codes and command structure 
within PERL is required in order to operate the text processor.  Furthermore, PERL can not 
account for misspelled words, the plural form of the word, or double negative terms.  The 
accuracy of  findings may be further reduced by these weaknesses.  
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Another form of search agent, which can be used to analyze large amounts of text data, is 
the ATLAS.ti software.  This application operates with a command line driven programming 
search that can analyzes data found in a textual, graphical, or video format (Muhr, 2003).  This 
software agent uses an easy “drag and drop” approach to code, merge and link the data 
(ATLAS.ti-The Knowledge Workbench: Features).  Searches are conducted using a modified 
version of Global Regular Expression Print (GREP), a form of line text coding where data 
outputs match each line.  A major advantage of the software is its ability to add structure to the 
data, and transforms the data so relationships between different parts of the data can be 
visualized.  Once the data has been extracted from the file it can be expressed as a single word, 
phrase, or classified into hierarchical trees or decision trees.  Data can then be exported in a 
variety of formats, which include SPSS, HTML, XML, and CSV.   
A disadvantage of using this type of software with the electronic medical records is the 
lack of ability to annotate the medical record in a way, which allows the software to search one 
record at a time.  The electronic medical record is made up of a group of documents (a) narrative 
clinical reports, including free text history and physicals; (b) dictated physicals; (c) 
consultations; (d) clinical follow up visits; (e) emergency room notes; (f) laboratory results; (g) 
surgery reports, and; (h) discharge summaries.  Each document contains a unique identifier 
number to represent the patient, a visit identifier to reference the visit, the date in which service 
was rendered and the record type, which classifies the type of visit through which a service was 
prescribed.  An annotation “E_O_R” is found at the end of each record to indicate where the 
record ends.  The limited line by line searching function in ATLAS.ti restricts the user from 
being able to use a full term document search by sentences, paragraph or sections within the 
record.  The specificity of information captured is further reduced by the lack of understanding 
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how to retrieve information using a more complex search expression for a status, which can not 
be determined.  Without a clear understanding of GREP, and knowledge on how to bypass the 
limited line by line searching feature of this software, the investigator is hesitant about 
suggesting the use of this software with EMRs based research. 
There are several knowledge based applications suitable for mining data from the 
electronic medical record.  However, each product comes with its own particular strengths and 
weaknesses.  Each application should be tested and difficulties presented.  The known successes 
and failures should be carefully weighed against the project under consideration.   
3.1.3 Value of the ICD 9 Code 
The systematic process of classifying diseases was first reported in the 18th century.  The 
progress in preventive medicine has lead to the development of an international classification 
system, which not only consisted of a list of deaths, but included a corresponding one for disease 
(Coiera, 2003, Chapter 17, Section).  The International Classification of Disease (ICD) system 
has become the standard way to collect and analyze mortality and morbidity data worldwide 
(World Health Organization [WHO], 1977)   Since its inception, the classification system is in its 
tenth revision.  Several countries including the U.S. have not fully adopted the 10th Revision.   
Proposed regulation will replace the 9th revision with ICD 10 code sets, effective October 1, 
2011 (American Academy of  Professional Coders, 2008).  However, for the purpose of this 
research the disease under investigation has been classified using an ICD 9 code [ninth revision] 
terminology.   
 The ICD code is accepted as a “defacto reference point for many healthcare 
terminologies,” (Coiera, 2003, Chapter 17, Section 17.1).  Administrative classification of the 
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ICD-9 code has played a critical role in health care history, particularly for reimbursement (O’ 
Malley, et al., 2005).  Healthcare agencies use the ICD-9 codes as an indicator to monitor work 
volume, measure disease, and as a method to establish reimbursement for diagnosis (Lazarus, et 
al., 2001; Espino & Wagner, 2001; O’Malley, et al., 2005)  More importantly for the 
epidemiologist, the use of the ICD-9 code can be used to study disease for a single diagnosis or 
grouping symptoms based on common diagnoses (Lazarus, et al., 2001; Lombardo et al., 2003; 
Sanders et al., 2007; Vollmer, et al., 2004; Donahue, et al., 1997; Hung et al., 1998).  Medical 
researchers have successfully demonstrated the use of  ICD- 9 coded chief complaint to detect 
the onset of gastrointestinal outbreaks (Wagner, et al., 2004) and respiratory related conditions 
(Espino & Wagner, 2001).  Several studies have demonstrated the accuracy of using the ICD-9 
coded physician diagnosis of asthma as a gold standard in conducting epidemiological research 
(Vollmer, et al., 2004, Sanders, et al., 2007).  O’Malley (2005) provides a review of the 
limitations identified in the coding process, which may affect the reliability of the ICD 9 coded 
physician diagnosis.  The limitations are defined in terms of a continuum from the time the 
patient presents to the emergency room until the time of discharge.  The ICD 9 coded physician 
diagnosis is assigned following discharge from the hospital.  The following information 
highlighted in Table 4  summarizes the potential sources of error along this continuum.   
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Table 4: ICD 9 Coding Process: Pathway for misclassification  
Measures of 
Diagnostic 
Accuracy 
Impacting factors  
Certainty or accuracy 
of diagnosis 
• Patient, physician and medical staff knowledge 
about the disease 
• Type of disease 
• Current state of medical technology 
• Translation of information into code   
Communication  • A patient needs to be a good historian 
• Providers need to ask appropriate questions and 
obtain a full medical history. 
• Physicians need to understand the patient 
Testing and 
diagnostic accuracy  
• Presentations and etiologies of disease need to be 
understood.   
• Physician knowledge of  best test and procedures 
• Availability of tests and procedures, and results 
interpreted correctly (sensitivity, specificity and 
predictive value). 
Change in medical 
knowledge or testing 
• Medical progress improves the ability to make 
diagnosis (i.e., stroke confirmed through non 
invasive testing using a brain MRI instead of a 
spinal tap or arteriography) (Provenzale et al. 
2003 study cited in O’Malley et al., 2005 p.1629). 
Medical record 
variance in 
terminology 
• Omission of medical information from chart by 
staff and physician) 
• Non legible physician hand writing  
• Imprecision (use of synonyms) 
Coder error variance  • Change in the coding classification system to 
include alphanumeric codes 
• One diagnosis code selected by the coder for a 
physician diagnosis.    
• Coder experience, and training [American Health 
Information Management Association-
credentialed]  
• Miscoding, resequencing of the codes (diagnoses 
are reversed), and upcoding for higher 
reimbursement  
Source:  Journal of Health Service Research (October 2005); 40(5 Pt 2); p. 1625-1628 
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Although, the use of ICD coding is a complex process, awareness of coding accuracy needs 
to be taken into account when conducting research using the ICD 9 coded physician diagnosis.  
Particularly for a disease such as asthma whose differential diagnosis can greatly vary. 
3.1.4 Diagnostic accuracy  
Currently, there is no operational definition for asthma (Pekkanen et al., 2005).  In order 
to conduct epidemiological research on asthma a standard case definition is needed to improve 
comparability across populations (CSTE, 1998).  The (1998) Council for State and Territorial 
Epidemiologist (CSTE) case classification definition for asthma allows states to collect data on 
mortality and morbidity through the (1) Hospital Discharge, (2) Clinical and Laboratory case 
classification definition and (3) Prevalence survey.  The classification status for definitions 1 and 
2 allows one to determine the number of asthma cases by reviewing the health service utilization 
records, and the clinical and laboratory notes of the medical record (Table 5).  The CSTE 
classification definitions for asthma are highly sensitivity and capture all levels of asthma from 
mild to severe.  In case definition 3 the prevalence classification, a diagnosis of asthma is 
obtained through a patient’s self report of the diagnosis, which relies on a patient’s memory and 
understanding of the questions pertaining to ascertainment of a diagnosis.  The CSTE 
recommends validating the accuracy of the self survey response through other reporting 
measures.   
Another classification system widely used to measure performance of care and service is 
the National Continuous Quality Assurance (NCQA), Healthcare Effectiveness Data and 
Information Set (HEDIS).  A classification definition exists for asthma, which is used by 
insurance companies to make comparisons across agencies.  The HEDIS measure also relies on 
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pharmacy and medical utilization claims data and is more specific than the CSTE case 
classification definition for asthma (Lichter, 2004).   
The CSTE case definition presents three methods for conducting asthma surveillance. 
Each method requires a baseline understanding of the health care utilization practices of 
individuals with asthma.  These data could not be obtained unless a preliminary review of the 
medical record and secondary data sources were conducted.     
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Table 5: Council and State Territorial Epidemiologist: Asthma surveillance and case 
definition   
Case Definition    Description 
__________________________________________________________________________ 
1. Hospitalization Discharge Classification  
 
• ICD-9 diagnosis codes 493.0 through 493.9 inclusive; (J45.0-J45.9) as primary diagnosis 
or secondary.  
  
2. Clinical and Laboratory Classification  
 
Definitive Clinical Criteria 
 
• Wheezing lasting 2 consecutive days or more,  
• Chronic cough that responds to bronchodilatation that persists 3-6 weeks in the absence 
of allergic rhinitis sinusitis 
• Nocturnal awakening with dyspnea, cough, and or wheezing in the absence of other 
medical conditions known to cause these symptoms. 
 
Definitive Lab Criteria  
 
• PFT (spirometry, FEV1, FVC) demonstrating a 12% increment after the patient inhales a 
short acting bronchodilator 
 
• 20% decrement in FEV1 after a challenge by histamine, methacholine, exercise or cold 
air 20% diurnal variation in peak expiratory flow over 1 to 2 weeks 
 
I. Confirmed -Met any clinical symptom at least 3 times during the past year AND at 
least one of the laboratory criteria. 
 
II. Probable meets any of the following: 
• In the absence of supporting laboratory criteria, presence of any of the clinical 
symptoms which have been reversed by physician, treatment with asthma 
medications and have occurred at least 3 times during the past year.  
• In the absence of supporting clinical criteria met at least one of the laboratory 
criteria during the past year.   
• In the absence of supporting laboratory or clinical criteria, taken medications in 
the past year that was prescribed by a physician for asthma. 
 
III. Possible meets any of the following: 
• Shortness of breath (SOB) on exertion 
• Presence of wheezing or chronic cough in the absence of obvious respiratory 
infection 
• Presence of increased nasal secretion, mucosal swelling, nasal polyps or chronic 
sinusitis 
• Hyper expansion of the thorax 
• Wheezing during normal breathing 
• Prolonged phased o forced exhalation 
• Chest x-ray showing hyper expansion 
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(Table 5 Continued)  
 
•  FEV1 less than 80% of predicted value 
 
 
Case Definition    Description  
 
3. Prevalence Classification  
  
I. Confirmed  
• There is no confirmed case classification for self-report. Health departments are 
encouraged to validate the accuracy of survey self-response data. 
 
  II. Probable:  
• A positive response to the survey question, “Did a doctor (or other health 
professional) ever tell you (or any household member) that you (they) had 
asthma?” AND  
 
A positive response to any of the following survey questions: 
 
“Do you (or the household member) still have asthma?”  
 
“Have you (or any household member) taken prescription medications for 
asthma (such as albuterol, inhaled steroids, cromolyn, theophylline, etc) 
during the past year?”  
 
“Have you had a wheeze episode in the past year?” 
 
 III. Possible:  
• A suspect case meets any of the following: A positive response to survey 
question “Have you (or any household member) used over-the-counter 
medications for asthma during the past year?”  
 
Positive response to survey question, “Have you (or any household member) 
experienced  episodes of wheezing during the past year? 
 
 
Table 5: Reproduced from the Council and State Territorial Epidemiologist. Asthma Surveillance 
Case Definition. CSTE position statement, 1998.   
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3.1.5  Healthcare utilization  
The different types of health care services utilized by individuals with asthma are an 
important component to understanding this diagnosis.  Particular to this work, an assessment of 
these health services for asthmatics in Allegheny County (AC) was needed to make meaningful 
interpretation of the results of the proposed research.  This background review was based on 
estimates reported in a descriptive study conducted in 2004 by the PITT-PM Health Outcomes 
Project Team (Talbott, Zborowki, & Bilonick, 2007; [unpublished report]).  A review of the 
(1994-2004) data from the Pennsylvania Health Care Cost Containment Council (PHC4)* was 
used to establish a baseline estimate of the proportion of persons living in AC who were admitted 
to the hospital for asthma.  There was 364,244 admissions reported for circulatory  (ICD-9 code 
390-459.0), and respiratory (ICD9 460-519) diseases between 1999-2004.  A total of 113,553 
hospital admissions were related to respiratory conditions.  The number of annual average daily 
admissions for respiratory diseases were 51.8 (range 20-167) per day.  The highest daily number 
of admissions for a particular respiratory disease was as follows: pneumonia (17.6/day), chronic 
bronchitis (11.1/day), other respiratory diseases (7.5/day) and asthma (6.5/day).  Hospital 
admission rates were highest in the oldest age groups 65-84 (445.7 per 10,000 population) and 
85+ (995.0 per 10,000) followed by the younger children less than five years of age (164.5 per 
10,000) (Table 6).  A steady rise in hospitalization rates were noted, as age increased hospital 
admissions increased.  These findings are consistent with national statistics on asthma 
hospitalizations (MMWR, 1980-2004; 2007, NCSH, 2007).   
For all types of respiratory admissions, females had a higher admission rate than males 
(157.5 vs. 136.7), respectively (Talbott et al., 2007, [unpublished report]).  However, males in 
  69
their early years less than five years of age and (5-24) were reported to have higher 
hospitalization rates (197.1 and 35.3 per 10,000 population) respectively, than females (130.5 
and 28.4 per 10,000 population).  This pattern in adolescent females after 25 years of age is 
reversed and continues up until age 65, when rates are higher for males.  The gender difference 
may reflect the influence of hormones in adolescent females, and smoking and occupational 
exposure in older adult men.  Seasonal effects were also evaluated by looking at hospitalizations 
for respiratory disease by month.  The colder months, December through March yielded high 
numbers of admissions than months with warmer temperatures.  
Table 6: Annual hospital admission rates Allegheny County residents 1999-2004 for 
respiratory disease by age 
 
Hospital admissions for diseases of the respiratory system by disease category and age in Allegheny County 
residents 1999-2004: Annual average admission rates (per 10,000) population.  First admissions and readmissions 
with primary discharge diagnosis (ICD9 460-519). 
Age group 
<5                5-24           25-44             4 5-64         65-84          85+            Total  
Diseases 
 
Acute bronchitis/bronchiolitis (466) 
Other acute respiratory (460-465)  
Other upper respiratory (470-478) 
Pneumonia (480-486)  
Influenza 487 
Bronchitis (490-491)  
Emphysema (492)  
Asthma (493) 
Other COPD (494-496)  
Lung disease/other respiratory  
Total  
45.9             0.3               1.4                  2.7                8.4          28.4 
14.2             1.9               1.4                 1.3                 2.1            3.4  
8.5               3.4                1.8                 1.6                 2.0           1.8 
41.4             7.4               11.5               35.4             155.9       462.6   
1.3               0.2                0.3                 0.5                  1.5           4.3 
0.2               0.2                2.5                 30.7             129.9       150.8 
0.0               0.0               0.1                  1.0                  3.1            2.7   
44.6            14.8              12.8                19.2              23.0           33.3 
0.0               0.0                0.1                  1.2                  6.9            9.2 
8.5               3.6                7.6                 26.0             113.1          298.4 
164.5          31.9               39.4              119.5              445.7        995.0        
     5.6 
     2.3 
     2.6 
    50.2 
     0.6 
    31.5 
      0.8 
    18.6 
      1.6 
     33.8 
   147.7 
Reproduced from /projects/PITT-PM/Final_Report/CONSOL/FinalReport1_ver65.odt with approval from Dr. 
Evelyn Talbott (2007) Table 28, p. 187. 
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 Data from emergency department (ED) visits in AC are reported by many health care 
agencies.  A total of 14(70%) of the 20 hospitals surveyed in AC by the PITT-PM Health 
Outcomes Project Team (2007) indicates electronic data were available for emergency room 
visits.  A total of 662,292 emergency room visits were reported in AC (2003-2004) of which 
46% were associated with the University of Pittsburgh Medical Center (UPMC).  Individuals 
living in AC reported their use of the larger (UPMC) emergency departments for care unless they 
lived on the outskirts of the city where smaller hospitals closer to their residence were used. 
The data available on emergency room visits can be found in the medical record.  The use 
of the medical record for data extraction can be timely and cost prohibitive for the health care 
agency.  Currently, data are being stored electronically at many large health care agencies in the 
country.  A total of the 14 hospitals surveyed in this analysis indicated they had the capacity to 
report data in an electronic format.  These hospitals were inclusive under the UPMC network that 
has a large interoperable electronic medical record reporting system.  
The UPMC Medical Archival Retrieval System (MARS) is used to provide de-identified 
electronic data on emergency room visits for the UPMC network of 10 hospitals.  This system 
provides data from hospitals, physician offices and outpatient visits.  MARS is useful as a tool 
for surveillance as it can provide information on demographics, past medical history, chief 
complaint, ICD 9 abstract, physical examination, discharge diagnosis and medication usage.  The 
proposed research will receive de-identified data from the MARS database via an electronic 
medical record abstract where the demographic information is stored.  Data for the emergency 
and admission intake, medication history, clinical and laboratory variables will be abstracted 
from the emergency note and history intake section of the medical record.  The data to be 
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analyzed for this research study represents data from 6 hospitals (60%) of the UPMC network or 
30% of the hospital network in Allegheny County. 
3.2 PRELIMINARY ANALYSIS  
In order to establish a baseline estimate of the burden of illness for the proposed study a 
preliminary analysis was conducted.  The best estimate of asthma prevalence in AC has been 
reported from the 2002 Behavioral Risk Factor Surveillance Survey [BRFSS] that represents 
lifetime prevalence of asthma.  Nine percent of AC residents responded “yes” to the question, 
“Have you ever been told by a doctor that you have asthma?”  Based on this 9% estimate, 
approximately 113,933 (2002-2004 yearly average) persons in AC have asthma.  Current asthma 
prevalence estimates from 2002-2005 for the Metropolitan Statistical Reporting Area of 
Pittsburgh which includes the U.S. Census-defined seven county region surrounding the city of 
Pittsburgh in Western Pennsylvania suggest that between (6.3-9.7%) of the population have 
asthma (BRFSS).  Although, these results are inclusive of prevalence estimates for multiple 
counties they are based on the subjective recall of a patient’s history.  These findings are not the 
most robust estimates of asthma prevalence and require another methodology to validate the 
results.  Hospital admission rates were determined to be a better indicator for measuring the 
impact of asthma morbidity for the proposed research.  
 To determine the rate of AC residents with a primary diagnosis of asthma who was being 
hospitalized due to asthma an analysis was conducted on the PHC4 and the MARS dataset.  
These datasets represented residents in AC with a first primary diagnosis of asthma who 
presented to the ED and were subsequently admitted for an asthma event from 2002-2005.  Cases 
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were de-duplicated in both datasets, meaning that patients were only counted once as a primary 
diagnosis of asthma for the time period specified.  The hospital admission rates are described in 
Table 7.  
 
Table 7: Asthma hospital admission rates per 1,000 persons in Allegheny County  
Comparing two data sources (2002-2005) for first admissions with primary discharge diagnosis 
ICD9 493.0-493.9.  (De duplicated) 
 
Column A Column B Column C Column D Column E Column F 
Year Population in 
AC 
Total Number 
inpatient 
admissions 
*(HC4) for 
asthma per 
year in AC 
 
Asthma hospital 
admission rates in AC 
and  95% CI 
 
 
Total number  
inpatient  
admissions ** 
(MARS 
dataset) for 
asthma per 
year in AC 
Asthma hospital 
admission rates in 
UPMC dataset and  
95% CI 
 
 
2002 1,272,640 1,590 1.24 (1.18-1.31) 442 .347 (.316-.380) 
2003 1,268,127 1,927 1.52 (1.45-1.58) 621 .489 (.452-.529) 
2004 1,263,617 1,841 1.45 (1.39-1.52) 640 .506 (.468-.546) 
2005 1,259,337  Not available  740 .587 (.546-.631) 
* 98% compliance reporting of PHC4 data  (not all admitted through ED for asthma) 
** inclusive of 6 hospitals in UPMC dataset 
 
 
 
It was determined that for 2002-2004 (PCH4 dataset) that 1.2 per 1,000 persons with 
asthma were being hospitalized due to an asthma event (Table 7, Column D).  Asthma hospital 
admission rates from the MARS dataset for the same time period were 300-400 times less than 
rates reported from the PCH4 data (Column F).  However, the MARS dataset in this proposed 
research accounts for only 60% (6 out of 10 hospitals) of the UPMC network and only 30% of 
the AC hospital network.  Both datasets represented children and adults.  The UPMC MARS 
dataset did not include asthma visits from Children’s Hospital but included individuals 0-
103(M= 38.73, SD = 20.99).  The PHC4 dataset age ranged from 0-103 (M= 44.72, SD= 26.36).  
The highest number of hospital admissions was reported for African Americans and females in 
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both datasets.  The conclusion drawn from comparing the two datasets was that the proposed 
study dataset only captured a fraction of the asthma hospital admissions.  
 To estimate the number of  AC residents with asthma who were utilizing the emergency 
room for asthma management, further analysis was conducted on the de-duplicated MARS 
dataset.  Of  the total 6,024 primary asthma cases, patients were seen in the ED and treated for 
asthma about 4-5 times more than those hospitalized for a diagnosis of asthma, respectively.  
This pattern was observed over a 4-year time period (Figure 10). 
Emergency room visits for primary asthma (6 
UPMC hospitals) by disposition 2002-2005 
(n=6024)
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Figure 10: Preliminary analysis: Primary asthma diagnosis for emergency room visits (6 
hospitals in UPMC network) by disposition 
 
To further determine if individuals with a primary diagnosis of asthma had a prior visit 
for asthma which was not captured in the initial medical record abstract or for patients who may 
have been treated on an outpatient basis, a random sample (n=50) of the primary asthma dataset 
was conducted to look at the frequency of all types of visits for these 50 individuals.  A total of 
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509 visits were identified (Table 8).  Asthma related visits represented 102(20%) of all total 
number of visits.  For individuals who presented to the ED for asthma, 75(73.5%) were being 
managed in the ED, 20(19.6%) admitted to the hospital for asthma, and 7(6.8%) treated on an 
outpatient basis.  The preliminary analysis provided evidence that emergency room visits are 
greater in number and could be used to evaluate the short-term variations in asthma.  Emergency 
room visits for asthma provide a better look at the “total” at risk population vs. asthma 
hospitalizations, which are reflective of those individuals who are at greatest risk with a more 
severe form of the disease.  Moreover, further analysis is needed to determine the contributing 
factors leading to asthma exacerbations, which leads to utilization of services either in the 
emergency room or for those hospitalized.  
 
Table 8:  Healthcare utilization patterns for individuals with a primary asthma diagnosis 
2002-2005  
 
Random sample (n=50) primary asthma 
Visit type Frequency of 
all types of  
visits 
Frequency of visits related to 
only asthma 
 
Percent  of 
visits related 
to asthma 
% 
Emergency room 178 75  73.5 
Inpatient 
hospitalizations 
44 20 19.6 
Outpatient  287 7 6.8 
Total * 509 102 100.0 
*Inclusive of 6 hospitals in UPMC network 
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3.3 RESEARCH METHODS AND DESIGN  
A cross sectional study was conducted for the period January 1, 2002 through December 
31, 2005 using data abstracted from the electronic medical records for emergency room visits 
identified through the UPMC Medical Archival Retrieval System (MARS).  The EMR abstract 
included data on emergency room visits from UPMC Braddock, Shadyside, Presbyterian, St. 
Margaret’s, McKeesport and South Side Hospitals where electronic data was available for 
reporting.  De-identified data was provided on the following variables: visit identifier, hospital, 
diagnostic related group, zip code,  patient type, visit type, age,  race, sex , insurance status,  
admission date, and discharge date, length of stay, chief complaint, and the admission and 
discharge diagnosis. 
The medical record abstract was approved under the Exempt Status of  the IRB# 0610013 
(Appendix A).  Four medical record abstracts were conducted which produced 4 different asthma 
datasets all with de-identified data for the variables mentioned above, and for the 6 hospitals 
included in the UPMC network.  Each medical record abstract was conducted for the time period 
January 1, 2002 through December 31, 2005.  The following criteria were used.  Population A 
was produced through a medical record abstract using ICD-9-Code (493.0- 493.9; ICD-10-CM 
Codes: J45.0-J45.9) to identify all primary or secondary diagnoses of asthma, Population A 
(n=18,284).  Population B included all first primary asthma ED visits with an ICD-9-CM code 
(493.0- 493.9; ICD-10-CM Codes: J45.0-J45.9).  The records were de-duplicated and marked for 
the first asthma visit by year, and individuals 0-17 years of age were removed, Population B 
(n=5,100).  Population C was obtained by conducting a 10% random sample of the all first 
primary asthma ED visits with an ICD-9-CM code (493.0- 493.9; ICD-10-CM Codes: J45.0-
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J45.9), Population C (n=488).  Population D included any visit to the ED with a primary 
diagnosis of asthma with an ICD-9-CM code (493.0-493.9).  These data for Population D 
represented recurrent visits for a primary asthma diagnosis in 6,979 individuals.  For the purpose 
of the time stratified case, crossover study conducted under specific aim #3, the numbers of visits 
were reduced to fulfill the assumptions required under conditional logistic regression that 
requires control of the dependency factor for each asthma visit.  A total of 10,183 visits were 
identified for the population of 6,979 persons, this was Population D (n= 10,183).  The methods 
used to reduce the number of asthma visits is further explained under the Methods Section 3.3, 
Specific Aim #3.  A diagram to outline the specific aims as they relate to each population of this 
research is illustrated in Figure 11. 
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Specific Aim #1 
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Any visit to the Emergency Room with 
asthma as a primary or secondary 
diagnosis (dx) (ICD 9 code 493.0-493.9) 
between 2002-2005 (n=18,284)
Inpatient 
(n=6,383) 
Any visit to the emergency 
room with a primary 
asthma dx (de-duplicated) 
(n=5,100)
Inpatient 
(n=1,095) 
Emergency Room Visits 
(n=4,005) 
10% Random Sample (adults) 
(n=488) visits 
Inpatient 
(n=103) 
Emergency Room Visits 
(n=385) 
488 visits had an ICD 9 code of 
(493.0-493.9) for a primary 
diagnosis of asthma. Only 180 of 
them were dictated in the electronic 
medical record. Remaining notes on 
Template System on paper. 
Emergency Room Visits 
(n=11,901) 
Electronic Medical Record 
Review 
(488 visits) 
Study 
Population 
A 
Study 
Population 
B 
Broken down 
further, each first 
visit with asthma as 
primary diagnosis 
by  year 
cont’d. next page 
Study 
Population 
C 
Allegheny County Descriptive Analysis 
 
Specific Aim #2  
 
Validation Study   
 
 
 
Is the electronic medical 
record (EMR) complete 
enough to use for 
asthma surveillance?
 
 
 
 
 
 
 
 
 
Can the use of automated software extract 
key discriminating clinical characteristics 
identified in the EMR to evaluate an 
asthma diagnosis? 
 
 
 
 
 
 
 
 
 
 
 
 
What is the degree of reliability between 
the different methodologies: Manual vs. 
automation? 
 
 
 
 
 
 
 
 
 
Can the application of the Council of State and 
Territorial Epidemiologists (CSTE) clinical and 
laboratory case classification definition be used against 
the robustness of an ICD-9 coded physician diagnosis of 
asthma on medical chart review? 
 
 
 
 
 
 
 
 
cont’d. next page 
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Specific Aim  # 3 
 
24-hour daily 
maximum ozone 
levels 2002 - 2005 
Study 
Population D 
Case Crossover Study 
To determine short term changes in air 
pollution concentrations and acute health 
effects of asthma in Allegheny County 
Any visit to the Emergency Room 
for primary asthma (ICD-9 code 
493.0-493.9) from  2002–2005 
           (n=10,183) 
 
 
Figure 11: Specific Aims 
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The goal of this research is to evaluate different methodologies for asthma surveillance 
and demonstrate the sensitivity of their results.  These specific aims are:   
1. To describe asthma in a population of Allegheny County residents, a descriptive 
analysis was conducted using the CSTE Hospital Discharge Classification for all primary or 
secondary diagnoses of asthma who presented to the ED from January 1, 2002 through 
December 31, 2005 with an ICD-9-Code (493.0- 493.9; ICD-10-CM Codes: J45.0-J45.9) for 
asthma, and for all first primary asthma ED visits with an ICD-9-Code (493.0- 493.9; ICD-10-
CM Codes: J45.0-J45.9).  The records were de-duplicated and marked for the first primary 
asthma visit by year.  The following variables were used in the descriptive analysis: age, sex, 
race, hospital, patient type, insurance type, zip code, chief complaint, and admitting and 
discharge diagnosis.  
2.  To describe whether the use of the electronic medical record was complete enough to 
use for asthma surveillance, a representative sample of the electronic medical records for 
individuals with a first primary asthma ED visit were obtained.  A total of 488 visits had an ICD 
9 code of (493.0-493.9) for a primary diagnosis of asthma.  Only 180 of these ED visits were 
dictated in the electronic medical record.  A summary describing the EMRs was based on the 
completeness of information found in the records when conducting the Validation Study and 
classify asthma cases according to the CSTE Clinical and Laboratory case classification 
definition.  A secondary goal under specific aim #2 included a Validation Study  to determine the 
following:  
A. Whether the use of automated software could be used to extract key 
discriminating clinical characteristics from the EMR to validate a diagnosis of 
asthma?  
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B. What the degree of reliability is between the manual vs. automated 
methodologies? 
C. Whether the use of the Council of State and Territorial Epidemiologists 
Clinical and Laboratory Case Classification definition could be used against the 
robustness of the ICD-9 coded physician diagnosis of asthma?  
3. A case crossover study was conducted to determine the association between short-term 
changes in air pollution concentrations for the 24-hour maximum ozone concentration and daily 
24 hour average PM2.5  level ) and the acute effects of any primary asthma emergency room visit 
for 6 hospitals in AC.  
 Specific Aim 1: In order to describe the asthma population used to conduct countywide 
asthma surveillance, the investigator had to find a methodology for properly identifying asthma 
cases.  The CSTE Hospital Discharge Classification definition using both the ICD 9 coded 
primary and secondary asthma diagnosis (physician diagnosed) was used to conduct the first 
EMR abstract.  To further explore other options for identifying asthma cases the CSTE Hospital 
Discharge Classification case definition criteria was modified to include only the ICD 9 coded 
primary asthma diagnosis.  A descriptive analysis of each Population A-B created through the 
medical record abstract was conducted.  The analysis included a review of the following 
variables, age, sex, race, hospital, patient type, insurance type, zip code, chief complaint, and 
admitting and discharge diagnosis.  A comparison was made between the primary asthma 
admitting diagnosis vs. hospital discharge diagnosis to determine if one diagnosis was superior to 
the other for ascertaining cases of asthma.  
Specific Aim 2: To explore whether the EMR was complete enough to conduct asthma 
surveillance, a sample of the electronic medical records representing individuals with a first 
  82
primary asthma ED visit was needed.   A 10% random sample of  (Population-B) was conducted.  
This step resulted in a third asthma dataset-Population C (n=488).  Of  the 488 visits, which had 
an ICD-9 code for a first primary diagnosis of asthma, only 180 of them were dictated in an 
electronic medical record.  This is due to the large percentage of ED visits, which are done, via a 
Template system on paper and they do not use an electronic medical record system.  This applies 
to UPMC hospitals, South Side, Braddock, McKeesport and Horizon.  Only the electronic 
medical record that had an ED summary note available for review was included in the analysis 
(n=180).  The descriptive summary of the electronic medical record was based on the 
completeness of data found in the records when conducting the validation study and classifying 
asthma cases according to the CSTE clinical and laboratory classification case definition.  
To begin the Validation Study a list of asthma symptoms or characteristics predictive of 
an asthma diagnosis was needed.  A set of seven indicators deemed by the researcher and the 
University Of Pittsburgh Graduate School Of Public Health Environmental Public Health 
Tracking Team was selected as the criterion for identifying a case of asthma (Figure 12).  The 
consensus was supported by evidence purported in the medical literature on asthma (Sanders et 
al., 2007; Hung et al., 1998;  Sistek et al., 2001; Sistek et al., 2006; Sanders et al., 2007; Yu, et 
al., 2004).  This step was necessary to test the diagnostic accuracy of using data abstracted from 
the EMR.  A lexicon of modifiers was also created that represented alternative keywords for each 
indicator to reflect levels of certainty, negation, and double negatives (Table 9).  A list of asthma 
medications adapted from the American Lung Association Asthma Medication Chart was 
included in the review (Table 10).   
 A trained medical technician conducted the medical chart review and recorded the 
findings onto the clinical questionnaire (Figure 12).  Each record was marked for one code to 
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reflect the absence [no], presence [yes] or not mentioned status for each indicator.  The use of 
these three classification concepts was needed for the automated application process by which 
these results would be compared for statistical validation. 
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 Questionnaire A 
 
        Asthma Validation Study: Selected Indicators 
 
Report ID: _______________________________________________ 
 
Admission Date:_____mm/dd/yr ______________ 
 
Age_________ 
Sex__________ 
Race_______ 
Chief Complaint_________________________ 
 
 
 
INDICATOR          ABSENCE (0)              PRESENCE (1)           NOT MENTIONED (2) 
 
Wheeze/wheezing 
 
Cough 
 
Shortness of breath (SOB)  
Dyspnea-difficulty breathing 
 
Rhinitis (allergic rhinitis  
Runny nose) 
 
Fever 
 
Asthma history (hx) 
Past medical history of asthma (PMH)  
 
Medications/inhaler/nebulizer* 
* Included asthma medications (Table  10) 
 
 
Figure 12: Questionnaire 
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As a quality control measure, a nurse reviewed the medical records for data recording 
accuracy.  The clinical documentation found in the medical record was useful to the nurse for 
data interpretation.  Alternative keywords such as the numeric component of the word fever were 
considered.  The presence of a fever was recorded if a numeric value was found to be 100° F or 
greater.  Contradictory statements as to the absence and or presence of an indicator were placed 
in the category which best reflected the acuteness of the sign or symptom as reported by the 
patient on presentation to the emergency room.  For example, a medical record was marked as 
the presence of wheezing if the following documentation was found.  A patient presented to the 
emergency room with coughing, wheezing and shortness of breath (SOB) which did not resolve 
in 20 minutes, thus promoting ED consultation.  The documentation found in the Chest and Lung 
Section under the physical exam indicated the patient had no wheezing.  This instance, although 
contradictory for wheezing was marked as a positive finding.  Medical abbreviations and 
acronyms known by the review nurse were also considered while reviewing the EMR.  
 A secondary goal under Specific Aim 2 was to validate the findings from the medical 
record chart review by using some form of automated software.  Three agents were employed, 
(a) ATLAS.ti software, (b) Practical Extraction and Reporting Language (PERL), and (c) 
Medical Language Extraction and Encoding (MedLEE) text processing.  The level of agreement 
between the gold standard medical chart review, and computer based methodologies were 
assessed for statistical validation.  ATLAS.ti software was used as a prelude to the more 
advanced agents employed in this research.  Therefore, the researcher reports on the ATLAS.ti 
software features only in the  review of  literature.   
In collaboration with CM, the programmer contracted through the University Of 
Pittsburgh Graduate School Of Public Health Department Of Epidemiology, a PERL program 
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was created to interact with the asthma medical record database.  The PERL code used to create 
the program is listed in Appendix B.  The list of words and phrases used to guide the 
programmer in developing the search expression are highlighted in Tables 9 & 10.  The file 
containing the search text is listed in Figure 13.  The search text was executed by PERL to match 
on the keywords found in the narrative of the EMR using these search terms.   
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 Table 9: Keywords used for Practical Extraction and Report Language (PERL) matching 
Coding scheme Selected 
Indicators  Absence  
(0 ) 
Presence  
(1) 
Not mentioned  
(2) 
Wheezing 
 
(No) (Absence of), 
(denies) (without) 
wheeze, wheezing, 
wheezes  
(Presence of) (patient 
with) Wheeze wheezing, 
Wheezes  
No mention of 
the words wheeze 
wheezing, 
wheezes in review  
Cough (No), (Denies) (Absence 
of)  
Cough, coughing  
(Productive), (chronic), 
(complains of ) (present)  
cough , coughing 
No mention of 
the word cough, 
coughing in review 
Shortness of breath (No) (denies) (Absence 
of) Shortness of breath, 
DOE, dyspnea, difficult 
breathing, can’t breath, 
hard time breathing, 
trouble breathing, 
labored breathing, 
breathing labored 
(Presence of) (patient 
with) 
(complains of ) 
Shortness of breath, 
DOE, dyspnea, difficult 
breathing ,can’t breath, 
hard time breathing, 
trouble breathing, 
breathing labored, 
labored breathing, can’t 
catch breath 
No mention of 
the word shortness 
of breath, DOE, 
dyspnea, difficult 
breathing 
Rhinitis (No) (Absence of), 
(without) rhinitis, 
allergic rhinitis 
(Presence of) (patient 
with) 
(complains of ) rhinitis, 
allergic rhinitis  
No mention of 
the word rhinitis, 
allergic rhinitis 
Fever (No) (Absence of), 
(without), (denies) 
Fever, temperature, 
Afebrile  
(Presence of) (patient 
with) 
Fever, temperature, 
Febrile  
 
No mention of  the 
word fever, 
temperature  
 
History Asthma ( No), (Absence of), 
(denies)  History of, hx, 
PMH, past medical 
history no asthma, no 
known asthma history   
(Presence of) (patient 
with) (yes) (confirmed) 
all with  
History of asthma, hx of 
asthma, PMH asthma, 
past medical history 
asthma, asthma history  
No mention of  the 
word -History of 
asthma, hx of 
asthma, PMH 
asthma, past 
medical history 
asthma,  asthma 
history 
Medications/Inhaler (No ) inhaler nebulizer, 
(denies use of), inhaled 
steroids, beta agonist 
drugs, inhaler 
(Yes) (use of), (taking) 
inhaler, nebulizer, 
theophyllene, steroids, 
beta agonist drugs, 
inhalers 
No mention of the 
word inhaler, 
nebulizer, inhaled 
steroids, beta 
agonist drugs,  
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Table 10: Asthma medications* 
Medicine Generic Name Brand Name 
Short Acting Beta-2 
Agonists (SABA) Inhaled 
or Oral Bronchodilator 
Albuterol  
  
Albuterol sulfate  
 
Accuneb® 
Proventil 
HFA® 
Ventolin 
HFA ®  
ProAir HFA ® 
Proventil Repetabs® 
(tablet) 
VoSpire ER® 
 Pirbuterol acetate  
 
Maxair®  
 
 Terbutaline Sulfate  
 
Brethine® (tabs only)  
 
 Levalbuterol hydrochloride  
 
Xopenex®  
 
 Levalbuterol tartrate 
 
Xopenex HFA® 
 
Anticholinergics, inhaled 
bronchodilator 
Ipratropium bromide 
 
Atrovent® 
 
Inhaled Corticosteroids Beclomethasone 
diaproprionate 
QVAR®   
QVAR® 
Beconase 
 Budesonide 
 
Pulmicort Respules® 
Pulmicort Turbuhaler®    
Rhinocort 
 
 Flunisolide AeroBid® 
Aerospan HFA , Nasarel 
 Fluticasone proprionate 
 
Flovent ® 
Flonase 
 Mometasone furoate 
 
Nasone 
Nasacort 
Asthmanex® 
 Triamcinolone Azmacort 
*Adapted from the American Lung Association, December 2007: Asthma Medication Chart  
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(Table 10 Continued) 
Long Acting Beta 2 
Agonists 
Formoterol  fumarate  
 
Foradil Aerolizer® 
 
 Salmeterol Xinofate Serevent Diskus® 
Combined Medication: 
Inhaled Bronchodilator and 
Steroid 
Budesonide + Formeterol 
fumerate  
Symbicort® 
 
 Flucticasone propionate + 
Salmeterol xinofate 
Advair Diskus® 
Leukotriene Modifiers: Oral 
Anti-inflammatory 
Zafirlukast  Accolate®  
 
 Zileuton Zyflo® 
 Montelukast Singulair® 
 
PERL search Text 
 
Wheeze;wheeze,wheezing,wheezes;no,absence of,denies,without 
Cough;cough,coughing;no,absence of,denies,without 
Shortness of breath; shortness of breath,DOE,dyspnea,difficult breathing,can’t breath,hard time breathing,trouble breathing,breathing labored,labored breathing,can’t 
catch breath;no,denies,absence of 
Rhinitis;rhinitis,allergic rhinitis;no,absence of,denies,without 
Fever;Fever,temperature;no,absence of,denies,without 
History of Asthma;History of asthma,hx of asthma,PMH asthma,past medical history of asthma,asthma history;no,absence of,denies,without 
Meds/Inhaler;inhaler,nebulizer,Albuterol,Accuneb,Proventil,Ventolin,ProAir,VoSpire,Pirbuterol,Terbutaline,Brethine,Levalbuterol,Xopenex,Atrovent,QVAR,Beconase, 
Budesonide,Pulmicort,Rhinocort,Flunisolide,Nasarel,AeroBid,Flovent,Flonase,Nasone,Nasacort,Asthmanex,Azmacort,Foradil,Serevent,Symbicort,Advair,Accolate, 
Zyflo,Zafirlukast,Zileuton,Montelukast,Singulairinhaler,nebulizer,theophyllene,steroids, beta agonist drugs,inhalers; No meds:No medications; 
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Figure 13: PERL script 
 
  
The following methods were written by the programmer CM to describe the logic of how the 
search expression was developed.  Permission was given by the author to reproduce these 
methods in support of this research.   
 
Regular Expression Methods  
 
“Regular expression (pattern matching) was used to determine the presence or 
absence of various words and phrases in the electronic medical records (EMR).  The 
presence or absence of these words or phrases were then used to determine whether a 
symptom was mentioned and whether that symptom was present in the patient or was not 
present in the patient. 
 
To process the file containing the EMRs, a script was developed to read various 
parts of the header and extract information that was useful in identifying the record.  
Then, the rest of the record was read and accumulated into a single string with the 
elimination of any line break (line feeds or carriage returns) characters.  The end of the 
record was determined by the E_O_R (end of record) line.  Once the entire record was 
entered into the string variable without line break characters it was copied (one copy for 
each regular expression) and the copies were scanned for character sequences that 
matched the regular expressions of interest.  
 
The regular expressions that were used to search the records can be divided into 
two categories, present or not present. In general, a regular expression for a symptom that 
was present was the name of the symptom or morphological equivalents (ex. wheeze and 
wheezing). The regular expression for this would look like: 
 
(wheeze,wheezing) 
 
This will match on any word in the positive list 
 
A regular expression for a symptom that was not present was the name of the symptom with a not, 
no, or some other negating term in front of the name within the sentence (ex. no wheezing or not 
wheezing). The regular expression for this would look like: 
 
 (no,not) [^.]+(wheeze,wheezing) 
 
This will match on any word in the negative list (no or not) preceded and followed by a space 
(there is an unseen space before the negative list), followed by a string of characters 0 or more long that 
does not include the period (the period is assumed to be the end of the sentence and this expression will 
only match inside the same sentence). Finally, a match from the positive list must follow before the end of 
sentence to produce a match. 
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 After the scans of the record was completed using each of the regular expressions 
that were created, the final decision, as far as whether or not a symptom was present, not 
present, or not mentioned was arrived at by the following logic.  First, if a symptom name 
was found with a negative modifier before it, then it was considered to be either 'not 
present' in that patient or denied by that patient.  Second, for the rest of the cases, if a 
symptom name was present, then the symptom was considered to be 'present' in that 
patient. Finally, for all the rest of the cases where the symptom name was found, neither 
by itself nor with a negative modifier, then it was considered to be 'not mentioned'.” 
  
 
Instructions for Using the Tool 
 
“To use the Medical Record Processing tool, first the Perl interpreter must be 
installed on the computer that is to be used. The installer may be downloaded at 
http://www.perl.org/get.html.   Then the script file (AutoRegex.pl ), the file containing 
the records that are to be scanned (input.txt), and the parameters file for the search 
(search.txt) are all placed into the same folder.  Finally the Perl script is executed by 
double clicking on the icon for the AutoRegex.pl file.  The output file will be created in 
the same folder that the other files are in and will be called regex.csv and will open in a 
spreadsheet program that reads comma separated value files. 
 
 The search file is organized with each line being a separate search. Each search 
being divided into 3 fields separated by semicolons. The first field is the title of the 
search. The second field is the positive search terms in a comma separated list with no 
spaces before or after the terms.  This list is the words or phrases that are expected to 
denote the symptom that is being examined (wheeze, wheezing, wheezed).  The final 
field is the negative list of words that are expected to negate the presence of the symptom 
(no, not, denies).” 
 
The second methodology MedLee, was employed by our collaborator, biomedical expert 
RT.  The goal of using MedLEE was to extract the set of indicators identified in the free text 
clinical documents using a lexicon library for translation and scientific interpretation.  The 
UMLS concepts codes, which correspond to each asthma indicator, are highlighted in Table 11.  
If an indicator had more than one concept code, the results were collapsed at the end of the 
analysis to reflect one set of results for each indicator.  The concept codes were used to match 
the words identified in the free text document along with the modifiers.  These concepts are then 
linked to a semantic network, which classifies the words into a set of categories.  The MedLee 
  93
lexicon provides a description of the findings, which is reported in an XML output file.  The 
results were consolidated in this research by the programmer to reflect the presence or absence of 
a finding.  If the indicator was not mentioned for the presence or absence of findings, a no 
mentioned status was assigned.   
 
Table 11: UMLS key concept codes for MedLEE 
Selected Indicators  Concepts Assigned  
UMLS Concept Codes 
Wheeze Wheezing, Wheeze, Wheezes, 
Wheezy,Wheezings 
C0043144 
Coughing, Cough C0010200 
Dry cough  C0850149 
Cough Non-productive C0239134 
Cough 
Cough Dry, Unproductive 
cough, on-productive cough 
C0850149 
Shortness of breath Shortness of breath, SOB, 
Breath Shortness 
C0392680 
Rhinitis  C0035455 Rhinitis 
Runny Nose C1260880 
Fever Fever, Hyperthermia, Febrile 
Pyrexia, Temperature elevation 
Body temperature increased, 
Temperature increase 
C0015967 
Asthma history C0455544 Asthma history 
Asthma C0004096 
Inhaler, Inhalator, Inhalators C0021461 Medications 
Nebulizers C0027524 
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The next step of the Validation Study was to review the EMRs, which were marked as 
asthma by  the ICD-9 coded physician diagnosis and classify the cases of asthma according to 
the criteria highlighted in the CSTE Clinical and Laboratory case definition (Table 5).  In order 
to comply with the criteria highlighted in the CSTE Clinical and Laboratory Classification 
definition under the “confirmed” asthma category, medical records from the previous year had to 
be reviewed to determine if there was an occurrence of any asthma clinical symptom reported at 
least three times in the past year for asthma.  A total of 838 clinical narrative reports, including 
free text history and physicals, dictated physicals, consultations, clinic follow up visits, ED 
notes, laboratory results, surgery reports and discharge summaries were obtained.  Three possible 
classifications were presented: Confirmed, Probable, and Possible.  If no determination could be 
made as to whether a patient met the criteria for any of  the classification categories the record 
was marked as not classified.  The criteria were modified from its original version to reflect the 
limited amount of laboratory data found in the EMR.  The modified criteria are listed in Table 
12.    
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Table 12: Modified CSTE Clinical and Laboratory case classification criteria 
Classification Criteria 
Confirmed Met any clinical symptom at least 3x during the 
past year 
• Wheezing lasting 2 consecutive days or 
more 
• Chronic cough responds to 
bronchdilatation that persists 3-6 weeks 
in the absence of allergic rhinitis 
sinusitis 
• Nocturnal awakening with dyspnea on 
exertion, cough, and or wheezing in the 
absence of other medical conditions 
known to cause these symptoms 
 
Presence of any symptom reversed with a 
physician treatment or asthma medication 3 times 
in the past year  
Probable 
 
Taken medications in the past year that were 
prescribed by a physician for asthma  
Possible Presence of any of the following symptoms 
during the past year 
• Shortness of breath 
• Wheezing or chronic cough in the 
absence of obvious respiratory 
infection   
• Presence of nasal secretions, mucosal 
swelling, nasal polyps or chronic 
sinusitis 
• Hyper expansion of the thorax 
• Prolonged phased to forced exhalation 
• Wheezing during normal breath 
• Chest X-ray noted to show hyper 
expansion  
 
Upon review of the EMR, the free text chief complaint was assessed to determine how 
well it correlated with the medical chart review and with the ICD-9 coded primary asthma 
diagnosis for substantiating a case of asthma.  The addition of reviewing the chief complaint in 
this portion of  the analysis increased the researcher’s ability to eliminate any misclassification of 
an asthma diagnosis.  
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Under Specific Aim # 3, a case crossover study was conducted to examine 10,135 
emergency room visits and determine the association between short term changes in daily 
maximum 24-hour ozone concentrations and PM2.5, and the acute health effects for asthma.  
Ozone and PM2.5 data from one monitoring station in Allegheny County, which is representative 
of the urban portion of the county was used in the analysis.  Data was adjusted for temperature in 
the model.    
 The Case Crossover Analysis Tool (C-CAT), a software application developed by 
researchers from the New York State Department of Health was used to conduct the research.  
The software operates using a SAS based program.  The statistical method used in this research 
was conditional logistic regression as the statistical estimator.  Power and sample size estimates 
were conducted using PS Statistical Program (Dupont, 2004).  The exposure variables were 
treated as a continuous variable using a matched study design to perform these calculations.  A 
time stratified case crossover analysis was used in this research study.  All referents (control 
periods) were based within the calendar month.  This research was defined by the following 
hypothesis:  
Test Ho:  Odds ratio=1.00      Ha:  Odd ratio ≠ 1.00 
The null hypothesis assumes there is no change in asthma ED visits for every 10-ppb 
increase in the 24-hour maximum ozone concentration level.   
3.3.1 Sample size and power estimate  
 The sample for the any primary asthma ED visit dataset originally had 11,286 visits for 
asthma.  This represented a total of  6,979 persons.  Individual’s events are linked to a unique 
identifier (CASEID) in the C-CAT software.  Individuals can have a repeat visit but only one per 
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day.  Furthermore, the use of conditional logistic regression in a case crossover methodology 
requires control of the dependency factor for recurrent events.  In order to assume an 
independence status for each visit, a “wash out” period was applied.  The wash out was set to 
remove anyone who had a repeat visit within a 28-day time period, thus, accounting for 
independence within the 28-day time strata.  A referent day was selected every 7 days from 21 
days before to 21 days after the event day.  A total of  1,103 ED asthma visits were washed out.  
This resulted in 10,183 visits represented by 30,405 referents: a 3:1 match (Haley et al., 2006).   
The estimated power  to detect a 10% increase in the risk estimate with a sample size of  6,979 
individuals is 74%, alpha = 0.05, two sided test; 3:1 matching, correlation =0.2, proportion of 
exposed controls =0.2 (Figure 14). 
 
Figure 14: Sample size and power estimate 
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3.4 STATISTICAL ANALYSIS AND RESULTS 
All data was analyzed using SPSS with the exception of the case crossover study, which 
employed the use of a SAS based program to conduct the analysis.  The case crossover study 
relies on conditional logistics regression as the statistical estimator of a binary outcome with one 
or more predictors.  The maximum likelihood values for the logistics model were used to report 
the best estimates or maximum probability of finding the results as reported by the odds ratios 
and 95% confidence limits.  
 All the descriptive analysis was conducted using summary statistics such as means, 
proportions, and standard deviations where appropriate.  The Pearson’s Chi Square statistic was 
used for categorical variables, and histogram and box plot for discrete and continuous variables.  
The Pearson’s correlation coefficient was used to measure the strength of association between  
variables where appropriate.  Ninety-five percent confidence intervals were constructed to 
determine whether statistically significant differences were noted between characteristics 
identified within each population.   
3.4.1 Populations descriptive analysis 
3.4.1.1 Population  A 
   A total sample of 18,284 emergency room asthma visits were identified which 
represented any one who presented to the emergency department (ED) for the 6 hospitals 
represented in this research study with a primary or secondary diagnosis of asthma from 2002-
2005.  The visits in this MARS dataset accounts for only 60% (6 out of 10 hospitals) of the 
UPMC network and only 30% of the AC hospital network.  Of the total number of ED visits, 
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11,901(65.0%) resulted in discharge and 6,395(35%) admitted.  For the entire asthma cohort the 
age range was 0-103 (M= 43.3, SD= 22.3) (Table 13).  The highest number of visits occurred in 
the 45-64 year old age group which represented 25.7%(4,700) of the population followed by 
individuals 30-44 years of age 23%(4,216).  Individuals who were discharged from the hospital 
were younger 0-98 years of age (M= 35.99, SD= 19.8) vs. individuals who were admitted 0-103 
years of age, (M= 56.97, SD = 20.14).  Individuals (65±) years of age represent the highest 
proportion of individuals admitted to the hospital.  This suggests that comorbidity plays a role in 
asthma hospitalizations for the oldest population (65±). 
A review of the gender differences demonstrated that the number of ED visits was 
greatest for females (65%) and almost twice that of males (35.0%) (Table 13).  When comparing 
gender differences by disposition, females were discharged from the ED more often than males, 
63.9%(95% CI 63.0-64.8); 36.1%(95% CI 35.2-37.0), and admitted more frequently than their 
male counterparts 67.4%(95% CI 66.0-68.3); 32.6%(95% CI 31.4-33.7), respectively.  This is 
consistent with the literature, which suggests that females are two times more likely than males 
to present to the ED for asthma care, to be admitted, and report a repeat asthma event (Singh et 
al, 1999). However, no conclusions can be made about the gender differences in this population 
since the higher proportion of females represent findings from only the 6 hospitals in the 
catchment area.  
Analysis of the data on racial backgrounds demonstrated that more Whites 68.4%(95% 
CI 67.7-69.0) visited the emergency room than Blacks 29.6(95% CI 28.9-30.2), and Others 
2.0%.(95% CI .018-.022.  The same distribution patterns were observed when disposition was 
taken into account, Whites still had more ED visits and more admissions than their Black counter 
parts and Others.   However, Blacks make up only 10% of the total population in AC, and 30% 
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of the population in the City of Pittsburgh (COP) (US Census, 2006).  According to national 
statistics (NCHS, 2004), Blacks utilize the emergency room more often than Whites (195 per 
10,000 vs. 43.6 per 10, 000) population, respectively; are hospitalized more frequently (33.3 vs. 
10 per 10,000) population, respectively; and die at higher rates (3.1 vs. 1.7 per 10,000) 
population, respectively, from asthma.  These national statistics suggest that asthma is not as 
well controlled in Blacks vs. Whites.  In this population, the proportion of Blacks utilizing the 
ED for asthma is high when comparing to the small proportion of the total Black population in 
AC as a whole.  However, no conclusions can be made from the findings in this research study 
since this was an abbreviated sample of 6 hospitals in the UPMC network.  
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Table 13: Primary and secondary asthma diagnosis for all emergency room visits (6 UPMC hospitals) by age, sex, race and 
disposition 
 Total Emergency room visits with primary and secondary asthma diagnosis (n=18,284) by disposition 
=emergency room visits with discharge or  emergency room visit with admission  
 
Total Emergency room visits with primary and 
secondary asthma diagnosis (n=18,284) 
 
Emergency room visits with 
discharge 
(n=11,901) 
 
Emergency room visits with 
admission 
(n=6,383) 
Age             n       %            CI 
 
0-17       2,267     12.3     11.9-12.9  
18-29     3,439     19.0     18.2-19.3  
30-44     4,216     23.0     22.4-23.6   
45-64     4,700     25.7     25.0-26.3  
65±        3,661     20.0     19.4-20.6  
 
 
Mean age=  43.3(SD 22.3) 
Range 0-103 years of age 
 
 
Total       18,284     100.0  
Age               n         %                CI 
 
 0-17         2,188       18.3           17.7-19.1   
 18-29       2,856       24.0           22.0-24.7     
 30-44       3,028        25.4          24.6-26.2    
 45-64       2,678        22.5          21.7-23.2     
    65±       1,150          9.6            9.1-10.2               
 
 
Mean age = 35.99 (SD 19.8) 
Range 0-98 years of age 
 
 
Total        11, 901    100.0 
Age                n            %           CI 
 
  0-17              79     1.2          .99-1.53  
 18-29           583     9.6           8.4-9.8  
  30-44         1,188    18.5       17.6-19.5  
  45-64         2,022    31.6       30.4-32.7  
   65+           2,511  39.33      38.0-40.4  
 
 
Mean age = 56.97 (20.14) 
Range 0-103 years of age  
 
 
Total     6,383      100.0   
Sex               n        %              CI 
 
Male        6,379     34.9     34.2-35.5  
Female  11,905      65.1     64.4-65.7  
 
Total       1,8284     100.0 
Sex               n         %                CI 
 
Male          4,296      36.1     35.2-37.0 
Female       7,605      63.9     63.0-64.8 
 
Total         11, 901    100.0 
Sex              n         %          CI 
 
Male          2,083     32.6       31.4-33.7 
Female       4,300    67.4       66.0-68.3 
 
Total         6,383      100.0       
Race             n         %             CI 
 
Black        5,414      29.6        8.9-30.2  
White      12,503      68.4      67.7-69.0  
Other            136          .7         .63-.88  
Unknown      231       1.3     1.11-1.43  
 
Total       18,284     100.0 
Race         n             %            CI 
 
Black        3,968      33.3      32.5-34.2  
White       7,750       65.1      64.3-66.0  
 Other          108         .9           .75-1.09    
 Unknown    75           .6          .50-.79    
 
Total        11, 901    100.0 
Race           n         %        CI 
 
Black         1,446      22.7       21.0-23.6  
White         4,753      74.5      73.5-75.3  
Other              28         .4           .30-.63  
Unknown      156      2.4            2.0-2.8  
 
Total            6,383      100.0   
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A review of the different insurance types for individuals who presented to the ED for 
asthma care demonstrated that the number of individuals who were discharged from the ED were 
younger (M= 35.99,  SD= 19.8) than those admitted (M= 56.97, SD= 20.14).  The proportion of 
individuals with managed care insurance was higher than the number of individuals without 
(Table 14).  The exception to this was for individuals who had Medicare insurance.  These 
individuals represent the oldest and sickest individuals in the entire cohort.  Individuals with 
Medicare Managed Care (MMC) insurance vs. their Medicare counterpart were less likely to 
visit the ED and if they did visit the ED were more likely to be discharged than admitted.   
Although, no conclusions can be drawn from these findings, enrollees in MMC insurance 
programs are more likely to report using preventive services such as immunizations and smoking 
cessation than their traditional Medicare counterparts (Landon, Zaslavsky, Shulamit, Cioffi, & 
Clearly, 2004).  Thus, it is possible that MMC individuals are healthier or more protected with 
these types of prevention initiatives.  The high number of individuals identified in the Self-pay 
group 1,590(8.7%) suggest that the emergency room is used for asthma treatment even if 
someone does not have health care insurance.  A more in-depth analysis is needed to evaluate the 
influences of different insurance types on the delivery and outcomes of asthma care. 
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Table 14: Insurance type for all primary and secondary asthma emergency room visits (6 UPMC hospitals) by disposition 
 Total Emergency room visits with primary and secondary asthma diagnosis (n=18,284) by disposition 
=emergency room visits with discharge or  emergency room visit with admission 
Total Emergency room visits with primary and 
secondary asthma diagnosis (n=18,284) 
 
 
Mean age=  43.3(SD 22.3) 
Range 0-103 years of age 
 
Emergency room visits with 
discharge 
(n=11,901) 
 
Mean age = 35.99 (SD 19.8) 
Range 0-98 years of age 
Emergency room visits with 
admission 
(n=6,383) 
 
Mean age = 56.97 (20.14) 
Range 0-103 years of age  
Financial            n         %        CI 
 
Medicare           3,199     17.5    16.9-18.0 
Medicare MC    2,014     11.0    10.5-11.4 
Medicaid               713       3.9      3.62-4.19 
Medicaid MC    3,323     18.2    17.6-18.3  
Commercial           813      4.4      4.15-4.75 
Commercial MC 2,835   15.5     14.9 -16.0 
Third PP             3,256    17.8    17.6 -18.3 
Third PPMC              0 
Self pay              1,590      8.7      8.29-9.11 
Other                     535      2.9      2.69-3.18    
VA                           5       .02        .012-006 
Unknown                 1 
Total               18,284      100.0    
Financial              n             %        CI 
 
Medicare             1,108       9.3    8.8-9.8 
Medicare MC      1,042       8.8    8.2-9.2 
Medicaid               283       2.4    2.1-2.6 
Medicaid MC      2,670     22.4   21.7-23.2 
Commercial          494       4.2     3.8-4.5  
Commercial MC 2,196     18.5   17.7-19.1 
Third PP              2,361    19.6   19.1-20.5 
Third PPMC               0 
Self pay                1,385    11.6   11.0-12.2 
Other                       361    3.0      2.7-3.3 
VA                           0              
Unknown                 1 
Total                   11,901     100.0 
Financial              n         %        CI 
 
Medicare          2,091      32.8    31.5-33.8   
Medicare  MC    972        15.2   14.3-16.1   
Medicaid             430       6.7       6.1- 7.3  
Medicaid MC      653        10.2    9.4- 10.9   
Commercial         319       5.0       4.4- 5.5   
Commercial MC  639      10.0     9.2-10.7   
Third PP               895      14.0    13.1-14.8   
Third PPMC            0 
Self pay               205        3.2      2.8-3.6   
Other                   174        2.7      2.3-3.1  
VA                          5           .1        .03-.16  
 
Total                 6,383     100.0 
  
 
 
 
The annual daily average of emergency room visits for primary and secondary asthma 
from 2002-2005 were from 12.1-13.5 per day (de-duplicated).  The highest number of visits was 
observed in 2005 with 13.5 per day.  The average number of yearly visits for asthma were from 
4,348(24.0%) - 4,943(27.0%) with the highest number of visits occurring in December-March 
with a second peak noted in October (Table 15).  Similar findings were observed when 
disposition was taken into account.  The highest number of asthma visits coincided with the fall 
and winter season where asthma morbidity has been shown to increase due to ragweed allergies 
and rhinovirus infection (Johnston & Sears, 2006; Dales, et al., 1996, Wansoo & Schneider, 
2005).  To determine whether the number of visits in this dataset were greater in the fall and 
winter months than spring and summer months, a Chi Square Goodness of Fit Test was used.  
The analysis showed that there was a statistically significant difference in the number of ED 
visits in the fall and winter months than spring and summer, X2(1, N=18,284), 33.4, p < 0 .05 
(Figure 15).  
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Table 15: Primary and secondary asthma emergency room visits (6 UPMC hospitals) for 
month and year by disposition 
 Total Emergency room visits with primary and secondary asthma 
diagnosis (n=18,284) by disposition =emergency room visits with discharge 
or emergency room visit with admission 
Total emergency room visits 
with primary and secondary 
asthma diagnosis (n=18,284) 
(De-Duplicated) 
Emergency room visits with 
discharge 
(n=11,901) 
Emergency room visits with 
admission 
(n=6,383) 
Year               n                 %          
2002            4,422             24.0 
2003            4,348             24.0 
2004            4,570             25.0 
2005            4,943             27.0 
Total         18,284          100.0    
Year               n               %          
2002              2,889          24.0 
2003              2,865          24.0 
2004              2,960          25.0 
2005              3,186          27.0 
Total            11,901       100.0 
Year               n             %          
2002           1,533          24.0 
2003            1,483         24.0 
2004            1,610         25.0 
2005            1,757         27.0 
Total            6,383       100.0 
Month               n             %          
January            1,563         8.5 
February          1,578         8.6 
March              1,741         9.5 
April                1,536         8.4  
May                 1,424         7.7 
June                 1,469         8.0  
July                 1,484          8.1 
August            1,364          7.4 
September       1,474          8.0 
October           1,576          8.6 
November       1,432          7.8 
December       1,643           8.9 
Total             18,284       100.0  
Month               n             %           
January           1,027         8.6 
February         1,013         8.5 
March             1101          9.2 
April                 967          8.1 
May                  934          7.8 
June                  996          8.3   
July                   979          8.2 
August              854          7.1 
September      1,005          8.4 
October           1,039         8.7 
November          961         8.0 
December        1025         8.6 
Total              11,901     100.0 
Month               n             %          
January            536          7.7 
February          565          8.8 
March              640        10.0 
April                569          8.8 
May                 490          7.6 
June                 473          7.3 
July                  505          7.8 
August             510          7.9 
September       469           7.3 
October           537           8.3  
November       471           7.3 
December        618           9.6 
Total              6,383     100.0 
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Primary and secondary asthma ED visits 
(6 UPMC hospitals) by month and year 
(n=18,284)
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Figure 15: Primary and secondary asthma ED visits (6 UPMC hospitals) by month and 
year 
 
 
  A review of the frequency of ED visits to the different hospitals by year showed that the highest 
number of total ED visits were observed at St. Margaret’s 4,279(23.4%) and Presbytarian 
Hospital 3,307(18.0%).  Southside Hospital had the least number of visits 1710(9.3%).  This 
pattern was consistent by year for the four-year period (Table 16).   
 
Table 16: Primary and secondary asthma emergency room visits for 6 UPMC hospitals by 
year 
Hospital 2002 2003 2004 2005 Total 
% 
Braddock 782 779 755 795 3,111(17.0) 
McKeesport  626 652 637 718 2,633(14.4) 
Presbytarian 806 748 862 893 3,307(18.0) 
Shadyside 745 752 824 921 3,242(17.7) 
St Margaret’s 1,025 1,030 1,064 1,160 4,279(23.4) 
Southside 438 388 428 456 1,710(9.3) 
Total* (%) 4,422(24.1) 4,347(23.7) 4,570(24.9) 4,943(27.0) 18,284(100.0) 
 
  107
The geographical distribution of asthma cases is another important feature in 
understanding the determinants of this disease.  The data in the primary and secondary asthma 
ED visit dataset was available for 16,178 zip codes of which, 8,492 (52.4%) were identified 
within the COP boundaries, and the remaining 7,686(47.5%) zip codes were in Allegheny 
County, excluding the COP, respectively.  142 zip codes are included in the boundaries of 
Allegheny County.  The total population, which resides in these zip codes is 1,259,337 persons.  
The population in the COP is 322,177 (US Census Data, 2000).  
 An analysis of the geographical distribution of these asthma cases showed that the 
highest number of cases was represented by individuals living in and around the City of 
Pittsburgh (COP) (Figure 16).  The highest number of asthma ED visits observed by individuals 
living in the COP is of no surprise since this dataset represented 6 UPMC hospitals centered on 
the COP.  Therefore, no conclusions can be made about the high proportion of asthma cases 
observed for the inner city residents and the possible role of environmental influences in these 
asthma cases.   
The demographic subgroups for the total primary and secondary asthma emergency room 
visits for the population residing in the zip codes for the City of Pittsburgh vs. Allegheny County  
are highlighted in Tables 17 & 18.  The highest frequency of ED visits by zip codes was 
observed in individuals 35-64 years of age, in Whites and females in both the COP and AC 
subgroups. 
  108
Table 17:  Primary and secondary asthma emergency room visits for the City of Pittsburgh 
(zip codes) by age, sex and race 2002-2005 (only 6 hospitals of UPMC network) 
Sex  
Age Male Female 
 
 
Total 
0-17        Race     Black 
                            White 
                            Other  
Total  
336 
 459 
 14 
 809 
 
18-34      Race     Black 
                            White 
                            Other  
Total  
 
 916 
1,336 
  , 41 
2,293 
 
35-64       Race     Black 
                            White 
                            Other  
Total  
          
                  1,488 
                  2,088 
                    ,  45 
                  3,621 
 
65+           Race    Black 
                            White 
                            Other  
Total  
 
                    370 
                 1,377 
                      51 
                 1,769    
 
Total  
190  146 
223  236 
    8                6  
421             388       
 
342  574 
496  840 
17 24 
855 1,438 
 
427 1,061 
650 1,438 
21   24 
      1,098           2,523 
 
91 279 
426 951 
16 35 
         526         1,243 
         
  2,900             5,592 
              
              n=  8,492(52.4%) 
  
Table 18: Primary and secondary asthma emergency room visits for Allegheny County (zip 
codes) minus the City of Pittsburgh by age, sex and race (2002-2005) (only 6 hospitals in the 
UPMC network) 
Sex Age 
Male Female 
 
Total 
0-17        Race     Black 
                            White 
                            Other  
Total  
                600 
                686 
                  21 
              1,307 
 
18-34      Race     Black 
                            White 
                            Other  
Total  
 
                 574 
              1,247 
                   17 
              1,832 
 
35-64       Race     Black 
                            White 
                            Other  
Total  
 
                 784 
              2,292 
                   21 
              3,097  
 
65+           Race    Black 
                            White 
                            Other  
Total  
 
                 161 
              1,276 
                   13 
              1,450 
 
Total  
338               262 
405                281 
  14                   7 
757                550 
 
207                367  
421                820 
   6                   11  
634             1,198 
 
194                590 
685             1,607 
    1                  20 
880             2,217 
 
   44               117 
 375               901 
     6                  7 
 425            1,025 
 
2,696           4,990 
      
         n =  7,686 (47.5%) 
 
 
  109
 Primary and Secondary Asthma Emergency Room Visits in Allegheny 
County by Zip Codes (2002-2005) (6 UPMC Hospitals)  
 
Figure 16: Primary and Secondary Asthma Emergency Room Visits in Allegheny County 
by Zip Code (2002-2005)  for 6 UPMC Hospitals 
 
* Available data on 16,178 zip codes. Presbytarian Hospital included in dataset, however, the hospital not listed on 
the map.  
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3.4.1.2 Population B 
A cohort of asthmatics with primary asthma were identified (n=5,100).  This represented 
any one who presented to the ED from 2002-2005 with a first primary asthma visit.  The age 
range was between 0-103 with the mean age distribution (M= 43.94, SD= 18.40) (Table 19).  
Individuals who were more likely to be admitted for asthma were older (M= 60.05, SD = 18.54) 
vs. individuals who were discharged from the ED (M = 39.53, SD= 15.72).  In each age group, 
except for those 65 years of age and over, a visit to the emergency room was more likely to result 
in a discharge than an admission.  
Gender differences were identical to those found in the primary and secondary asthma data 
set with females having higher number of ED visits 68.9%(95% CI 67.85-69.99) than males 
31.1%(95% CI 29.79-32.33). Females presenting to the ED were more likely to be admitted than 
males  73.8% (95% CI 71.1-76.3) vs. 26.2%(95% CI 23.6-28.8), respectively.   
An analysis of the data by race showed a higher proportion of ED visits in Whites than 
Blacks and Others, 63.2% (95% CI 61.9-64.5); 35.0%(95% CI 33.7-36.3); and 1.1%(95% CI .9-
1.5), respectively.  In this dataset, Whites were more likely to visit the ED and be admitted than 
Blacks (Table 19).  No conclusions can be made about these findings since the White population 
in this sample represents a higher proportion of cases from the catchment area.  The sample 
represents only 60% of the UPMC network, and 30% of all hospitals in AC.  The hospitals 
represented in this sample were concentrated in and around the COP.  The Black population in 
the COP is 30% and 10% in AC (US Census, 2006).  Therefore, without an asthma population 
entirely representative of AC residents inclusive of the entire network of hospitals in AC, no 
conclusions can be made.   
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Table 19: First primary asthma emergency room visits (6 UPMC hospitals) by age, sex, and race by disposition 
Total emergency room visits  
first primary asthma diagnosis  
(n=5,100) 
Total emergency room visits  
first primary asthma diagnosis 
with an  
emergency room discharge 
(n=4,005) 
Total emergency room visits  
first primary asthma diagnosis with 
an  
admission 
(n=1,095) 
Age            n          %             CI 
  
0-17           
18-29         1338        26.2         25.0-27.4
30-44         1537        30.1         28.0-31.4 
45-64         1415        27.7         26.5-28.9 
65+              810        16.0        14.9-16.0  
 
Mean age= 43.94(SD 18.40)   
Range=18-103 
 
 
Total         5,100      100.0  
Age             n            %         CI 
 
0-17                
18-29         1,268         31.6       30.2-33.1   
30-44         1,360         33.9       32.5-35.4   
45-64         1,052         26.2       24.9-27.6   
65+               325          33.0       31.6-34.5   
 
Mean age= 39.53(SD 15.72) 
Range=18-96 
 
 
Total          4,005        100.0 
Age             n            %         CI 
 
0-17                 
18-29           70         6.3            5.0-8.0  
30-44          177        16.1       14.1-18.4  
45-64          363        33.1       30.4-35.9  
65+             485        44.2        41.3-47.2  
 
Mean age= 60.05(SD 18..54) 
Range= 18-103 
 
 
Total       1,095        100.0 
Sex               n         %            CI 
 
Male        1,584        31.1       29.79-32.33  
Females   3,516       68.9        67.85-69.99  
 
Total         5,100   100.0 
Sex               n         %           CI 
 
Male           1,297        32.4       30.9-33.8  
Female        2,708        67.6       66.1-69.0  
 
Total           4,005     100.0 
Sex              n         %           CI 
 
Male          287       26.2         23.6-28.8  
Female       808      73.8          71.1-76.3  
 
Total        1,095    100.0 
Race            n        %               CI 
  
Black          1,789     35.0        33.7-36.3  
White          3,225     63.2        61.9-64.5  
Other             61        1.1            .9-.1.5  
Unknown      28          .5            .38-.77  
Total           5,100  100.0 
Race             n         %            CI 
  
Black         1,512          37.8       36.2-39.2  
White         2,419          60.4       58.8-61.9  
Other             55            1.4        1.05-1.78  
Unknown      19              .5          .30- .73*  
Total         4,005         100.0 
Race           n         %            CI 
  
Black           274        25.0      22.2-27.6  
White           806        73.6      70.9-76.1  
Other                6            .5       .25-1.18    
Unknown          9            .8       .43-1.55 
Total            1,095    100.0 
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The impact of insurance type on asthma ED visits was examined.  Insurance types 
included: Medicare, Medicaid, Managed Care enrollees, and Self-pay (Table 20).  Analysis by 
disposition for each insurance type demonstrated that a higher proportion of individuals had 
managed care insurance with the exception of the Medicare population.  Individuals with 
traditional Medicare insurance were more likely to visit the ED, and be admitted than individuals 
with Medicare Managed Care insurance.  Landon et al (2004) report that this phenomenon may 
likely represent a healthier cohort in the Medicare Managed Care group who report a higher use 
of  prevention services than traditional Medicare enrollees.  Furthermore, a correlation has been 
drawn between Medicaid Health Maintenance Organization (HMO) plan enrollment and a 
reduction in emergency room utilization and hospitalizations, and an increase use of outpatient 
services for asthma (Baker & Afendulis, 2005).  A reduction in ED services and hospitalizations 
was not observed for the Medicaid HMO group in this dataset.  This group had a higher 
proportion of ED visits than the Medicaid group.  This higher proportion of visits could be 
related to lower co-pay for the Medicaid managed care population.  Overall individuals who 
were discharged from the hospital were younger (M = 39.53, SD= 15.72) than individuals who 
were admitted (M= 60.05, SD= 18.54).  An in-depth analysis of the different insurance types, by 
disposition and demographic subgroups is needed to gain a better understanding of how these 
factors may influence asthma outcomes.  
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Table 20: Insurance type for all first primary asthma emergency visits (6 UPMC hospitals) by disposition 
Total emergency room visits  
First primary asthma diagnosis  
(n=5,100) 
 
 
 
Mean age= 43.94(SD 18.40)   
Range=18-103 
 
Total emergency room visits  
first primary asthma diagnosis 
with an  
emergency room discharge 
(n=4,005) 
 
Mean age= 39.53(SD 15.72) 
Range=18-96 
 
Total emergency room visits  
first primary asthma diagnosis with 
an  
admission 
(n=1,095) 
 
Mean age= 60.05(SD 18..54) 
Range= 18-103 
 
Financial           n         %        CI 
 
Medicare             747       14.6     13.7-15.6 
Medicare MC      474        9.2      8.5-10.1 
Medicaid             176        3.4      2.9-3.9 
Medicaid MC      872       17.0    16.0-18.1 
Commercial        204        4.0       3.4-4.5 
Commercial MC  923     18.0     17.0-19.1 
Third PP             977      19.1      18.1-20.2 
Third PPMC       0 
Self pay              680      13.3     12.4-14.2 
Other                  45         .88     .66-1.1 
VA                       2         .03     .01-.14 
 
Total                   5,100     100.0 
Financial        n         %          CI 
 
Medicare           368      9.1     8.3-10.1  
Medicare MC    292     7.2     6.5- 8.1  
Medicaid           136      3.3    2.8- 4.0  
Medicaid MC    743     18.5   17.3-19.7    
Commercial       188      4.6       4.0-5.3  
Commercial MC 796     19.8   18.6-21.1   
Third PP            814      20.3    19.1-21.5   
Third PPMC         0 
Self pay             638      15.9    14.8-17.0  
Other                   30          .7        .5-1.06   
VA                        0 
 
Total                4,005     100.0 
Financial          n         %        CI 
 
Medicare            379   34.6     31.8-37.4  
Medicare MC     182   16.2     14.5-18.9   
Medicaid              40     3.6     2.69-4.93  
Medicaid MC      251    22.9   20.5-25.5  
Commercial           16      1.4     .90-2.35   
Commercial MC  127       11.5   9.8-15.6   
Third party payer  163      14.8   12.9-17. 1   
Third PPMC             0       
Self pay                   42      3.8    2.8-5.1   
Other                       15       1.3    .8.-2.24 
VA                           11     1.00    .56-1.7 
 
Total                     1,095    100.0 
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The annual daily average of ED visits for a primary asthma diagnosis was between 3.18 
and 4.15 per day.  Yearly ED visits for 2002-2005 were from 1,090(21.4%) to 1,455(28.5%) 
(Table 21).  The highest reported number of visits occurred in December– March with a second 
peak beginning in September.  A significant difference was observed between the number of ED 
visits in the fall and winter months vs. the spring and summer,  X2(1, N = 5,100) = 70.5, p < .05. 
These seasonal differences may be related to environmental influences from a rise in weed 
pollens and rhinovirus infections occurring during the fall and winter months (Dales, et al., 1996; 
Johnston & Sears, 2006; Wansoo & Schneider, 2005).  Both ED visits with discharge and 
admissions during the fall and winter months are greater (Figure 17). 
Table 21:  All first primary asthma emergency room visits (6 UPMC hospitals) by month, year and disposition 
Total emergency room visits  
First primary asthma diagnosis  
(n=5,100) 
Total emergency room visits  
first primary asthma diagnosis 
with an  
emergency room discharge 
(n=4,005)   
Total emergency room visits  
first primary asthma diagnosis 
with an  
admission 
(n=1,095) 
Year               n                   %          
 
2002                 1,455           28.5 
2003                 1,480           29.0 
2004                 1,075           21.1      
2005                 1,090           21.4       
Total                5,100           100.0    
Year               n                 %                
 
2002                 1,182       30.0 
2003                 1,201       30.0 
2004                  821         20.0  
2005                  801         20.0    
Total                4,005      100.0   
Year                n                 %               
 
2002                    273        27.1 
2003                    279        25.4   
2004                    254        23.1     
2005                    289        26.3    
Total                 1,095      100.0     
Month               n                  %          
 
January              488           9.6 
February            507           9.6 
March                489           9.6 
April                  422           8.3 
May                   432           8.5 
June                   403           7.9 
July                    287          5.6 
August               303          5.9 
September          424          8.3 
October              461          9.0     
November          416          8.2 
December          468           9.2 
Total                 5,100       100.0 
Month               n              %                 
 
January               367       9.1 
February             368       9.1 
March                 364       9.0 
April                   327       8.1  
May                    345       8.6 
June                    333       8.3 
July                     235      5.8 
August                244      6.0 
September           364       9.0 
October               370       9.2 
November           336       8.3 
December           352       8.7 
Total                 4, 005   100.0    
Month               n                %          
        
January              121          11.0   
February            129          11.7   
March                125          11.4   
April                   95             8.6           
May                    87             7.9    
June                    70             6.3    
July                     52             4.7    
August                59             5.3    
September           60            5.4   
October                91            8.3   
November            80            7.3  
December            116          10.5 
Total                  1,095       100.0 
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Figure 17: Emergency room visits for all first primary asthma by month and disposition 
 
The highest number of visits was observed in and around the COP with St.  Margaret’s 
1201(23.5%) and Shadyside Hospital’s 917(18.0%) having the highest number of ED visits 
(Table 22).  Southside Hospital had the least number of visits 489(9.6%).  The observed 
differences by hospitals may be solely due to individuals choosing the larger emergency 
departments closest to the city for asthma care or a referral bias by practitioners treating asthma 
patients. 
 
Table 22: First primary asthma emergency room visit for 6 UPMC hospitals 
Hospital Total 
% 
Braddock 892(17.5) 
McKeesport  732(14.4) 
Presbytarian 869(17.0) 
Shadyside 917(18.0) 
St Margaret’s 1,201(23.5) 
Southside 489(9.6) 
Total (%) 5,100(100.0) 
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 The geographic distribution of primary asthma ED visits were similar to patterns seen 
with the primary and secondary asthma dataset with the highest number of cases concentrated 
around the city limits (Figure 18).  This is no surprise since the 6 hospitals in this study were 
concentrated around the COP.  
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Emergency room visits for primary asthma (n=5,100) for 6 UPMC 
hospitals in Allegheny County 
Asthma rates in Allegheny Country based on ED 
visits for primary asthma:  6 UPMC hospitals only 
No cases reported in asthma dataset 
 
Figure 18: Emergency room visits for primary asthma (n=5,100) for 6 UPMC hospitals in 
Allegheny County 
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3.4.1.3 Population C 
  A 10% random sample was taken from the first primary asthma dataset.  This random 
sample represented a total of (n=488) adults.  The age range was from 18-103, (M=43.87, 
SD=19.08).  The proportion of individuals within each age group was fairly similar with the 
exception of individuals 65± who were represented by the smallest proportion of individuals 
82(16.8%) (Table 23).  The mean age for individuals discharged from the hospital were much 
less than for those who were admitted (M= 38.91, SD= 16.22), (M= 62.38, SD= 17.61), 
respectively.  A higher frequency of ED visits was observed for females than males 69.3%(95% 
CI 65-73.1) vs. 30.7%(95% CI 26.8-34.9), respectively.  This same pattern was observed for 
gender by disposition.  
Differences were observed by race with Whites (58.6%) having a higher proportion of 
emergency room visits than Blacks (39.8%) and Others, (1.6%).  The differences were observed 
for individuals whether they were discharged or admitted.  The higher proportion of whites 
reflects the higher number of Whites in the catchment area.  The hospitals in this research study 
were drawn from the UPMC network, which represented 6 hospitals centered on the COP.  The 
Black population in the COP is 30% and 10% in AC (US Census, 2006).  Therefore, without an 
asthma population representative of AC residents inclusive of  the entire network of hospitals in 
AC, no conclusions can be made about racial differences in this population.   
 
 
Table 23: Random Sample- First Primary asthma emergency room visits (6 UPMC hospitals) by age, sex, and race by 
disposition 
Total emergency room visits first 
primary asthma diagnosis  
 (n=488) 
Total emergency room visits  
first primary asthma diagnosis 
with an  
emergency room discharge 
 (n=385) 
Total emergency room visits  
first primary asthma diagnosis 
with an  
admission 
 (n=103) 
Age            n          %       CI 
 
0-17 0 
18-29         137       28.0    24.2-32.2 
30-44         139       28.4    24.6-32.6 
45-64         130       26.6    22.9-30.7 
65              82         16.8    13.7-20.3 
 
 
 
 
Mean age= 43.87(SD 19.08)   
Range=18-103 
 
Total         488        100.0 
Age             n            %        CI 
 
0-17              0  
18-29          134         34.8     30.2-39.6 # 
30-44          126         32.7     28.2-37.5 # 
45-64           94          24.4     20.3-28.9* 
65+              31            8.0        5.7-11.2*# 
 
 
 
 
 
Mean age= 38.91(SD 16.22) 
Range=18-93 
 
Total         385        100.0 
Age             n            %        CI 
 
0-17               0            
18-29             3            2.9    1.05-8.19*# 
30-44            13         12.6     7.5-2.0 *# 
45-64            36         34.9     26.4-44.5 
65+               51         49.5      40.0-59.0 # 
 
 
 
 
Mean age= 62.38(SD 17.61) 
Range=19-103 
 
Total         103        100.0 
Sex               n         %        CI 
 
Male             150        30.7    26.8-34.9 
Female          338       69.3     65-73.1 
Total            488        100.0 
Sex             n         %           CI 
 
Male             119      30.9      26.5-35.6  
Female         266       69.1      64.3-73.4  
Total            385        100.0 
Sex           n         %           CI 
 
Male           31           30.0    22.0-39.5  
Female       72            70.0     60.4-77.9  
Total          103        100.0 
Race            n        %          CI 
  
Black          194          39.8        35.5-44.1     
White          286         58.6        54.1-62.8  
Other               6           1.2          .57-2.65 
Unknown         2            .4           .12-1.46 
Total            488        100.0 
Race             n         %        CI 
  
Black          169        43.8    39.0-48.8  
White          209        54.2    49.2-59.1  
Other              6          1.5     .73-3.35 
Unknown       1           .25      .06-1.43  
Total            385        100.0 
Race           n          %      CI 
  
Black           25           24.2    17.0-33.4  
White           77           74.7    65.5-82.1  
Other              0                
Unknown        1            .25     .23-5.24  
Total           103       100.0 
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 Insurance type was reported for all first primary asthma visits (Table 24).  Enrollees in all 
insurance categories except Medicare were more likely to be discharged than admitted.  This 
data was consistent with the primary asthma dataset.  Significant differences were observed 
between the mean ages for individuals who were discharged vs. admitted, (M= 38.91, SD = 
16.22) vs. (M= 62.38, SD = 17.61), respectively, t(486),  = 12.80, p < 0.03 (two-tailed). Older 
adults were more likely to be admitted.  However, this is an abbreviated representation of ED 
visits of which no significant conclusions can be drawn.  A larger sample of ED visits is need to 
conduct further analysis looking at the different insurance types, and factors influencing health 
service utilization. 
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Table 24: Random Sample- Insurance status for all first primary asthma emergency room visits by disposition 
Total emergency room visits first 
primary asthma diagnosis  
 (n=488) 
 
 
 
Mean age= 43.87(SD 19.08)   
Range=18-103 
 
Total emergency room visits  
first primary asthma diagnosis 
with an  
emergency room discharge 
 (n=385) 
 
Mean age= 38.91(SD 16.22) 
Range=18-93 
Total emergency room visits  
first primary asthma diagnosis 
with an  
admission 
 (n=103) 
 
Mean age= 62.38(SD 17.61) 
Range=19-103 
 
Financial           n         %        CI 
 
Medicare              70     14.3      11.5-17.7 
Medicare MC       48      9.8         7.5-12.8 
Medicaid              14      2.8          1.7-4.7  
Medicaid MC       78      15.9      13.0-19.5    
Commercial          20       4.0         2.6-6.2 
Commercial MC   92      18.8      15.6-22.5 
Third PP               92      18.8       15.6-22.5 
 Third PPMC        0   
Self pay                 68      13.9      11.1-17.2 
Other                      7        1.4           .70-2.9 
VA                          0 
 
Total                     488       100.0 
Financial        n         %          CI 
 
Medicare             31     8.0   5.7-11.2    
Medicare MC      28    7.2    5.0-10.3   
Medicaid             14    3.6     2.1-6.0   
Medicaid MC       69   17.9  14.4-22.0     
Commercial         17     4.4     2.7-6.9  
Commercial MC  73    18.9   15.3-23.1 
Third PP              86    22.3    18.4-26.7   
Third PPMC         0  
Self pay               65      16.8   13.4-20.9   
Other                    5       1.27      .57-2.99 
VA                       0 
 
Total                  385       100.0 
Financial          n         %        CI 
 
Medicare             39       37.8    29.0-47.5   
Medicare MC      20       19.4    12.9-28.1   
Medicaid               1        .97     .23-5.24   
Medicaid MC        7         6.7   3.3-13.3    
Commercial           3       2.9    1.05-8.19 
Commercial MC  20       19.4    12.9-28.1 
Third party payer   6       5.8      2.7-12.1   
Third PPMC          0     
Self pay                 3        2.9      1.05-8.19   
Other                     2        1.0        .59-6.7 
VA                         0 
 
Total                          103          100.0 
  
 
  
A review of the ED visits by month and year demonstrated that the highest numbers of 
ED visits were observed in October-December and March-June.  No significant difference was 
observed between the number of ED visits which occurred in the fall and winter months vs. the 
spring and summer months, X2(1, N=488) = .03, p > .05  (Figure 19). 
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Figure 19: Random Sample: First primary asthma visits by month and year 
  
 An analysis of the data was conducted for each hospital by year.  St. Margaret’s Hospital 
had the highest number of ED visits 116(23.7%), followed by Presbytarian 90(18.4%), and 
Braddock 85(17.4%).  Southside Hospital had the least number of visits 42(8.6%) (Table 25).  
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Table 25: Random Sample –First Primary asthma emergency room visits by hospital and 
year 
 
Hospital 2002 2003 2004 2005 Total 
% 
Braddock 27 27 13 18 85(17.4) 
McKeesport  18 22 16 19 75(15.3) 
Presbytarian 27 20 22 21 90(18.4) 
Shadyside 23 33 16 8 80(16.3) 
St Margaret’s 28 46 21 21 116(23.7) 
Southside 10 15 11 6 42(8.6) 
Total*(%) 133(27.5) 163(33.4) 99(20.2) 93(19.5) 488(100.0)
*includes  6 UPMC hospitals  
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3.4.2 Comparison ICD-9 Coded chief complaint: Admitting vs. Hospital discharge 
diagnosis for asthma 
Several studies have assessed the validity of using the ICD 9 coded chief complaint to 
study disease (Wagner, et al, 2004; Espino &  Wagner, 2001).  Available to the researcher in this 
dataset was the ICD 9 coded chief complaint admitting diagnosis and hospital discharge 
diagnosis.  An analysis was conducted to determine which diagnosis improved the sensitivity of 
identifying a case of asthma.   The admission diagnosis is sort of a working hypothesis of the 
physician’s conclusion of the best explanation that fits the patient’s symptoms as they enter the 
hospital.  A discharge diagnosis is most often the diagnosis which best fits the patient’s 
symptoms, history, examination and test results (S. McLinden, personal communication, 
February 8, 2007).  Wagner et al (2004) report that as a patient moves through the admission 
process, the diagnostic accuracy for assigning a discharge (primary) diagnosis to the patient 
increases as more information becomes available.  To determine which diagnosis was better at 
identifying a case of asthma, a comparison of the ICD-9 coded chief complaint admitting 
diagnosis was compared to the hospital discharge diagnosis (Table 26).  The analysis which 
relied on the admitting diagnosis to classify an ED visit demonstrated that 1,479 visits received 
an ICD 9 coded diagnosis for asthma [493.0-493.9], 5,001 visits were grouped under the signs 
and symptoms category using the ICD 9 code [780.01-799.3] for wheezing, shortness of breath, 
tachypnea, respiratory distress, cough and orthopnea, and 1,251 visits were given an ICD 9 code 
[460-519.9] for a respiratory related condition.  When the discharge diagnosis was used to 
classify the visits, 6,024 visits received an ICD 9 coded diagnosis for asthma [493.0-493.9].  The 
number in the sign and symptoms category decreased from 5001 to 1376, respectively, which 
suggests that by using the admission diagnosis to study asthma a great deal of primary asthma 
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cases were not being captured.  However, many were being assigned into the sign and symptoms 
category for which described the patient’s complaint or rationale for admission.  These findings 
suggest that the admission diagnosis is more consistent with the chief complaint or the term or 
phrase, which describes the patient’s complaint on admission.  As the patient moves through the 
admission process and into the discharge phase of admission, the discharge diagnosis became 
more specific for a diagnosis of asthma.   
 
Table 26: A comparison of the ICD-9 Coded chief complaint admitting diagnosis to the 
primary hospital discharge diagnosis 
 
Grouped by Admitting Diagnosis  
Chief Complaint  ICD-9 Code            n 
 
Infection/parasite ( 005.9-136.9)          71 
Neoplasm’s            (146.9-239.6)         35     
Endocrine/Renal   (242.0-276.8)       115        
Blood                    (280.0-288.0)          36 
Mental Health       (291.0-312.9)        533  
Nervous System    (320-388.7)           334 
Circulatory            (401.0-459.9)        622 
Respiratory           (460-519.9)         1,251 
Asthma                 (493.0-493.9)      1479 
Digestive               (520.6-579.3)       502 
Genitourinary       (584.5-628.9)        188 
Preg comps           (640.93-674.8)         6 
Cutaneous/skin     (680.3-708.9)        146 
Musculoskeletal    (710.1-733.99)    1127 
Perinatal                (760.9)                      1 
Sign/symptoms     (780.01-799.3)    4,706 
Wheezing, SOB,    (786.0-786.9)     5,001       
tachypnea, respiratory distress 
cough  & orthopnea                       
Injury/poisonings  (802.4-998.89)     1,643 
Supplement Vcodes  (V01.6-V72.9)    478  
Missing                                                     9 
Total                                                18,284      
 
Grouped by Primary Diagnosis  
Chief Complaint ICD-9 Code                   n 
                       
Infection/parasite ( 005.9-136.9)                  362 
Neoplasm’s            (146.9-239.6)                 143 
Endocrine/Renal   (242.0-276.8)                  306       
Blood                    (280.0-288.0)                    81 
Mental Health       (291.0-312.9)                  878 
Nervous System    (320-388.7)                     395  
Circulatory            (401.0-459.9                 1,268 
Respiratory           (460-519.9)                   1,667 
Asthma                 (493.0-493.9)                 6,024 
Digestive               (520.6-579.3)                1,006 
Genitourinary       (584.5-628.9)                    452 
Preg comps           (640.93-674.8)                    51 
Cutaneous/skin     (680.3-708.9)                    307 
Musculoskeletal    (710.1-733.99)                  515 
Perinatal                (760.9)                                  9 
Sign/symptoms     (780.01-799.3)                1,041 
Wheezing, SOB,   (786.0-786.9)                  1,376 
 tachypnea, respiratory distress 
 cough & orthopnea                                      
Injury/poisonings  (802.4-998.89)                2,276 
Supplement Vcodes  (V01.6-V72.9)               117 
Missing                                                                9 
Total                                                           18,284 
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3.5 VALIDATION STUDY RESULTS 
3.5.1 Electronic Medical Record: Composition and Completeness  
A total of 180 EMRs were included this analysis.  The EMRs represented adults who had 
a first primary asthma visit to the ED from 2002-2005.  This primary asthma diagnosis was 
ascertained through an electronic medical record abstract using the corresponding ICD-9 code 
for primary asthma (493.0-493.9).  The review assessed for completeness of findings in the EMR 
by identifying the selected indicators and CSTE clinical and laboratory case definition criteria 
used to classify a case of asthma.  The following 838 documents were reviewed as part of the 
EMR: clinical narrative reports, including free text history and physicals, dictated physicals, 
consultations, clinic follow up visits, ED notes, laboratory results, surgery reports and discharge 
summaries.  Age was not reported in 16(9%) of the records, gender was absent in 5(3%), and 
race was missing in 105(58.3%).  Complete data was found for chief complaint, patient type, 
visit type, admission and discharge date, and type of record.  No information was provided in the 
record about the hospital where the patient was being treated, resident zip code status, or 
insurance type.  The identifying dataset used to locate the electronic medical record provided all 
the missing de-identified data.  This feature increased the sensitivity of findings to 99% for each 
specific de-identified data point.  
 In this research project it was necessary to have the medical record data from the 
previous year to determine if there was an occurrence of any asthma symptom reported at least 
three times in the past year for asthma.  This created one year of additional records for the 
reviewer to consider as supporting evidence to assist in classifying a case of asthma.  Having the 
EMR dataset made it very easy to determine if a patient had three visits or more in the past year 
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simply by ordering the records by admission date.  If a patient did not have three or more visits 
in the past year noted by the date of admission, the patient automatically did not meet the 
requirements to be classified into the confirmed asthma category.  Therefore, all the remaining 
medical records were used to determine whether a case of asthma could be corroborated through 
existing documentation and to identify the respective probable and possible asthma classification 
category to which the patient belonged.  This step took the most time, particularly when a case of 
asthma could not be substantiated by the documentation found in the ED visit summary.  The 
automated feature of the medical record provided quick access to the record of interest, ease of 
navigation through the multiple record types, and the ability to revisit any supporting document 
to classify an asthma case.  Since this process had to be repeated numerous times due to the 
overlap in classification criteria, and late addition of adding the comprehensive list of asthma 
medications to the study, the automated feature reduced the review time in half for each review 
cycle.  However, the complexities surrounding the use of the EMRs were challenging.  Since 
there is no standardized method for documenting in the medical record, good clinical judgment 
was necessary to sort out all contradictory statements found while reviewing the records.  
Follow-up consultations and progress notes associated with the respective ED visit, were not 
always in chronological order.  This made it very confusing to the reviewer when an asthma sign 
and symptom or characteristic pertaining to the original ED visit were contradicted in another 
part of the medical record.  The date of service rendered by the date marked on the record was 
used as the link to the initial asthma ED visit.  If the date of the consultation or progress notes 
were not the same as the ED visit such as in the case of a visit originating on one day, and the 
corresponding progress note written after midnight, this situation required a great deal of time to 
sort out whether the record belonged to a new visit or an addendum to the existing visit.  If an 
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asthma diagnosis was in question and no information pertaining to the diagnosis could be 
ascertained from the ED visit note, all the supporting records were used as evidence to classify 
the asthma diagnosis.   
Overall, the use of the EMR provided the researcher the ability to have immediate access 
to key data.  The automated feature made it easy to select records of interest and move freely 
about the dataset without a large paper trial of information.  The use of multiple record types 
increased the sensitivity of findings for specific endpoints such as an asthma medication.  
Furthermore, the complex nature of this research study involving all previous 1-year visits 
coupled by the multiple records associated with each ED visit, and need to discriminate the broad 
range of criteria designated by the CSTE clinical and laboratory classification definition 
underscores the need to have access to data in an automated format.  The use of the EMR greatly 
improved the ability to carryout this research in a timely, efficient manner.  Moreover, the EMR  
served as a comprehensive tool to conduct epidemiological research on asthma.  
3.5.1.1 Electronic Medical Record: Descriptive analysis  
 Of the total 180 ED visits, 146(81.1%) were confirmed discharges and 34(18.9%) 
admissions.  Emergency department visits were reported for all six hospitals with Presbytarian 
44(24.4%) and St. Margaret’s Hospital 38(21.1%) having the highest number of ED visits and 
Southside Hospital 14(7.7%) the least (Table 27).   
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Table 27: Electronic Medical Record: First primary asthma ED visit by hospital and 
disposition 
Hospital Frequency 
of ED visit 
with 
discharge 
 
Frequency 
of ED visit 
with 
admission 
Total 
% 
Braddock 24 5 29(16.1) 
McKeesport 21 6 27(15.0) 
Presbytarian 35 9 44(24.4) 
Shadyside 22 6 28(15.5) 
St Margaret’s 32 6 38(21.1) 
Shadyside 12 2 14(7.7) 
Total*(%) 146(81.0) 34(18.9) 180(100.0) 
 * includes 6 UPMC hospitals  
 
A breakdown of the demographic characteristics of this cohort included individuals 
whose age ranged from 18-103 (M=46.71, SD=20.63).  The frequency of visits was equally 
distributed across all age groups (Table 28).  A gender difference was observed with female ED 
utilization being over twice that of males (70%) to (30%), respectively.  Racial differences were 
observed for individuals presenting to the emergency department.  Whites reported a higher 
frequency of ED visits than Blacks and Others, 56.1% to 43.3% and 0.5%, respectively.  This is 
not a complete representation of the proportion of Whites and Blacks in Allegheny County as 
this represents only a small proportion of asthma cases from the six hospitals in this sample.  
These hospitals are located around the COP.  The Black population in the COP is 30% and 10% 
in AC as a whole (US Census, 2006).  Therefore, no conclusions can be made on these data 
based on the limited representation of  hospitals in the UPMC network and county as a whole.    
However, a comparison of the demographic characteristics of the population identified 
through the EMRs was made to confirm that this population was representative of the 488 
primary asthma cases identified in the random sample, and the total primary asthma dataset 
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(n=5,100).   The age distribution of the EMR population is almost identical to the random sample 
and primary asthma dataset (Appendix F).  The proportion of cases by sex and race are equal 
across demographic subgroups.  
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Table 28: Electronic Medical Record: First primary asthma ED visit by age, sex and race 
EMR emergency room visits with first 
primary asthma diagnosis (n=180) 
  Age               n       %        
 
0-17                
18-29             41       22.7 
30-44             49       27.2 
45-64             50       27.7 
65+                40       22.2 
 
Mean 46.71(SD 20.20) 
Range 18-103 
 
Total            180     100.0       
Sex               n        %         
 
Male           54       30.0 
Female      126       70.0 
 
Total            180      100.0       
Race             n         %        
 
Black            78      43.3 
White          101     56.1 
Other              1         .5 
Unknown       0 
Total            180       100.0       
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3.6  ASTHMA SELECTED INDICATOR RESULTS 
3.6.1 Manual Review 
The manual review of the medical record was conducted to identify the selected 
indicators proposed to validate a case of asthma for this research study.  The medical record 
review is considered to be the gold standard methodology.  This process took approximately 80 
hours of review time. The findings were validated using two automated applications by which 
the gold standard methodology results would be compared. 
 The following is a summary of the results of the medical chart review (Table 29).  Of the 
clinical signs and symptoms and characteristics reported for asthma, shortness of breath was 
reported most frequently 128(71.1%), followed by wheezing 104(57.7%), and cough 
102(56.7%).  Surprisingly, wheezing the most frequently reported symptom for asthma was not 
present in 16(8.8%) of the visits and not mentioned in 60(33.3%).  Rhinitis and fever were 
present almost equally 20(11.1%) to 19(10.5%), respectively.  Rhinitis has been reported to 
result in low sensitivity for predicting asthma (Hung et al., 1998).  Rhinitis was not mentioned in 
148(82.2%) of the ED visits.  Fever, a sign which is routinely assessed on every ED visit was not 
mentioned in 53(29.4%) of the cases.  This finding could have resulted from an oversight on the 
reviewers behalf since there is a numeric component and several keywords that represent the 
word fever which may not have been picked up on initial chart review.  The presence of an 
asthma history was found in 120(66.7%) records and was not mentioned in 58(32.2%).  Two 
records were marked for no history of asthma.   
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 The indicator, which had the highest level of sensitivity for predicting a diagnosis of 
asthma, was current use of an asthma medication.  A total of 140(77.7%) of all patients 
presenting to the ED were on an asthma medication.  Only eleven persons were not using any 
asthma medication prior to their ED visit and 29(16.1%) of the cases had no mention of an 
asthma medication.  Individuals who were using their inhaler on presentation to the emergency 
department were counted as presence of being on an asthma medication.  Individuals whose 
medical record did not contain any information other than given a nebulizer treatment in the 
emergency department with no evidence to substantiate an asthma diagnosis including, previous 
mention of an asthma medication was marked as absence of being on an asthma medication.  
Previous research has suggested that a nebulizer treatment without any further substantiate 
evidence to back up an asthma diagnosis including the past use of an asthma medication results 
in a low (27%) positive predictive value for asthma (Vollmer, 2004).    
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     Table 29: Selected Indicators: Manual Review results 
Selected Indicators Total 
n=180 
Wheezing  
 
0 absence 
1 presence  
2 not mentioned  
Total  
 
 
16(8.8) 
104(57.7) 
60(33.3) 
180(100.0) 
Cough  
0 absence 
1 presence  
2 not mentioned  
Total 
 
27(15.0) 
102(56.7) 
51(28.3) 
180(100.0) 
Shortness of Breath  
 
0 absence 
1 presence  
2 not mentioned  
Total 
 
 
15(8.3) 
128(71.1) 
37(20.5) 
180(100.0) 
Rhinitis 
0 absence 
1 presence  
2 not mentioned  
Total 
 
12(6.7) 
20(11.1) 
148(82.2) 
180(100.0) 
Fever  
0 absence 
1 presence  
2 not mentioned  
Total 
 
108(60.0) 
19(10.6) 
53(29.4) 
180(100.0) 
History of asthma 
 
0 absence 
1 presence  
2 not mentioned  
Total  
 
2(1.1) 
120(66.7) 
58(32.2) 
180(100.0) 
Asthma Medications  
0 absence 
1 presence  
2 not mentioned  
Total 
 
11 (6.1) 
140(77.7) 
29(16.1) 
180(100.0) 
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3.6.2 Manual vs. Automation Review 
Two automated methodologies were employed to validate the data extracted from the medical 
record on manual chart review.  Each knowledge base methodology provided different 
approaches at structuring the data for scientific interpretation.  However, the goal was to find a 
methodology equal or superior to the gold standard manual chart review.  A comparison of the 
results from the three methodologies is provided in Table 30.  
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   Table 30: Selected Indicators results: Manual vs. Automation 
Indicators Manual Chart Review  PERL MedLEE* 
Wheezing  
0 absence 
1 presence  
2 not mentioned  
Total  
 
16(8.8) 
104(57.7) 
60(33.3) 
180(100.0) 
 
14(7.8) 
117(65.0) 
49(27.2) 
180(100.0) 
 
18(10.0) 
84(46.7) 
78(43.3) 
180(100.0) 
Cough * 
0 absence 
1 presence  
2 not mentioned  
Total 
 
27(15.0) 
102(56.7) 
51(28.3) 
180(100.0) 
 
29(16.1) 
103(57.2) 
48(26.7) 
180(100.0) 
 
31(17.2) 
97(53.8) 
52(28.9) 
180(100.0) 
Shortness of Breath  
0 absence 
1 presence  
2 not mentioned  
Total 
 
15(8.3) 
128(71.1) 
37(20.5) 
180(100.0) 
 
26(14.4) 
131(72.8) 
23(12.8) 
180(100.0) 
 
13(7.2) 
112(62.2) 
55(30.6 
180(100.0) 
Rhinitis* 
0 absence 
1 presence  
2 not mentioned  
Total 
 
12(6.7) 
20(11.1) 
148(82.2) 
180(100.0) 
 
0 
5(2.8) 
175(97.2) 
180(100.0) 
 
             14(7.8) 
             21(11.7) 
           145(80.6) 
         180(100.0) 
Fever  
0 absence 
1 presence  
2 not mentioned  
Total 
 
108(60.0) 
19(10.6) 
53(29.4) 
180(100.0) 
 
48(26.7) 
94(52.2) 
38(21.1) 
180(100.0) 
 
126(70.0) 
25(13.9) 
29(16.1) 
180(100.0) 
History of asthma* 
0 absence 
1 presence  
2 not mentioned  
 Total  
 
2(1.1) 
120(66.7) 
58(32.2) 
180(100.0) 
 
3(1.7) 
53(29.4) 
124(68.9) 
180(100.0) 
 
              2(1.1) 
          116(64.4) 
62(34.4) 
180(100.0) 
 
Asthma Medications * 
 
0 absence 
1 presence  
2 not mentioned  
Total 
 
 
11 (6.1) 
140(77.7) 
29(16.1) 
180(100.0) 
 
 
2(1.1) 
141(78.3) 
37(20.6) 
180(10.00) 
 
 
2(1.1) 
82(45.6) 
96(53.3) 
180(100.0) 
  
             Combined UMLS Concept Codes for MedLee for selected indicators * 
    MedLee asthma medications results reported for Nebulizer/Inhalers only  
 
 The results for each classification concept for the presence; absence and not mentioned 
status for each indicator matched by PERL in comparison to the medical chart review were close 
(±10% difference) for all indicators except rhinitis, fever and past medical history (Table 30).  
Rhinitis was not a sensitive indicator for asthma as evident by the limited presence of this 
symptom 20(11.5%) reported in the medical record.  PERL only matched on 5(2.8%) instances 
for the presence of rhinitis, zero matches in the absence category, and not mentioned in 
175(97.2%) records.  The percent difference observed between PERL and the medical chart 
review for rhinitis was 15% as noted in the not mentioned category 175(97.2%) vs. 148(82.2%), 
respectively.  For the indicator fever, PERL matched on the presence of this finding in 94 
records, whereas the manual chart review picked up nineteen-a difference of 80%.  Furthermore, 
a fifty-five percent difference was reported between PERL and the medical chart review for the 
absent of fever 108(60.0%) vs. 48(26.7%), respectively.  A past medical history of asthma, an 
indicator with a moderate to high degree of sensitivity was confirmed in 120(66.7%) records 
through manual chart review.  PERL was only able to identify less than half of these cases 
53(29.4%).  PERL also reported that a history of asthma was not mentioned in 124(68.9%) of the 
EMRs.  The results from the manual review showed that only 58(32.2%) of the cases had no past 
medical history of asthma.  This represented a 53% discrepancy in finding.  More favorably for 
PERL, the results for the asthma medication concept categories were almost identical to that of 
the medical chart review.  PERL and the manual chart review results were nearly identical for 
the presence of an asthma medication 140(77.7%) vs. 141(78.3%) respectively.  This finding is 
likely due to the highly specific asthma medication script created for PERL, which matched on 
the list of each asthma medication.  A small difference was observed for instances where not 
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medications were found or were not mentioned, 2(1.1%) vs. 11(6.1%), and 37(20.6%) vs. 
29(16.1%), respectively. 
The findings from MedLee matched the manual chart review very closely for every 
indicator by category status with the exception of fever and asthma medications.  A comparison 
of MedLee to the manual chart review for the absence of fever was 126(70.0%) vs. 108(60.0%), 
presence 25(13.9%) vs. 19(10.6%), and not mentioned status 29(16.1%) vs. 53(29.4%), 
respectively.  PERL did not perform as well as MedLee against the medical chart review for 
fever; absence 48(26.7%), presence 94(52.2%), and not mentioned status 38(21.1%).  The 
MedLee results for asthma medications were only reported for the mention of the word inhaler 
and nebulizer.  This was a limitation for this study.  Currently, there are 2 UMLS concept codes, 
which can be used to represent asthma medications, inhaler (C0021461), and nebulizer 
(C0027524).  The use of an inhalers was present in 59(32.8%) of the records, absent in 2(1.1%) 
and not mentioned in 119(66.1%).  The presence of a nebulizer was reported in 36(20%) of the 
records and not mentioned in 144(80%).  The combined presence of these two concepts is 
reported in Table 31.  The use of an inhaler and nebulizer were identified in 82(45.6%) of the 
EMRs.  A limitation of using MedLee with the asthma project was the inability to have results 
included for the specific list of asthma medications.  This was not discovered until a later phase 
of  this research study.   Since there are no UMLS concepts codes yet developed for the selected 
asthma medications, a proxy measure was reported for the combined results of an inhaler and 
nebulizer.  
Table 31: MedLEE combined UMLS concept codes: Comparison to manual chart review and PERL 
 Manual Chart 
Review 
PERL                              MEDLEE 
Cough  
 
0 absence 
1 presence  
2 not mentioned  
Total 
 
 
27(15.0) 
102(56.7) 
51(28.3) 
180(100.0) 
 
 
29(16.1) 
103(57.2) 
48(26.7) 
180(100.0) 
C0010200- All cough* 
 
3(17.2) 
97(53.8) 
52(28.9) 
180(100) 
 
         C0850149-dry 
 
0 
20(11.1) 
160(88.9) 
180(100.0) 
     C0850149-productive 
 
169(93.9) 
4(2.2) 
7(3.9) 
180(100.0) 
Rhinitis 
 
0 absence 
1 presence  
2 not mentioned  
Total 
 
 
12(6.7) 
20(11.1) 
148(82.2) 
180(100.0) 
 
 
0 
5(2.8) 
175(97.2) 
180(100.0) 
         Combined 
 
             14(7.8) 
             21(11.7) 
           145(80.6) 
           180(100.0)  
C0035455-rhinitis 
 
1(.6) 
4(2.2) 
175(97.2) 
180(100) 
 
C1260880-runny nose 
 
13(7.2) 
19(10.6) 
148(82.2) 
180(100.0) 
History of asthma 
 
0 absence 
1 presence  
2 not mentioned  
 Total  
 
 
2(1.1) 
120(66.7) 
58(32.2) 
180(100.0) 
 
 
3(1.7) 
53(29.4) 
124(68.9) 
180(100.0) 
Combined  
 
              2(1.1) 
          116(64.4) 
62(34.4) 
180(100.0) 
 
C0455544-asthma hx 
 
3(1.1) 
65(36.1) 
112(62.2) 
180(100.0) 
C0004096-asthma 
 
2(1.1) 
99(55.0) 
79(43.9) 
180(100.0) 
Asthma Medications  
 
0 absence 
1 presence  
2 not mentioned  
Total 
 
 
11 (6.1) 
140(77.7) 
29(16.1) 
180(100.0) 
 
 
2(1.1) 
141(78.3) 
37(20.6) 
180(10.00) 
Combined  
 
2(1.1) 
82(45.6) 
96(53.3) 
180(100.0) 
 
C0021461-inhaler 
 
2(1.1) 
59(32.8) 
119(66.1) 
180(100.0) 
 
C0027524-nebulizer 
 
0 
36(20.0) 
144(80.0) 
180(100.0) 
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Several UMLS concept codes were identified for each selected indicator with a separate 
set of MedLee results for each concept code (Table 31).  The data from the multiple concept 
categories were collapsed to make a comparison against the selected indicator results.  For 
example, the UMLS concept code for rhinitis (C0035455) was represented by a second set of 
concept results for runny nose (C1260880).  MedLee results for rhinitis were very similar to the 
PERL results, but very low in comparison to the manual chart review findings.  Results for 
rhinitis were absent in 1(.6%) of the records, present in 4(2.2%) and not mentioned in 
175(97.2%) of the records.  When runny nose, the second UMLS concept code (C1260880) was 
used the MedLee findings were almost identical to that of the medical chart review; absent 
13(7.2) vs. 12(6.7%), present 19(10.6%) vs. 20(11.1%) and 148(82.2%) vs. 148(82.2%), 
respectively. Thus, the concept “runny nose” was more sensitive for a diagnosis of asthma than 
the word rhinitis.  Combined results for the two terms were almost identical to the manual chart 
review findings.  The term past medical history for asthma was another indicator, which was 
represented by 2 UMLS concept codes.  The concept code asthma (C0004096) was found to 
have higher levels of agreement against the findings observed from the manual review than the 
concept code for asthma history (C0455544). Furthermore, the concept code for asthma 
(C0455544) performed better at identifying asthma cases then reported by PERL.  Combined 
results for the two concept code results were almost an identical match to the manual chart 
review findings.  The selected indicator cough was reported using one concept code (C0010200) 
to represent all combined total cough certainties.  Only one other UMLS concept code 
(C085149) was identified to represent productive and dry cough.  These results are reflected in 
the all cough category* as highlighted in Table  31. 
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In summary, the goal was to determine which automated methodology, PERL or MedLee 
performed better at identify the selected indicators from the manual chart review.  The degree of 
concordance was calculated to determine this estimate using the following methods.  The manual  
chart review results for one indicator were matched against the findings from the automated 
method for the same indicator.  The sum of all instances where agreement was found between 
both methodologies for the negative (absent), positive (present) and not mentioned status 
matches for a particular indicator were divided by the total number of reviews.  Data reported in  
Table 32 were used to calculate a degree of concordance between the manual chart review and 
PERL for the indicator wheeze.  The results of the manual chart review suggest that PERL 
agreed on 3 absent, 64 present and 12 not mentioned instances.  This is a total of 79 agreed upon 
matches, which divided by the total of 180 reviews yields a degree of concordance estimate of 
43.8%.  This methodology was applied for each indicator for both PERL and MedLee.  The 
results for the degree of concordance estimates are listed in Table 33 . 
  
 
            Table 32: Methodology used to establish degree of concordance 
PERL:   Wheeze  Manual 
Chart Review Absent Present Not 
mentioned
Total 
    Absent  3 11 2 16 
Present 5 64 35 104 
Not 
mentioned 
6 42 12 60 
Total 14 117 49 N=180 
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                  Table 33: Degree of Concordance: Manual chart review vs. automation 
Manual  Automation 
Medical Chart Review  PERL MedLEE 
Wheezing 
 
43.8%. 52.7% 
Cough 
 
45.0% 62.2% 
Shortness of Breath 
 
56.1% 56.1% 
Rhinitis* 
 
80.0% 75.5% 
Fever 
 
52.0% 58.3% 
History of asthma* 
 
41.6% 50.0% 
Asthma Medications 64.4% ** can not be 
determined 
                   *Combined UMLS concept codes   
                  **Complete data not available to make comparison  
 
The degree of concordance was greater for MedLee in all categories with the exception of  
rhinitis.  Overall, the performance of MedLee was more superior to PERL for validating data 
extracted from the EMR.  Several limitations were identified with PERL and not corrected with 
multiple attempts to resolve the issues.  These limitations reduced the level of sensitivity in 
findings in this research study.  PERL was not able to distinguish between a past, present or 
future event.  Therefore, if a diagnosis of asthma were suggested as a possibility, PERL would 
not be able to account for ruling out this likelihood.  A double negative such as cannot rule out 
asthma further reduced the differential.  The inability of PERL to section out portions of the 
electronic medical record also increased the likelihood that a history of asthma reported for a 
family member may also have been included as a positive finding in this asthma review.  Since 
PERL was used to match on all regular search expressions for all possible categories, there was 
no way to adjust the script to account for misspelled words, plurals or for word variations.  PERL 
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was not able to account for these differences.  This potentially reduced the sensitivity of findings 
in question.  Furthermore, the PERL expression did not include the acronym SOB for shortness 
of breath.  This was an oversight that could be corrected in future search applications.  The 
positive feature of PERL was the ability to match on highly specific words such as those 
represented for each asthma medication.  The complex nature of the lexicon used to represent 
asthma in the EMR abstract made it difficult to create a script that could be applied to this study 
with a high degree of sensitivity.  Moreover, based on the low levels in degree of concordance 
reported between the gold standard manual chart review and PERL with the except of the 
medication indicator (66.4%), PERL would not be recommended as a tool for validating asthma 
data extracted through the electronic medical record.  Additional techniques would have to be 
applied to handle the various challenges for the disease specific terms needed to validate this 
diagnosis.   
 The high level of agreement observed between MedLee and the manual chart review 
suggests that MedLee could play a valuable role in asthma research.  This tool did as well as a 
human for extracting and interpreting data from the EMR.  A high degree of accuracy was 
observed for identifying both the presence and absence of key concept terms.  The unique ability 
of  MedLee to parse out  text from the EMR through the mapping of the UMLS concept codes 
and modifiers, including the manual creation of a set of textual rules improved the ability to 
handle ambiguities.  However, for terms where no decision could be made or contradictory 
statements were found for the absence or presence of the selected indicator term, results were 
placed in the unknown or not mentioned category.  Based on the comparative results between the 
two methodologies, this limitation was not reflected in the findings.  The ability of MedLee to 
account for past events was evident by the high level of agreement reported for past medical 
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history of asthma.  Furthermore, MedLee did very well at identifying “acuteness” of illness.  
This is evident by the high level of concordance observed for the symptoms of asthma, which 
include shortness of breath, wheezing and cough.  With each desired finding selected for the 
asthma Validation Study, MedLee performed very well at parsing out the information from the 
EMR.  One challenge with using MedLee was identified at the end of the study when the 
reviewer was attempting to quantify the  results.  Three of the selected indicators had 2 or more 
concepts codes, which resulted in an overlap in findings.  No method was described in the 
literature to handle this issue.  A decision was made to collapse the data into one category for 
each selected indicator.   This step may have resulted in an imprecise measure for rhinitis, past 
medical history of asthma and the proxy measure used to report on asthma medications.  
However, based on the degree of concordance observed against the manual chart review results 
this was not the case. Another issue found with MedLee was the inability to isolate asthma 
medications in the EMR.  For this research study, a proxy measure could be reported for asthma 
medications using MedLee since UMLS concept codes have been designed for the word inhaler 
and nebulizer.  The lack of the UMLS concepts codes for the specific asthma medications limited 
the ability to have meaningful results reported for asthma medication usage in this cohort, 
However, this issue has been brought to the attention of the developers of MedLee by the 
programmer. Thus, the implication of this finding has assisted in advancing practice in natural 
language research using MedLee.  In conclusion, the process of a manual chart review is time 
consuming and costly.  The use of MedLee over both PERL and the manual chart review 
substantially improved the efficacy and efficiency for conducting this type of  research.     
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3.7 CLASSIFICATION OF ASTHMA POPULATION: CSTE CLINICAL AND 
LABORATORY CASE CLASSIFICATION DEFINITION RESULTS 
  Data was classified according to the modified version of the CSTE Clinical and 
Laboratory case classification definition (Table 12).   The criterion was modified due to the 
limited amount of  laboratory data found documented in the medical record.  A summary of the 
classification results are highlighted in Table 34.  The classification results are based on a review 
of the electronic medical record.  A descriptive analysis was conducted to compare the 
demographic subgroups, and selected indicator characteristics for each asthma classification 
category.  
3.7.1  Confirmed Classification  
A confirmed case of asthma was based on individuals meeting the clinical symptoms identified 
in the CSTE case definition at least 3 times in the past year.  A total of 14(7.7%) individuals met 
the criteria to be classified as a confirmed case of asthma.  Wheezing lasting 2 consecutive days 
or more was the most frequent symptom reported in 7(50%) of the cases.  Chronic cough treated 
with bronchodilators in the absence of an allergic sinusitis was reported in 4(28.5%) of the 
asthma cases.  No individuals had nocturnal awakening with dyspnea on exertion, cough and or 
wheezing in the absence of another medical conditions known to cause the symptoms.  Three 
cases were classified into the confirmed asthma category because documentation was found on 
three or more ED visits in the past year for an asthma attack, including an asthma history and 
verification of being on an asthma medication for treatment of the asthma attack symptoms.  
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Although this criterion was not considered part of the case definition for this classification 
category sufficient evidence was available to support a confirmed asthma diagnosis. 
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Table 34: CSTE Clinical and Laboratory case definition classification results (n=180) 
Classification Criteria Frequency % 
Confirmed (n=14) 
 
 
 
 
 
 
 
 
 
 
 
Met any clinical symptom/event at least 3x during the past year: 
• Wheezing lasting 2 consecutive days or more 
• Chronic cough responds to bronchdilatation 
that persists 3-6 weeks in the absence of 
allergic rhinitis sinusitis 
• Nocturnal awakening with dyspnea on 
exertion, cough, and or wheezing in the 
absence of other medical conditions known to 
cause these symptoms 
• Asthma attack supported by documentation of  
a history of asthma and use of asthma 
medications* 
 
7(50.0%) 
4(28.5%) 
 
0 
 
 
 
3(21.4%) 
 
 
Total =14(7.7%) 
Presence of any symptom reversed with a physician treatment or 
asthma medication 3 times in the past year. ** 
 Probable (n=126) 
 
Taken medications in the past year that was prescribed by a physician 
for asthma.  
 
126(100.0%) 
 
Total=126(70.0%) 
Possible (n=27) Presence of any of the following symptoms during the past year: 
• Shortness of breath 
• Wheezing or chronic cough in the absence of obvious 
respiratory infection   
• Presence of nasal secretions, mucosal swelling, nasal 
polyps or chronic sinusitis 
• Hyper-expansion of the thorax 
• Prolonged phased to forced exhalation 
• Wheezing during normal breath  
• Chest X-ray noted to show hyper expansion  
• Supporting documentation (current or past asthma 
history)* 
 
20(74.0%) 
8(29.6%) 
 
4(14.8%)0 
 
0 
0 
11(40.7%) 
 
1(3.7%) 
5(18.5%) 
 
Total=27(15.0%) 
Not Classified (n=13)  Not criteria to substantiate an asthma diagnosis  Total=13(7.2%) 
*documentation to support confirmed asthma  
**Same asthma cases identified in confirmed category (CSTE recommends collapsing probable and confirmed due to overlap in criteria) 
  
3.7.2  Probable Classification  
A probable case of asthma case was classified using the following criteria (a) presence of 
any symptom reversed with a physician treatment or asthma medication three times in the past 
year, (b) and taken medications in the past year that were prescribed by a physician for asthma.  
In order to be eligible for criteria (a) under the probable classification category individuals had to 
have three visits to the ED in the past year where their asthma symptom was treated by a 
physician or with an asthma medication.  This step resulted in identifying the same 14 patients 
classified under the confirmed asthma category.  Since the Council for State and Territorial 
Epidemiologists recommends combining both the confirmed and probable asthma categories due 
to similarities in the criteria, these 14 asthma patients were kept in the confirmed asthma 
category for the initial portion of the classification process.  The two classification categories 
were later collapsed for further analysis.  
A probable case of asthma was the easiest to validate by confirming that the individual 
was taking medications in the past year that were prescribed by a physician for asthma.  The list 
of asthma medications previously reported in the methods section of this research was used to 
differentiate the presence of an asthma medication (Table 10).   
126 (100%) persons met the eligibility criteria for probable asthma (Table 34).  One 
person who presented to the emergency room for asthmatic bronchitis was non-complaint with 
using an inhaler but had previously been prescribed the inhaler in the past for asthma.  This 
person was included in the probable asthma category.   
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3.7.3 Possible Classification 
A total of 27(15.0%) of all cases were classified into the possible asthma category based 
on the criteria highlighted in Table 34.  The criteria in this category were not mutually exclusive.  
Thus, the findings reflect whether each criterion was present for the ED visit.  Shortness of 
breath on exertion or the notation of shortness of breath without exertion was the most common 
symptom reported 20(74.0%), followed by cough and wheezing in absence of an obvious 
respiratory infection 8(29.6%).  The presence of rhinitis or increased nasal secretions, mucosal 
swelling, nasal polyps and or chronic sinusitis was reported in 4(14.8%) possible asthma cases.   
The presence of wheezing was reported in 11(40.7%) of the cases.  No documentation was found 
to support the following criteria: hyper expansion of the thorax and prolonged phase for forced 
exhalation.  Documentation was found in one record to suggest that a patient had hyperinflation 
of the lungs as identified on the chest X-ray.  A total of 5(18.5%) records did not meet any of the 
criteria highlighted under this classification category.  However, a review of supporting 
documents including previous 1-year ED visits and documentation of a past medical history of 
asthma, and or mention of asthma in the current ED note provided enough evidence to 
substantiate a possible asthma diagnosis.    
3.7.4 Not Classified  
A total of 13 cases that had been previously marked as asthma by the ICD 9 coded 
physician diagnose, had no supporting documentation in the EMR to corroborate this diagnosis. 
The total number of documents reviewed to substantiate the asthma diagnosis is highlighted in 
Table 35.  A list of the presenting chief complaints found in the write up of the ED visit 
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summary notes were compiled for comparison.  No records in the not classified group were 
found to have any of the signs and symptoms or asthma characteristics represented in the set of 
Selected Indicators.  A non-productive cough was found in one case.  A total of 13(7.2%) of the 
EMR were marked as not classified.  
 
Table 35: ICD-9 coded physician diagnosis of asthma: Unable to classify 
All ED visits with a primary asthma diagnosis [ICD 9 Code 493.0-
493.9] (n=13)  
 
Chief complaint on admission 
 
Number of 
records reviewed 
to substantiate 
an asthma 
diagnosis  
Diarrhea 1 
Diabetes-swelling back of neck 8 
Five-day shoulder pain 1 
Severe chest tightness 1 
Bilateral temporal headache 1 
Regulate anticoagulants 11 
Right sided pain and weakness, status post stroke, hypokalemia 1 
Right sided abdominal pain- Appendicitis 1 
Muscle ache, joint pain, fibromyalgia 2 
Back pain 6 
Depression 1 
Breast Biopsy 13 
Tightness in chest-congestion 2 
  
 
A comparison of the demographic subgroups by age, sex, and race were reviewed for 
each person represented in the CSTE clinical and laboratory asthma classification study (Table 
36).  This descriptive analysis was done solely to determine if any differences could be observed 
by classification category.  Individuals classified as possible asthma were older in comparison to 
the other 3 classification groups (M =54.74, SD 20.63).  More females were observed than males 
consistently across each classification category.  Racial differences were also noted across 
classification categories with Whites having more visits than Blacks and Others.  The higher 
proportion of Whites in the population represents the increased numbers of Whites in the 
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catchment area.  These data reflect only 6(60%) hospitals out of the UPMC network and 
therefore can make no assumptions about the demographic breakdown as these data clearly 
reflect only a small portion of asthma visit.   
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Table 36: CSTE clinical and laboratory classification status by age, sex and race 
Confirmed (n=14) Probable (n=126) Possible (n=27) Not Classified (n=13) 
Age               n       %         
 
0-17              0         
18-29            4     28.5 
30-44            4     28.5  
45-64            4     28.5 
65+               2     14.2 
 
Mean 43.0(SD 17.03)       
Range 18-77 
 
Total           180    100.0 
Age               n       %         
 
0-17               0        
18-29           32       25.3 
30-44           34       26.9 
45-64           34       26.9 
65+              26       20.6 
 
Mean 45.61(SD 20.35) 
Range 18-103 
 
Total      180        100.0 
Age               n       %          
 
0-17             0         
18-29           3      11.1 
30-44           6      22.2   
45-64           8      29.6 
65+             10     37.0 
 
Mean    54.74(SD 20.63) 
Range   18-95 
 
Total           180      100.0 
Age               n       %          
 
0-17              0 
18-29            2       15.4 
30-44            5       38.4 
45-64            4       30.7  
65+               2       15.3  
 
Mean  45.6(17.65) 
Range  18-86 
 
Total            180    100.0  
Sex               n        %         
 
Male             6        42.8 
Female          8       57.1   
 
 
Total           180    100.0 
Sex               n        %         
 
Male            33      26.2 
Female         93     73.8 
 
 
Total         180    100.0 
Sex               n        %          
 
Male             11      40.7 
Female          16     59.3 
 
 
Total           180    100.0 
Sex               n        %          
 
Male             4      30.8 
Female          9      69.2  
 
 
Total         180    100.0 
Race               n         %        
 
Black              5       35.7 
White             9        64.2 
Other              0             
Unknown       0      
Total           180    100.0       
Race             n         %        
 
Black          48         38.1 
White         77          61.1 
Other            1             .8 
Unknown     0  
Total          180    100.0 
Race             n         %         
 
Black           10        37.0    
White           17        63.0 
Other             0  
Unknown      0      
Total           180    100.0        
Race             n         %         
 
Black            5         38.5 
White            8        61.5 
Other              0 
Unknown       0 
Total          180    100.0 
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 The results from the selected indicators obtained from the gold standard medical chart 
review were compared to those observed in the CSTE clinical and laboratory classification 
categories.  This step was conducted to determine how well the selected indicators were 
represented in individuals classified with asthma as defined by the CSTE clinical and laboratory 
case definition.  Because neither methodology, the selected indicators nor the CSTE clinical and 
laboratory classification definition are considered to be the gold standard for conducting asthma 
research, a descriptive comparison of the results can only be made.  The confirmed and probable 
asthma categories were collapsed into a probable asthma grouping as recommended by the 
Council for State and Territorial Epidemiologist (1998).  The comparison was based on 2 
classification statuses, probable and possible asthma (Table 37). 
Table 37: Comparison of Selected Indicators to CSTE Clinical and Laboratory Case Classification Definition 
Selected Indicators CSTE Clinical and Laboratory Case Classification Definition Manual Chart Review 
Indicators  Probable  
n=140 
Possible   
n=27 
Total asthma 
n=167 
Total 
N=180 
Wheezing  
                      0 absence 
                      1 presence  
2 not mentioned  
Total  
 
11(7.8) 
93(66.4) 
36(25.7) 
140(100.0) 
 
3(11.1)  
11(40.7) 
13(48.1) 
              27(100.0) 
 
14(8.3) 
104(62.2) 
49(29.3) 
167(100.0) 
 
16(8.8) 
104(57.7) 
60(33.3) 
180(100.0) 
Cough  
                      0 absence 
                      1 presence  
2 not mentioned  
Total 
 
24(17.1) 
82(58.5) 
34(18.8) 
140(100.0) 
 
3(11.1) 
19(70.4) 
5(18.5) 
27(100.0) 
 
27(16.1) 
101(60.4) 
39(23.3) 
167(100.0) 
 
27(15.0) 
102(56.7) 
51(28.3) 
180(100.0) 
Shortness of Breath  
 
                      0 absence 
                      1 presence  
2 not mentioned  
Total 
 
 
7(5.0) 
108(77.1) 
25(17.8) 
140(100.0) 
 
 
2(7.4) 
20(74.1) 
5(18.5) 
27(100.0) 
 
 
9(5.3) 
128(76.6) 
30(17.9) 
167(100.0) 
 
 
15(8.3) 
128(71.1) 
37(20.5) 
180(100.0) 
Rhinitis 
                      0 absence 
                      1 presence  
2 not mentioned  
Total 
 
9(6.4) 
16(12.7) 
115(63.8) 
140(100.0) 
 
3(11.1) 
4(14.8) 
20(74.1) 
27(100.0) 
 
12(7.1) 
20(11.9) 
33(19.7) 
         167(100.0) 
 
12(6.7) 
20(11.1) 
148(82.2) 
180(100.0) 
Fever  
                      0 absence 
                      1 presence  
2 not mentioned  
Total 
 
86(61.4) 
10(7.1) 
44 (31.4) 
140(100.0) 
 
14(51.9) 
9(33.3) 
4(14.8) 
27(100.0) 
 
100(59.8) 
19(11.3) 
48(28.7) 
167(100.0) 
 
108(60.0) 
19(10.6) 
53(29.4) 
180(100.0) 
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History of asthma 
                      0 absence 
                      1 presence  
2 not mentioned  
Total  
 
0 
115(82.1) 
25(17.8) 
140(100.0) 
 
2(7.4) 
5(18.5) 
20(74.1) 
27(100.0) 
 
2(1.1) 
120(71.8) 
45(26.9) 
167(100.0) 
 
2(1.1) 
120(66.7) 
58(32.2) 
180(100.0) 
Asthma Medications  
     0 absence 
     1 presence  
     2 not mentioned  
Total 
 
0 
140(100) 
0 
140(100) 
 
11(40.7) 
  0 
16(59.3) 
27(100.0) 
 
11(6.5) 
140(83.3) 
16(9.5) 
167(100.0) 
 
 
  11 (6.1) 
140(77.7) 
   29(16.1) 
    180(100.0) 
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(Table 37 Continued) 
  
 
 
A total of 167(92.7%) cases of asthma were confirmed through a review of the EMR.  One 
hundred and forty of these cases 140(77.7%) were probable asthma, and 27(15.0%) possible.  
The highest frequency of observed values for a probable asthma diagnosis matched the selected 
indicator for presence of shortness of breath in 108(77.1%) cases, followed by wheeze 
93(66.4%) and cough 12(58.5%).  A possible case of asthma matched on the presence of 
shortness of breath in 20(74.0%) of the cases followed by cough, 19(70.4%) and wheeze, 
11(40.7%).  Rhinitis was more frequently observed in the probable vs. possible asthma cases 
16(12.7%) vs. 4(14.8%), respectively.  Fever, a symptom always assessed on presentation to the 
ED was present in 10(7.1%) of the probable asthma cases and not mentioned in 44(31.4%).  For 
the possible asthma category, fever was present in 9(33.0%) of the cases and not mentioned in 
4(14.8%).  The fact that fever was not mentioned in 44% of the probable asthma cases is most 
likely due to an oversight on medical chart review.  The presence of a history of asthma was 
found in 115(82.1%) of the probable asthma cases, and only 5(18.5%) for the possible.  An 
asthma history was not mentioned in 25(17.8%) of the probable asthma cases and 20(74.1%) of 
the possible.  The absence of documentation to support a past medical history for asthma in 
74.1% of  the possible asthma cases made it difficult to validate the diagnosis.  A case of asthma 
could not even be validated through the use of an asthma medication since none of these cases 
were on an asthma medication. The only criteria that could be used to classify a possible case of 
asthma were through the clinical signs or symptoms.  In contrast, the probable asthma cases 
which had no documentation to support a past medical history 25(17.8%) of asthma were all on 
an asthma medications.  The presence of being on an asthma medication was 100% predictive in 
the probable category and 0% in the possible.  
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 Overall, the presence of being on an asthma medication was the most sensitive indicator 
for asthma 140(83.3.0%).  The presence of the shortness of breath was the most prevalent 
clinical indicator observed 128(76.6.1%), followed by wheezing 104(62.2%) and cough 
101(60.4%).  The symptoms of rhinitis and fever were not highly sensitive for an asthma 
diagnosis.  The presence of rhinitis and fever were found in less than 12% of all asthma cases.  A 
past medical history of asthma was found in 120(71.8%) of all asthma cases.  
3.8 VALIDATION STUDY DISCUSSION 
The use of the CSTE Clinical and Laboratory case classification definition against the 
physician diagnosis of asthma on medical chart review provided similar estimates of asthma. 
Thirteen (7.2%) out of the 180 primary asthma cases could not be validated against the physician 
diagnosis.  The CSTE case definition has a high level of sensitivity for identifying asthma that 
accounts for a wide range of asthma cases from mild to severe.  Although each clinical and 
laboratory criteria are important indicators to substantiate an asthma diagnosis the lack of 
specificity in the criteria made it difficult to classify the asthma cases.  Individuals in the 
confirmed asthma category are likely being treated by a physician and on an asthma medication 
to treat the asthma signs and symptoms.  However, this criterion was not used to classify patients 
into the confirmed category, but instead the probable category.  Moreover, the similarities in the 
criteria illustrated in the confirmed and probable classification categories introduce a 
misclassification bias for estimating asthma cases in one year by relying on asthma events from 
the previous year (Dombkowski, Wasilevich & Lyon-Callo, 2005).  The CSTE Asthma 
Surveillance workgroup recommends combining both categories to enumerate asthma cases for 
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surveillance (CSTE, 1998).  This step was done to make comparison with the selected indicators 
found on medical chart review and to determine the presence of the indicators within each 
asthma classification category.  The criteria used to classify individuals within the possible 
asthma category were not mutually exclusive.  Thus, individuals could have met one of several 
criteria.  The symptoms described in this category such as shortness of breath is not specific, and 
fit within the range of signs and symptoms that characterize other disorders.  Therefore, a review 
of all sections of the electronic medical record was needed to eliminate any misclassification of 
diagnoses.  Individuals diagnosed with asthma may have persistent or intermittent exacerbation 
of disease.  Even when individuals are symptom free, airway passages are still compromised 
(Marks, 2005).  Therefore, depending on when along the course of illness a patient is clinically 
evaluated or enrolled as a study participant can impact whether a patient is considered for a 
diagnosis of asthma.  Thus, a cross sectional study may not fully capture a cohort entirely 
representative of the asthma population.  This is unlikely the case for the 13 individuals in this 
study whose asthma diagnosis could not be substantiated on medical chart review even though 
all records from the 1-year time period prior to the initial ED visit were assessed.  The likely 
explanation in this instance was related to upcoding for financial reimbursement and not related 
to medical record search time error. 
In conclusion, Vollmer and associates (2004) report that a combination of searching 
multiple databases and length of time searching increases the likelihood of positively identifying 
a case of asthma.  A benefit to this study was the ability to have access to the medical record in 
an electronic format and multiple records for the 1-year study period prior to the initial ED visit.  
The automated feature provided a quick and easy solution to record selection, reduced the search 
and review time in half, and proved to be an efficient methodology for conducting this type of 
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research.  The CSTE clinical and laboratory case classification definition lacks specificity and is 
very time consuming to validate using a medical chart review and  through the use of the EMR.  
However, due to the overlap bias of symptoms for asthma, and lack of specificity in the CSTE 
criteria the selected indicator findings from the medical chart review were helpful to classify the 
asthma cases.  After removing the 13 not classified asthma cases from the cohort, the presence of 
the selected indicators in the asthma classifications categories were not significantly different 
than what was reported on manual chart review.  The use of selected indicators could be 
considered another adjunct tool to assist with classifying asthma cases if rhinitis and fever were 
removed.  
 A more comprehensive approach is needed to conduct asthma research using multiple 
methodologies or developing a gold standard that is statistically valid for this diagnosis.  Neither 
the selected indicators nor the CSTE clinical and laboratory case classification definition are 
approved gold standard methodologies for diagnosing asthma.  
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4.0  CHAPTER 4- CASE CROSSOVER STUDY 
4.1 POPULATION D 
A total of 6,979 individuals were used in this case crossover analysis.  This represented 
10,183 asthma ED visits for individuals presenting to the ED for any primary case of asthma 
from 2002-2005.  A total of  77.0%(5,431) of the any primary asthma population had one visit, 
and 22.2%(1,548) had multiple visits.  A breakdown of the demographics for this population is 
highlighted in Table 38.  
The age range for these individuals was from 0-103, (M=39.25, SD=20.82).  Individuals    
65 ± years were represented by the smallest proportion of individuals in this cohort 13.5%(948), 
followed by individuals 0-17  years of age who made up 14.3%(1004) of  the population.  These 
two groups have been reported to be the most compromised groups of individuals from air 
pollution exposure (ALA, 2008). 
Gender differences were observed with females having a higher frequency of ED visits 
than males (65.9% vs. 34.1%), respectively.  The higher female- to- male ratio observed in this 
cohort may due to the biological differences in gender or reflect a higher proportion of  females 
in the catchment area represented by the 6 respective hospitals used in this analysis.   
For the any primary asthma ED visit population racial differences were observed with 
Whites (60.1%) having the highest number of ED visits than Blacks (37.9%) and Others (2.0%). 
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The higher proportion of Whites is of no surprise considering this sample reflects only 6 
hospitals from the UPMC network, which also reflects a higher proportion of Whites in the 
catchment area.  The proportion of Blacks is high when compared to AC as a whole, which is 
made up by only 10% of the Black population and 30% in the COP.  
 
Table 38: Individuals with any primary asthma emergency room visit (6 UPMC hospitals) 
by age, sex, and race 
Any Primary asthma diagnosis for 
all individuals 
(n= 6,979) 
Age            n          %         CI 
 
0-17         1,004      14.3     13.57-15.21 
18-29       1,523      21.8     20.85-22.79 
30-44       1,815      26.0     24.98-27.04 
45-64       1,687      24.1     23.17-25.17 
65+             948    13.5      12.7-14.38 
 
Range 0-103 
Mean 39.25(SD 20.82) 
 
Total         6,979    100.0 
Sex               n         %        CI 
 
Male            2,380       34.1    32.99-35.21 
Female        4,599      65.9   58.99-61.29 
 
Total            6,979        100.0 
Race            n        %          CI 
 
Black          2,645      37.9     36.76-39.04 
White         4,197      60.1      58.99-61.29 
Other             137       2.0       1.63-2.29 
 
 
Total            6,979        100.0 
      
 
 
The annual daily average of any primary asthma visit from 2002-2005 were from 6.06-
7.83 per day.  These data are not de-duplicated since they represent recurrent visits.  The highest 
numbers of visits were observed for Shadyside 2,192(21.5%) and McKeesport Hospital’s 
2,003(19.6%).  Southside had the least amount of visits 1,122(9.9%).  The low number of visits 
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observed at Southside Hospital 1,055(10.3%) could be due to an individual preference for 
hospital selection or a lower referral pattern in physicians treating asthma at this hospital (Table 
39).  
 
Table 39: Any primary asthma ED visit by hospital 
Hospital 2002 2003 2004 2005  Total 
% 
Braddock 413 534 454 494 1,895(18.6) 
McKeesport  485 556 453 509 2,003(19.6) 
Presbytarian 377 380 313 366 1,436(14.1) 
Shadyside 466 583 546 597 2,192(21.5) 
St Margaret’s 374 433 387 397 1,591(15.6) 
Shadyside  95 372 317 271 1,055(10.3) 
Unknown  1 2 1 2 6(1.0) 
Total * % 2,212 (21.7) 2,861(28.0) 2,471(24.2) 2,639(25.9) 10,138(100.0)
*6 UPMC hospitals  
 
The seasonal distribution for all visits was observed to be higher in September and 
October with a second peak beginning December through March.  These findings are consistent 
with the literature, which suggests that the highest number of asthma visits coincided with the 
fall, and winter season where asthma morbidity has been shown to be high due to rag weed 
allergies and rhinovirus infections (Johnston & Sears, 2006; Dales, et al., 1996, Wansoo & 
Schneider, 2005).  The data was analyzed to determine whether there were any statistically 
significant differences between the number of visits in the fall and winter months vs. spring and 
summer.  A higher number of visits were found in the months with cooler temperatures.  This 
difference was found to be statistically significant, X2(1, N =10,183) = 37.5, p = < 0.05.  The 
sharp rise in 2003 for the month of December could be a result of the influenza season and its 
affect on asthma ED visits (Figure 20).  
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The geographical distribution of the population with asthma is highlighted in Figure 21.  
The highest numbers of individuals with asthma were concentrated in and around the COP.  This 
is of no surprise since the 6 hospitals in this sample were all close to the inner city.  
Figure 20: Any primary asthma ED visit by month and year 
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Figure 21: Any primary asthma visit for 6 UPMC hospitals by zip code in Allegheny County 2002-2005 
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A case crossover analysis was conducted using ozone and PM2.5.   The summary statistics 
for the distribution of daily concentrations of the air pollutants and temperature for all months 
are reported in Table 40.  A distinction was made by first reporting on each pollutant and 
temperature for all months, and the second set of summary statistics representing the summer 
months only (Table 41).  The effects of ozone has been reported to be greatest in months with 
warmer temperatures (Villenueve, et al., 2007; Barnett et al., 2005; Ito et al., 2005; Bell, et al., 
2007; Burnett et al., 2001; Bell et al., 2005; Paulu & Smith, 2008).   
 
Table 40: Distribution of daily concentration of ozone, PM2.5, and temperature for all 
months (2002-2005) 
Pollutant Measure 
 
Mean Minimum 10th 25th 50th 75th 90th Maximum
Ozone(ppb)  
 
24 hour 
maximum 
40.6 .00 16.0 25.0 37.0 55.0 68.0 130.0 
PM2.5 24 hour 
average 
13.1 2.0 4.6 7.1 11.4 16.8 24.4 55.1 
Temperature  24 hour 
average   
51.6 6.5 26.2 36.9 54.7 67.8 69.9 83.1 
 
The National Ambient Air Quality Standards (NAAQS) for ozone are based on the 1-
hour and 8-hour standards.  The 24-hour maximum ozone concentration level (ppb) was 
calculated for use in this study and agreed upon by the review committee for this analysis.  The 
boxplots and histograms for all pollutants and temperature are reported in Appendix C. 
The average 24-hour maximum ozone concentration level was 40.6-ppb with a range of 
.00-ppb to 130-ppb (Table 40).  The spread of distribution of the 10th to the 90th percentile was 
16.0-ppb to 68-ppb.  Fifty percent of the 24-hour maximum ozone exposure levels were below 
the mean at 37-ppb.   
 The national standard for the 24-hour average PM2.5 level is set at 65.0ug/m3.  The mean 
PM2.5 concentration level in this dataset was 13.1ug/m3, with a range of  2.0ug/m3 to 55.1ug/m3.   
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These levels are well below the standard.   The average temperature for all months was 51.6°  
with a range of  6.5° to 83.1°.   
 
 
Table 41: Table 41: Distribution of daily concentration of ozone, PM2.5, and temperature 
for summer months (2002-2005) 
Pollutant Measure 
 
Mean Minimum 10th 25th 50th 75th 90th Maximum
Ozone(ppb)  
 
24 hour 
maximum 
55.5 16.0 34.0 43.0 55.0 66.0 78.0 130.0 
PM2.5 24 hour 
average 
16.1 2.0 6.1 9.2 14.4 21.2 31.2 55.1 
Temperature  24 hour 
average   
65.4 32.2* 50.0 60.0 67.7 72.6 76.2 83.17 
Summer months (April*- September) 
 
The concentration levels for the summer months are reported in Table 41.  Contrasting to 
all months, the 24-hour maximum ozone concentration in the summer months was higher at 
55.5-ppb with a range of 16-ppb to 130-ppb.  The spread of distribution from the 10th to the 90th 
percentile was 34-ppb to 78-ppb.  Fifty percent of the exposure levels were equal to the mean at 
55-ppb.   
The 24-hour average PM2.5 level for the summer months was 16.1ug/m3,  with a range of  
2.0ug/m3 to 55.1 ug/m3.  The distribution range for PM2.5 concentration levels in the summer 
months were still below the national standard.   Temperature levels were higher in the summer 
months with an average of 65.4°, range 32.2° to 83.1°.  The lowest reported temperature of  
32.2° was observed in April.  The summary statistics for the summer months are also reported in 
Appendix C.  
Data are reported for Pearson’s correlation coefficients for air pollutants, temperature and 
humidity (Table 42).  Both ozone and PM2.5  were strongly correlated with temperature (r = .72), 
(r = .529), (p < .01), respectively.    However, the correlation was greatest for ozone.  A positive 
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correlation was also observed for PM and ozone (r = .573), (p < .01).  Humidity was positively 
correlated with PM2.5 (r = .08), (p < .01).  This same relationship was not observed for ozone and 
humidity.   
 
Table 42: Correlation coefficients for ozone and PM2.5 and weather variables 
 PM2.5 Temperature Humidity Ozone 
PM2.5 1 .529** .084** .573** 
Temperature .529** 1 .034** .722** 
Humidity .084** .034 1 -.042 
Ozone .573** .722** -.042 1 
Correlation is significant at the p = < 0.01,(2-tailed)  
 
A comparison of the different lag distributions were used in order to explore the 
relationship between different exposure levels and asthma events.  The first step included the use 
of a single lag model for ozone and PM.   No effect was observed for ozone alone 1.01(95% CI 
.999-1.03), or PM alone 1.03(95% CI .00-1.06) (Table 43).  Unadjusted single lag model 
estimates for the 24-hour maximum ozone for 2-day lag and 5-day average lag were found to be 
significant (p =  <.05); 2-day (1.03(95% CI 1.01-1.05)), and 5-day average (1.04(95% CI 1.01-
1.07)), respectively.  After adjusting for temperature, the effect estimate was only significant for 
the 2-day lag (1.02(95% CI 1.01-1.04), (p = < .05).  This estimate represents a 2% increase in 
asthma admissions for every 10-ppb increase in 24-hour maximum ozone concentration level.  
No effect was observed for PM2.5 after adjusting for temperature, 1.00(95% CI  .997-1.04).   
The combined effect for ozone and  PM2.5  were tested in a multiple lag model.  The risk 
estimate was 1.01(95% CI .999-1.03).  Adding temperature to the model did not result in any 
significant risk, OR= 1.00.  
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Table 43: Single and multiple lag models for 24-hour maximum ozone, PM2.5 and 
temperature: All seasons 
Maximum Likelihood Estimates (Singe and Multiple lag Models) 
for 24 our Maximum Ozone, temperature and PM 2.5 
All Months 
Single Models Multiple Models 
 Odds Ratio (95%)  Odds Ratio (95%) 
1. Ozone Alone    
 (day 0) 
1.01 (.999 – 1.03) 1. Ozone & PM2.5       1.01 (.999 – 1.03) 
2. PM 2.5 Alone    
     (day 0) 
1.03 (1.00 – 1.06) 2. Ozone & 
Temperature   
1.00 (.998 – 1.02) 
3.  Temperature 1.05 (1.03 – 1.08) 3. PM 2.5 & 
Temperature 
1.00 (.997 – 1.04) 
  4. Ozone, 
Temperature  & 
PM2.5 
1.00 (.997 – 1.04) 
Unadjusted (ozone only)  Adjusted for Temperature 
Lags as separate 
model 
  (Ozone only) 
 Lags adjusted for 
temperature 
 
1. Day One 1.02 (1.00 – 1.04) Day One 1.02 (1.00 – 1.04) 
2. Day Two 1.03 (1.01 – 1.05)* Day Two 1.02 (1.01 – 1.04)* 
3. Day Three 1.01 (.999 – 1.03) Day Three 1.01 (.999 – 1.03) 
4. Day Four 1.00 (.998 – 1.02) Day Four 1.00 (.998 – 1.02) 
5. Day Five 1.00 (.998 – 1.02) Day Five 1.00 (.998 – 1.01) 
5-Day Average 1.04 (1.01 – 1.07)* 5-Day Average 1.02 (.999 – 1.05) 
* indicates significance p = <0.05 
 
The second step was to evaluate ozone levels during the summer months to determine if 
any association could be observed for asthma ED visits during months with warmer 
temperatures.  Regardless of whether ozone was used in a single model, or in combination with 
PM2.5, no effect was observed, ozone alone 1.01 (95% CI .999 – 1.03) and ozone with PM2.5 
.999(95% CI .997-1.02), respectively (Table 44).  PM2.5 alone during the summer months was 
not significant 1.04(95% CI 1.00 – 1.08).  Furthermore, single lag estimates for day-1 through 5- 
and the 5-day average lag for 24-hour maximum ozone concentration level was not significant 
during this time period.  All confidence limits included one.  The no ozone effect observed in 
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this analysis for all single and multiple models was believed to be a sample size issue since the 
dataset was reduced by half when conducting this portion of the analysis.   
 
Table 44: Single and multiple lag models for 24-hour maximum ozone, PM 2.5: Summer 
months (April-September) 
 
      Models Odds Ratio (95%) 
1. Ozone Alone    
 (day 0) 
1.01 (.999 – 1.03) 
2. PM2.5  Alone    
     (day 0) 
1.04 (1.00 – 1.08) 
3. Ozone & PM     .999(.997-1.02) 
Lags as separate 
model 
  (Ozone only) 
Odds Ratio(95%) 
1. Day One 1.01(.999-1.04) 
2. Day Two 1.01(.999-1.03) 
3. Day Three 1.00(.998-1.02) 
4. Day Four .999(.997-1.01) 
5. Day Five .998(.996-1.01) 
5- Day Average 1.00(.997-1.04) 
 
The results for the all months model was based on the full sample which represented 
individuals of all ages, including younger children and adolescents 0-17 years of age.  Since the  
literature reports a differential in asthma prevalence by age, children (0-17 years of age) were 
removed from the dataset.  This allowed us to determine whether the statistically significant 
results from the day-2 lag estimate observed in the all month’s ozone model adjusted for 
temperature for all ages was influenced by the younger cohort.   1,007 individuals 0-17 years of 
age were removed from the dataset.  The analysis was conducted using single lag models for 
ozone and a multiple lag model for ozone and PM2.5 after adjusting for temperature. 
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Table 45: Single and multiple lag models for 24-hour maximum ozone, PM2.5 and 
temperature for adults only: All months 
 
 
Models 
 
Odds Ratio (95%) 
Odds Ratio (95%) 
Adjusted for temperature 
 
1. Ozone Alone    
 (day 0) 
1.00(.998-1.02) .999(.997-1.01) 
2. PM2.5  Alone    
     (day 0) 
1.02(.998-1.05) .999(.996-1.03) 
3. Ozone & PM  1.00(.996-1.04)     .999(.997-1.02) 
Lags as separate 
model 
  (Ozone only) 
Odds Ratio(95%) Odds Ratio(95%) 
Adjusted for temperature  
 
1. Day One 1.02(1.00-1.04) 1.00(.999-1.03) 
2. Day Two 1.03(1.01-1.05) 1.02(1.00-1.04)* 
3. Day Three 1.01(.999-1.03) 1.01(.999-1.03) 
4. Day Four 1.00(.998-1.02) 1.00(.998-1.02) 
5. Day Five 1.00(.999-1.02) 1.00(.998-1.02) 
5- Day Average 1.03(1.00-1.07) 1.00(.998-1.05) 
*Borderline significant  
 
The single model lag estimate for ozone and PM2.5 alone, or adjusted for temperature 
showed no risk (Table 45).  The combined model of ozone and PM2.5 adjusted for temperature 
was unchanged with no effect observed.  The single lag model for days 0 through 5 and 5-day 
average showed no effect with the exception of the point estimate for the 2-day lag for ozone 
adjusted for temperature 1.02(95% CI 1.00-1.04).  Although, the estimate is borderline 
significant this result suggests the need to conduct further analysis with the adult population 
using a larger sample size.  The literature reports the influence of ambient pollutants on 
childhood asthma hospitalizations (Villeneuve, et al., 2007; Barnett, et al., 2005; Pope et al., 
1991; Paulu & Smith, 2008).  However, little research has been conducted which looked at the 
effects of ozone on asthma emergency room visits in adults.  One study which adjusted for 
different age groups throughout found no effect from ozone in older adults in age groups 65-74 
and 75+ (Villeneuve, et al., 2007).  A significant effect was also observed for individuals 5-14 
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and 15-44 years of age for the 3-day average and 5-day average lag in the all month’s and 
summer month’s ozone model  (p = < 0.05).  In the same study, the 1-day lag was significant in 
both models for the 15-44 year old age group and the 5-day average lag in the all month’s model 
for individuals 45-64 years of age.  
 Paulu & Smith (2008) also report an increase risk for the 4-day average lag estimate for 
ozone, which was associated with an 11% increase in asthma, related ED visits.  The increase 
was more apparent among females than males, 12%(95% CI 6-18)  vs. 11% (95% CI 4-18), 
respectively.   An influence of age was observed with younger males 2-14 years of age having a 
17% increase (95% CI 3-32) and  females 15-34 years of age having a 20% increase (95% CI 10-
31).  
The influence of age has been reported as a significant factor that affects exposure levels.  
The body burden from exposure on children is greater due to a smaller body size and weight 
(Mathieu-Nolf’s study cited in Villeneuve et al 2007, p. 10).  Furthermore, the cells of children 
are not fully developed thus, placing them at increased risk for increased airway vulnerability 
(ALA, 2000).  Contrasting to adults, particularly the elderly who are more susceptible due to 
comorbidity factors (Sandstrom et al. 2003 study cited Villeneuve et al 2007, p. 10).  Thus, a 
misclassification of exposure in this case crossover study could have resulted from the 
differences in age.   
4.2 DISCUSSION 
The findings in this research study implicate ozone as a factor in asthma morbidity as 
evident by the 2% increase observed in asthma ED visits for a 10-ppb increase in the 24-hour 
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maximum ozone concentration at 2-day lag.  This result was based on all individuals being 
included in the model.  The all adults model, which removed children 0-17 years of age, was 
found to have a borderline risk estimate for the 2-day lag 1.02(1.00-1.04).  A larger sample 
estimate may provide a different estimate of  risk for adults.  
 Other studies have reported significant findings with different effect estimates using 
different ozone standards.  Sample size estimates have been larger and smaller than what was 
used in this study.  No study was identified in the literature, which neither used the 24-hour 
maximum ozone concentration level nor identified an effect estimate at 2-day lag for asthma 
morbidity.  The only documentation found in the literature which reported a significant effect 
estimate for day-2 lag was observed with ozone and total mortality, cardiovascular and 
respiratory mortality and non-accidental mortality (Bell et al., 2004; Bell et al., 2005; Bell et al., 
2007; Ito et al., 2005).  
 Paulu and Smith (2008) report an overall 11% increase in asthma emergency room visits 
associated with a 4-day average lag [0-3-days] for a 10-ppb increases in the 8-hour average 
ozone level.  The differences reported for age were greater in the 15-34 year olds vs. the 2-14 
year olds, 16(95% CI 8-24) vs. 11%(95% CI 1-23), respectively.  However, the concentration of 
cases was greatest in males 2-14 years 17%(95% CI 3-32) and females 15-34 years of age 
20%(95% CI 10-31).   
A 34% increase in respiratory admissions was reported by Burnett et al (2001) in 
individuals less than 2 years of age for the 5-day average lag for the 1-hour maximum ozone 
concentration of 45-ppb, May through August.  In this same study, an 18% increase in 
respiratory admissions was observed January through December for the 5-day average, but the 
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effect was not as great as that observed May through August.  No effect was observed September 
through April.  
 Villeneuve (2007) reports that ozone exposure is the pollutant most frequently associated 
with asthma hospitalizations.  An increase in asthma hospitalizations were observed for day-1 lag 
and 3 and 5-day averages for all months, and a greater effect observed in the summer months for 
the respective point estimates 1.04(95% CI  1.02-1.06); 1.07(95% CI 1.04-1.10); 1.08(95% CI 
1.05-1.11), respectively, and 1.06(95% CI 1.04-1.09); 1.11(95% CI 1.07-1.16); 1.11(95% CI 
1.06-1.15), respectively.  The increases were statistically significant and observed for the 5-14 
and 15-44 year old population for the 3 and 5-day lag average estimates.  The effect was greatest 
in the summer months.  An effect was also observed for the 45-64 year olds in all months for the 
5-day lag average.  No effect was observed with ozone for the oldest age groups 65-74, and 75+.   
In summary, results from this research study were sufficient to demonstrate a significant 
2-day lag effect, which corresponds to a 2% increase in all asthma ED visits related to a 10-ppb 
increase of the 24-hour maximum ozone concentration.  The effect  was not observed during the 
summer months when ozone has been reported to have its greatest effect on mortality and 
morbidity.   However, due to a small sample size no risk was observed for ozone and asthma 
morbidity during that period.  The 2% increase observed in asthma ED visits represents an 
addition of 203 asthma emergency room visits.  These visits result in an increase use of  
emergency room services, which place a financial burden on the health care system.  The total 
direct costs for asthma, which includes emergency room visits, asthma hospitalizations, 
physician services and medication use, are estimated at 14.7 billion dollars.  Thus, a 2% increase 
observed for asthma ED visits noted from the 10ppb increase in the 24-hour maximum ozone 
concentration is significant when the financial burden is considered.  If a larger sample estimate 
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were used the number of asthma ED visits would be significantly greater representing an even 
larger financial burden.  
In conclusion, the findings from this research study are significant for several reasons. 
First, the use of emergency room visits is an extremely valuable methodology for conducting 
asthma surveillance.  The larger number of visits per year in comparison to asthma 
hospitalizations represents a more definitive at risk population.  Second, the short-term 
evaluation of asthma requires information on physician diagnosis and the hallmark signs and 
symptoms, which are the more detailed data that characterize this disorder.  These data cannot be 
found in one location thus, by using the electronic medical record, data is available in one central 
location, which can be used to evaluate this diagnosis.  The automated feature of the EMR 
improves the ability to apply knowledge-based models for scientific interpretation and validation 
of these data.  The evaluation of these data can be done off site with an electronic transfer of the 
data.  Furthermore, the facilitation of these data through an electronic system would support 
national tracking efforts for testing environmental hypotheses related to this chronic condition 
(L. Brink, personal communication, April 15, 2008).  The linkage of the environmental data to 
the asthma ED visit in this research study generated significant findings regarding ozone 
exposure and asthma health risk.  These findings are of great public health significance.  The 
largest burden from asthma rests on the public at large.  The 2008, ‘State of the Air Report” 
published by the American Lung Association (ALA) indicates that nearly half of the US 
population (46.0%) live in areas where either ozone or particulate levels are at unhealthy levels.  
Even at levels meeting the standard, Bell reports “that there is still a significant link between 
ozone and premature mortality” (Bell, Peng, & Dominici, 2006).  In Allegheny County alone, the 
change in the national 8-hour ozone standard from 0.084-ppm to 0.075-ppm in May 2008 has 
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resulted in the identification of 9 days that attainment was exceeded.  Had the standard not have 
been lowered, only 3 days would have been regarded as exceeding the standard (Allegheny 
County Health Department, Air Quality Program, May 2008) (Appendix E).  In Allegheny 
County, a health alert is used to alert the public about exceedance days for ozone and 
particulates.  This action not only serves as an educational intervention to alert the vulnerable 
populations with acute asthma, but also to inform public health policy for more stringent laws on 
ozone.  
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 ################################################# 
#  
#   
# Processing Medical Records  # 
################################################# 
 
open (INDAT, "<search.txt") || die "Error -  unable to open input file $!";  
 
while (<INDAT>){ 
 chomp($_); 
 $_ =~ /;/; 
 $title = $`; 
 $' =~ /;/; 
 $positive = $`; 
 $negitive = $'; 
 
 while ($positive =~ /,/){ 
  $positives{$`} = $`; 
  $positive = $'; 
  $pos = $'; 
 } 
 $positives{$pos} = $pos; 
 
 while ($negitive =~ /,/){ 
  $negitives{$`} =$`; 
  $negitive = $'; 
  $neg = $'; 
 } 
 $negitives{$neg} =$neg; 
 
 $search{title} = $title; 
 $search{positives} = {%positives}; 
 $search{negitives} = {%negitives}; 
 
 $searches{$title} = {%search}; 
  
 %positives = (); 
 %negitives = (); 
 %search = (); 
} 
 
close (INDAT); 
 
open (INDAT, "<input.txt") || die "Error -  unable to open input file $!";  
 
while (<INDAT>){ 
 chomp($_); 
 $record = $record.$_;   #Accumulate the text of the record 
into a single string without line feeds 
 if (/^Report ID/){ 
  $reportID = substr($_, 31); 
 }elsif (/^Visit IDentifier/){ 
  $visitID = substr($_, 24, 39); 
 }elsif (/^Principal Date/){ 
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  $time = substr($_, 30, 8).substr($_, 39, 4); 
 }elsif (/^Record Type/){ 
  $_ =~ /[A-Z]+$/; 
  $recordtype = $&; 
 }elsif (/^E_O_R/){   #Create data structure for record 
  $record{reportID} = $reportID; 
  $record{visitID} = $visitID; 
  $record{time} = $time; 
  $record{recordtype} = $recordtype; 
  $record{record} = $record; 
 
  $records{$reportID} = {%record}; 
 
  $record = ""; 
 } 
} 
 
close (INDAT); 
 
open (OUTDAT, ">regex.csv") || die "Error - unable to open output file $!"; 
print OUTDAT ",reportID,visitID,time,Record Type"; 
 
foreach (sort keys%searches) { 
 $s = $searches{$_}; 
 %search = %$s; 
 print OUTDAT ",$search{title},pos,neg"; 
  
} 
print OUTDAT "\n"; 
 
foreach (sort keys%records) { 
 $s = $records{$_}; 
 %record = %$s; 
 
 print 
OUTDAT"$record{reportID},$record{visitID},$record{time},$record{recordtype}"; 
print "$_\n"; 
 foreach (sort keys%searches) { 
  $s = $searches{$_}; 
  %search = %$s; 
   
  $s = $search{positives}; 
  %positives = %$s; 
    
  foreach (sort keys%positives){ 
   $pregex = $pregex . "$positives{$_}|"; 
  } 
  chop($pregex); 
  $pregex = "(" . $pregex . ")"; 
   
  $s = $search{negitives}; 
  %negitives = %$s; 
    
  foreach (sort keys%negitives){ 
   $nregex = $nregex . "$negitives{$_}|"; 
  } 
  chop($nregex); 
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  $nregex = " (" . $nregex . ") [^\\.]+" . $pregex; 
  
print "$pregex\n$nregex\n\n";  
  
  $answer = 2; 
  if ($record{record} =~ /$pregex/i){ 
   $answer = 1; 
$phit = $&; 
  } 
  if ($record{record} =~ /$nregex/i){ 
   $answer = 0; 
$nhit = $&; 
  } 
  print OUTDAT ",$answer,\"$phit\",\"$nhit\"";  
 
$phit = ""; 
$nhit = ""; 
  $pregex = ""; 
  $nregex = ""; 
 } 
 print OUTDAT "\n"; 
} 
 
close(OUTDAT); 
#EOF 
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Background information on ozone and PM 2.5 for Allegheny County (AC) 
 
Air Pollutant data for Allegheny County: National Ambient Air Quality Standard (NAAQS)- Highest Concentration and 
Number of Exceedances 2006 
Ozone  NAAQS 
Standard 
Highest 
Recorded 
Concentration 
Number of 
NAAQS 
Exceedances  
Monitoring 
Station  
1-hour average 0.12ppm 0.118ppm 0 3 
8-hour average 0.08ppm 0.093ppm 7 3 
PM 2.5     
24-hour 
average 
65.0 ug/m3 100.7 ug/m3 3 12 
Annual 
arithmetic mean 
15.0 ug/m3 19.0 ug/m3 2 12 
 
Number of Exceedances for 2003-2006  
  
 
 
 
 
 
 
 
On May 27, 2008, the 8-hour standard was changed by EPA from 0.084 ppm to 0.075 ppm.  Since that time, AC had 9 days that 
attainment was exceeded.  Of those 9, only 3 would have exceeded the new standard.   
 
Ozone Exceedance Days with level of exceedance above 8-hour standard (ppb) 
 6/11/08 7/12/208 7/15/08 7/16/08 7/17/08 7/18/08 7/19/08 7/29/08 8/1/08 
Harrison   76 76 91 83 82 88 86 81 
Lawrenceville 76       76   79 84   
South Fayette                   
  
Ozone  2003 2004 2005 2006 
1-hour Average 2 0 0 0 
8-hour Average 11 1 11 7 
PM-2.5     
24-hour average 9 7 10 3 
Annual arithmetic mean 6 4 7 2 
APPENDIX F 
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Comparison of random sample and EMR to primary asthma dataset by demographics  
 Age Gender 
(M/F) 
Race 
(B/W/O) 
 
Primary (n=5,100) M= 43.94 
(SD 18.40) 
31% 
69% 
35% 
63% 
20% 
Random Sample 
(n=488) 
M = 43.87 
(SD 19.08) 
31% 
69% 
40% 
59% 
1.0% 
EMR (n=180) M= 46.71 
(SD 20.28) 
30% 
70% 
43% 
56% 
1.0% 
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